NO822255L - PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE SULFIMIN DERIVATIVES. - Google Patents
PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE SULFIMIN DERIVATIVES.Info
- Publication number
- NO822255L NO822255L NO822255A NO822255A NO822255L NO 822255 L NO822255 L NO 822255L NO 822255 A NO822255 A NO 822255A NO 822255 A NO822255 A NO 822255A NO 822255 L NO822255 L NO 822255L
- Authority
- NO
- Norway
- Prior art keywords
- butoxy
- group
- general formula
- theoretical
- yield
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims description 15
- 238000000034 method Methods 0.000 title claims description 11
- 230000001225 therapeutic effect Effects 0.000 title 1
- -1 methylene, vinylene Chemical group 0.000 claims description 146
- 150000001875 compounds Chemical class 0.000 claims description 54
- 125000004432 carbon atom Chemical group C* 0.000 claims description 32
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 18
- 239000002253 acid Substances 0.000 claims description 17
- 125000000217 alkyl group Chemical group 0.000 claims description 16
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 15
- 150000003839 salts Chemical class 0.000 claims description 11
- 229910052801 chlorine Inorganic materials 0.000 claims description 10
- 239000000460 chlorine Substances 0.000 claims description 8
- 150000007513 acids Chemical class 0.000 claims description 7
- 125000002252 acyl group Chemical group 0.000 claims description 7
- 125000005843 halogen group Chemical group 0.000 claims description 7
- 125000003545 alkoxy group Chemical group 0.000 claims description 6
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 claims description 6
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 5
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 5
- 150000003568 thioethers Chemical class 0.000 claims description 5
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 claims description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 4
- 125000001246 bromo group Chemical group Br* 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 125000001624 naphthyl group Chemical group 0.000 claims description 4
- 125000004076 pyridyl group Chemical group 0.000 claims description 4
- 239000011541 reaction mixture Substances 0.000 claims description 4
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims description 4
- 150000003462 sulfoxides Chemical class 0.000 claims description 4
- VXNZUUAINFGPBY-UHFFFAOYSA-N 1-Butene Chemical group CCC=C VXNZUUAINFGPBY-UHFFFAOYSA-N 0.000 claims description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 3
- 150000001447 alkali salts Chemical class 0.000 claims description 3
- 125000002947 alkylene group Chemical group 0.000 claims description 3
- 150000001408 amides Chemical class 0.000 claims description 3
- 125000003118 aryl group Chemical group 0.000 claims description 3
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 3
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 3
- 125000005678 ethenylene group Chemical group [H]C([*:1])=C([H])[*:2] 0.000 claims description 3
- 229910052731 fluorine Inorganic materials 0.000 claims description 3
- 239000011737 fluorine Substances 0.000 claims description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- 150000007530 organic bases Chemical group 0.000 claims description 3
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 125000001424 substituent group Chemical group 0.000 claims description 3
- BDHFUVZGWQCTTF-UHFFFAOYSA-N sulfonic acid Chemical compound OS(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-N 0.000 claims description 3
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 2
- 239000007795 chemical reaction product Substances 0.000 claims description 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 2
- 125000005059 halophenyl group Chemical group 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- JUINSXZKUKVTMD-UHFFFAOYSA-N hydrogen azide Chemical compound N=[N+]=[N-] JUINSXZKUKVTMD-UHFFFAOYSA-N 0.000 claims description 2
- 150000002440 hydroxy compounds Chemical class 0.000 claims description 2
- 230000000269 nucleophilic effect Effects 0.000 claims description 2
- 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 claims 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims 1
- 239000005977 Ethylene Substances 0.000 claims 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims 1
- 125000000547 substituted alkyl group Chemical group 0.000 claims 1
- 238000002844 melting Methods 0.000 description 119
- 230000008018 melting Effects 0.000 description 119
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 57
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 45
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 42
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 39
- CHKQALUEEULCPZ-UHFFFAOYSA-N amino 2,4,6-trimethylbenzenesulfonate Chemical compound CC1=CC(C)=C(S(=O)(=O)ON)C(C)=C1 CHKQALUEEULCPZ-UHFFFAOYSA-N 0.000 description 39
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 36
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 24
- 239000000741 silica gel Substances 0.000 description 24
- 229910002027 silica gel Inorganic materials 0.000 description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 23
- 238000006243 chemical reaction Methods 0.000 description 19
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- 210000001772 blood platelet Anatomy 0.000 description 18
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 16
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 15
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 14
- 239000002904 solvent Substances 0.000 description 14
- 239000011347 resin Substances 0.000 description 13
- 229920005989 resin Polymers 0.000 description 13
- 238000003756 stirring Methods 0.000 description 13
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 10
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 10
- 230000000740 bleeding effect Effects 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 9
- KAQKFAOMNZTLHT-VVUHWYTRSA-N epoprostenol Chemical compound O1C(=CCCCC(O)=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]21 KAQKFAOMNZTLHT-VVUHWYTRSA-N 0.000 description 9
- 229960001123 epoprostenol Drugs 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 description 8
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 description 8
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 8
- 239000013078 crystal Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- SJUGPXBWZCQTKM-UHFFFAOYSA-N n-chloro-4-methylbenzenesulfonamide;sodium Chemical compound [Na].CC1=CC=C(S(=O)(=O)NCl)C=C1 SJUGPXBWZCQTKM-UHFFFAOYSA-N 0.000 description 8
- 229920000137 polyphosphoric acid Polymers 0.000 description 8
- 239000007858 starting material Substances 0.000 description 8
- 239000011877 solvent mixture Substances 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- LXRZVMYMQHNYJB-UNXOBOICSA-N [(1R,2S,4R)-4-[[5-[4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate Chemical compound CC1=C(C=C(S1)C(=O)C1=C(N[C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)C2)N=CN=C1)[C@@H]1NCCC2=C1C=C(Cl)C=C2 LXRZVMYMQHNYJB-UNXOBOICSA-N 0.000 description 6
- 239000002585 base Substances 0.000 description 6
- DVECBJCOGJRVPX-UHFFFAOYSA-N butyryl chloride Chemical compound CCCC(Cl)=O DVECBJCOGJRVPX-UHFFFAOYSA-N 0.000 description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 6
- 235000011121 sodium hydroxide Nutrition 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 6
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 5
- RKIDDEGICSMIJA-UHFFFAOYSA-N 4-chlorobenzoyl chloride Chemical compound ClC(=O)C1=CC=C(Cl)C=C1 RKIDDEGICSMIJA-UHFFFAOYSA-N 0.000 description 5
- 206010027476 Metastases Diseases 0.000 description 5
- 229960000583 acetic acid Drugs 0.000 description 5
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 239000012362 glacial acetic acid Substances 0.000 description 5
- 230000009401 metastasis Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 5
- JVSFQJZRHXAUGT-UHFFFAOYSA-N 2,2-dimethylpropanoyl chloride Chemical compound CC(C)(C)C(Cl)=O JVSFQJZRHXAUGT-UHFFFAOYSA-N 0.000 description 4
- FFNYHBCNHLIWOO-UHFFFAOYSA-N 2,6,6-trimethylbicyclo[3.1.1]heptane-1-carbonyl chloride Chemical compound C12(C(CCC(C1(C)C)C2)C)C(=O)Cl FFNYHBCNHLIWOO-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 230000023555 blood coagulation Effects 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- LXFQSRIDYRFTJW-UHFFFAOYSA-M 2,4,6-trimethylbenzenesulfonate Chemical compound CC1=CC(C)=C(S([O-])(=O)=O)C(C)=C1 LXFQSRIDYRFTJW-UHFFFAOYSA-M 0.000 description 3
- JJKWHOSQTYYFAE-UHFFFAOYSA-N 2-methoxyacetyl chloride Chemical compound COCC(Cl)=O JJKWHOSQTYYFAE-UHFFFAOYSA-N 0.000 description 3
- OLKNUHLCNLDYJN-UHFFFAOYSA-N 6-[4-(3,4-dichlorophenyl)sulfanylbutoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C1=C(Cl)C(Cl)=CC=C1SCCCCOC1=CC=C(NC(=O)CC2)C2=C1 OLKNUHLCNLDYJN-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 230000002785 anti-thrombosis Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000015271 coagulation Effects 0.000 description 3
- 238000005345 coagulation Methods 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 125000004494 ethyl ester group Chemical group 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- MSYBLBLAMDYKKZ-UHFFFAOYSA-N hydron;pyridine-3-carbonyl chloride;chloride Chemical compound Cl.ClC(=O)C1=CC=CN=C1 MSYBLBLAMDYKKZ-UHFFFAOYSA-N 0.000 description 3
- 239000005457 ice water Substances 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 description 3
- GKKCIDNWFBPDBW-UHFFFAOYSA-M potassium cyanate Chemical compound [K]OC#N GKKCIDNWFBPDBW-UHFFFAOYSA-M 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 2
- USKSSUIWVBMHGS-UHFFFAOYSA-N 6-[4-(3,4-dichlorophenyl)sulfinylbutoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C1=C2CCC(O)=NC2=CC=C1OCCCCS(=O)C1=CC=C(Cl)C(Cl)=C1 USKSSUIWVBMHGS-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- QDHHCQZDFGDHMP-UHFFFAOYSA-N Chloramine Chemical compound ClN QDHHCQZDFGDHMP-UHFFFAOYSA-N 0.000 description 2
- YIIMEMSDCNDGTB-UHFFFAOYSA-N Dimethylcarbamoyl chloride Chemical compound CN(C)C(Cl)=O YIIMEMSDCNDGTB-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 230000007059 acute toxicity Effects 0.000 description 2
- 231100000403 acute toxicity Toxicity 0.000 description 2
- 230000010933 acylation Effects 0.000 description 2
- 238000005917 acylation reaction Methods 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 2
- KXDHJXZQYSOELW-UHFFFAOYSA-N carbamic acid group Chemical class C(N)(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- IPZJQDSFZGZEOY-UHFFFAOYSA-N dimethylmethylene Chemical group C[C]C IPZJQDSFZGZEOY-UHFFFAOYSA-N 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 210000002889 endothelial cell Anatomy 0.000 description 2
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 2
- 125000001207 fluorophenyl group Chemical group 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000007800 oxidant agent Substances 0.000 description 2
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical compound C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000012261 resinous substance Substances 0.000 description 2
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- QIQITDHWZYEEPA-UHFFFAOYSA-N thiophene-2-carbonyl chloride Chemical compound ClC(=O)C1=CC=CS1 QIQITDHWZYEEPA-UHFFFAOYSA-N 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 1
- IWYDHOAUDWTVEP-ZETCQYMHSA-N (S)-mandelic acid Chemical compound OC(=O)[C@@H](O)C1=CC=CC=C1 IWYDHOAUDWTVEP-ZETCQYMHSA-N 0.000 description 1
- MOWXJLUYGFNTAL-DEOSSOPVSA-N (s)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol Chemical compound N1=NC(OC)=CC=C1[C@@H](O)C1=CC(C=2C3=CC=C(C=C3N=CN=2)N2CCOCC2)=C(F)C=C1Cl MOWXJLUYGFNTAL-DEOSSOPVSA-N 0.000 description 1
- ABDDQTDRAHXHOC-QMMMGPOBSA-N 1-[(7s)-5,7-dihydro-4h-thieno[2,3-c]pyran-7-yl]-n-methylmethanamine Chemical compound CNC[C@@H]1OCCC2=C1SC=C2 ABDDQTDRAHXHOC-QMMMGPOBSA-N 0.000 description 1
- ADAKRBAJFHTIEW-UHFFFAOYSA-N 1-chloro-4-isocyanatobenzene Chemical compound ClC1=CC=C(N=C=O)C=C1 ADAKRBAJFHTIEW-UHFFFAOYSA-N 0.000 description 1
- YXQOHKDSLJLAFD-UHFFFAOYSA-N 1-chlorosulfonyloxy-2,3,4,5,6-pentamethylbenzene Chemical compound CC1=C(C)C(C)=C(OS(Cl)(=O)=O)C(C)=C1C YXQOHKDSLJLAFD-UHFFFAOYSA-N 0.000 description 1
- LXFQSRIDYRFTJW-UHFFFAOYSA-N 2,4,6-trimethylbenzenesulfonic acid Chemical compound CC1=CC(C)=C(S(O)(=O)=O)C(C)=C1 LXFQSRIDYRFTJW-UHFFFAOYSA-N 0.000 description 1
- APLNAFMUEHKRLM-UHFFFAOYSA-N 2-[5-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]-1-(3,4,6,7-tetrahydroimidazo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NN=C(O1)CC(=O)N1CC2=C(CC1)N=CN2 APLNAFMUEHKRLM-UHFFFAOYSA-N 0.000 description 1
- NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical compound C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 description 1
- HDECRAPHCDXMIJ-UHFFFAOYSA-N 2-methylbenzenesulfonyl chloride Chemical compound CC1=CC=CC=C1S(Cl)(=O)=O HDECRAPHCDXMIJ-UHFFFAOYSA-N 0.000 description 1
- HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 1
- WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 description 1
- ICFZWESBQTTYOC-UHFFFAOYSA-N 4-(4-bromobutylsulfinyl)-1,2-dichlorobenzene Chemical compound ClC1=CC=C(S(=O)CCCCBr)C=C1Cl ICFZWESBQTTYOC-UHFFFAOYSA-N 0.000 description 1
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 1
- USEDMAWWQDFMFY-UHFFFAOYSA-N 4-cyanobenzoyl chloride Chemical compound ClC(=O)C1=CC=C(C#N)C=C1 USEDMAWWQDFMFY-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- XIDZGSSBOHLKFE-UHFFFAOYSA-N 5-[4-(4-methoxyphenyl)sulfinylbutoxy]-3,3-dimethyl-1h-indol-2-one Chemical compound C1=CC(OC)=CC=C1S(=O)CCCCOC1=CC=C(NC(=O)C2(C)C)C2=C1 XIDZGSSBOHLKFE-UHFFFAOYSA-N 0.000 description 1
- SXLHKITZFZRBHX-UHFFFAOYSA-N 5-[4-(benzenesulfinyl)butoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound N1C(=O)CCC2=C1C=CC=C2OCCCCS(=O)C1=CC=CC=C1 SXLHKITZFZRBHX-UHFFFAOYSA-N 0.000 description 1
- VCYVPKHHMVPUSC-UHFFFAOYSA-N 6-(3-ethylsulfinylpropoxy)-1h-quinolin-2-one Chemical compound N1C(=O)C=CC2=CC(OCCCS(=O)CC)=CC=C21 VCYVPKHHMVPUSC-UHFFFAOYSA-N 0.000 description 1
- UCAVCLLUQVIFNF-UHFFFAOYSA-N 6-(3-ethylsulfinylpropoxy)-3,4-dihydro-1h-quinolin-2-one Chemical compound N1C(=O)CCC2=CC(OCCCS(=O)CC)=CC=C21 UCAVCLLUQVIFNF-UHFFFAOYSA-N 0.000 description 1
- NBLXFXWGJOWLPA-UHFFFAOYSA-N 6-(4-cyclohexylsulfanylbutoxy)-3,4-dihydro-1h-quinolin-2-one Chemical compound C=1C=C2NC(=O)CCC2=CC=1OCCCCSC1CCCCC1 NBLXFXWGJOWLPA-UHFFFAOYSA-N 0.000 description 1
- RENVYJZVDWEBLK-UHFFFAOYSA-N 6-(4-hexylsulfinylbutoxy)-3,4-dihydro-1h-quinolin-2-one Chemical compound N1C(=O)CCC2=CC(OCCCCS(=O)CCCCCC)=CC=C21 RENVYJZVDWEBLK-UHFFFAOYSA-N 0.000 description 1
- DIIHRLJFBULDTL-UHFFFAOYSA-N 6-(4-methylsulfanylbutoxy)-3,4-dihydro-1h-quinolin-2-one Chemical compound N1C(=O)CCC2=CC(OCCCCSC)=CC=C21 DIIHRLJFBULDTL-UHFFFAOYSA-N 0.000 description 1
- XBAOPDIIDDENAJ-UHFFFAOYSA-N 6-(4-methylsulfinylbutoxy)-3,4-dihydro-1h-quinolin-2-one Chemical compound N1C(=O)CCC2=CC(OCCCCS(=O)C)=CC=C21 XBAOPDIIDDENAJ-UHFFFAOYSA-N 0.000 description 1
- VNKUIWUYOIQBMP-UHFFFAOYSA-N 6-(4-phenylsulfanylbutoxy)-3,4-dihydro-1h-quinolin-2-one Chemical compound C=1C=C2NC(=O)CCC2=CC=1OCCCCSC1=CC=CC=C1 VNKUIWUYOIQBMP-UHFFFAOYSA-N 0.000 description 1
- WTFUTSCZYYCBAY-SXBRIOAWSA-N 6-[(E)-C-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-N-hydroxycarbonimidoyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C/C(=N/O)/C1=CC2=C(NC(O2)=O)C=C1 WTFUTSCZYYCBAY-SXBRIOAWSA-N 0.000 description 1
- DFGKGUXTPFWHIX-UHFFFAOYSA-N 6-[2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]acetyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)C1=CC2=C(NC(O2)=O)C=C1 DFGKGUXTPFWHIX-UHFFFAOYSA-N 0.000 description 1
- WIJZUUDWVJTPCL-UHFFFAOYSA-N 6-[3-(3,4-dichlorophenyl)sulfinylpropoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C1=C(Cl)C(Cl)=CC=C1S(=O)CCCOC1=CC=C(NC(=O)CC2)C2=C1 WIJZUUDWVJTPCL-UHFFFAOYSA-N 0.000 description 1
- DEXFNLNNUZKHNO-UHFFFAOYSA-N 6-[3-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-3-oxopropyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)C(CCC1=CC2=C(NC(O2)=O)C=C1)=O DEXFNLNNUZKHNO-UHFFFAOYSA-N 0.000 description 1
- CTRULGCXCTXNDK-UHFFFAOYSA-N 6-[4-(2-phenylethylsulfinyl)butoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C=1C=C2NC(=O)CCC2=CC=1OCCCCS(=O)CCC1=CC=CC=C1 CTRULGCXCTXNDK-UHFFFAOYSA-N 0.000 description 1
- UURXBTHJZQYWEK-UHFFFAOYSA-N 6-[4-(3,4-dichlorophenyl)sulfanylbutoxy]-1h-quinolin-2-one Chemical compound C1=C(Cl)C(Cl)=CC=C1SCCCCOC1=CC=C(NC(=O)C=C2)C2=C1 UURXBTHJZQYWEK-UHFFFAOYSA-N 0.000 description 1
- RDJSMZHIMWPJCI-UHFFFAOYSA-N 6-[4-(3,4-dichlorophenyl)sulfinylbutoxy]-1h-quinolin-2-one Chemical compound C1=C(Cl)C(Cl)=CC=C1S(=O)CCCCOC1=CC=C(NC(=O)C=C2)C2=C1 RDJSMZHIMWPJCI-UHFFFAOYSA-N 0.000 description 1
- PEIJPTAKOWAWAD-UHFFFAOYSA-N 6-[4-(3,4-dimethoxyphenyl)sulfinylbutoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C1=C(OC)C(OC)=CC=C1S(=O)CCCCOC1=CC=C(NC(=O)CC2)C2=C1 PEIJPTAKOWAWAD-UHFFFAOYSA-N 0.000 description 1
- XCWAOHBKRPBTLP-UHFFFAOYSA-N 6-[4-(3,4-ditert-butyl-4-hydroxycyclohexa-1,5-dien-1-yl)sulfinylbutoxy]-1H-quinolin-2-one Chemical compound C(C)(C)(C)C1C=C(C=CC1(O)C(C)(C)C)S(=O)CCCCOC=1C=C2C=CC(NC2=CC=1)=O XCWAOHBKRPBTLP-UHFFFAOYSA-N 0.000 description 1
- WSEBJNCJMMRECO-UHFFFAOYSA-N 6-[4-(3,5-ditert-butyl-4-hydroxyphenyl)sulfinylbutoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound CC(C)(C)C1=C(O)C(C(C)(C)C)=CC(S(=O)CCCCOC=2C=C3CCC(=O)NC3=CC=2)=C1 WSEBJNCJMMRECO-UHFFFAOYSA-N 0.000 description 1
- HBRZPSFBJFGFJU-UHFFFAOYSA-N 6-[4-(3-methoxyphenyl)sulfanylbutoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound COC1=CC=CC(SCCCCOC=2C=C3CCC(=O)NC3=CC=2)=C1 HBRZPSFBJFGFJU-UHFFFAOYSA-N 0.000 description 1
- ILCHJFIETGBOGF-UHFFFAOYSA-N 6-[4-(4-amino-3,4-dibromocyclohexa-1,5-dien-1-yl)sulfinylbutoxy]-3,4-dihydro-1H-quinolin-2-one Chemical compound BrC1C=C(C=CC1(N)Br)S(=O)CCCCOC=1C=C2CCC(NC2=CC=1)=O ILCHJFIETGBOGF-UHFFFAOYSA-N 0.000 description 1
- OIDGRMDWLNZHHE-UHFFFAOYSA-N 6-[4-(4-amino-3,5-dibromophenyl)sulfinylbutoxy]-1h-quinolin-2-one Chemical compound C1=C(Br)C(N)=C(Br)C=C1S(=O)CCCCOC1=CC=C(NC(=O)C=C2)C2=C1 OIDGRMDWLNZHHE-UHFFFAOYSA-N 0.000 description 1
- BTICLYSXNKODHZ-UHFFFAOYSA-N 6-[4-(4-bromo-3-methylphenyl)sulfinylbutoxy]-1h-quinolin-2-one Chemical compound C1=C(Br)C(C)=CC(S(=O)CCCCOC=2C=C3C=CC(=O)NC3=CC=2)=C1 BTICLYSXNKODHZ-UHFFFAOYSA-N 0.000 description 1
- SLITUGUQQMYSIT-UHFFFAOYSA-N 6-[4-(4-bromophenyl)sulfinylbutoxy]-1h-quinolin-2-one Chemical compound C1=CC(Br)=CC=C1S(=O)CCCCOC1=CC=C(NC(=O)C=C2)C2=C1 SLITUGUQQMYSIT-UHFFFAOYSA-N 0.000 description 1
- LOVABRWXJRAPRS-UHFFFAOYSA-N 6-[4-(4-chlorophenyl)sulfinylbutoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C1=CC(Cl)=CC=C1S(=O)CCCCOC1=CC=C(NC(=O)CC2)C2=C1 LOVABRWXJRAPRS-UHFFFAOYSA-N 0.000 description 1
- NMUWLPZCRYURDW-UHFFFAOYSA-N 6-[4-(4-cyclohexylphenyl)sulfinylbutoxy]-1h-quinolin-2-one Chemical compound C=1C=C2NC(=O)C=CC2=CC=1OCCCCS(=O)C(C=C1)=CC=C1C1CCCCC1 NMUWLPZCRYURDW-UHFFFAOYSA-N 0.000 description 1
- MXIYQSCMJBOBLM-UHFFFAOYSA-N 6-[4-(4-cyclohexylphenyl)sulfinylbutoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C=1C=C2NC(=O)CCC2=CC=1OCCCCS(=O)C(C=C1)=CC=C1C1CCCCC1 MXIYQSCMJBOBLM-UHFFFAOYSA-N 0.000 description 1
- IFGNCVVIGAORLS-UHFFFAOYSA-N 6-[4-(4-fluorophenyl)sulfanylbutoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C1=CC(F)=CC=C1SCCCCOC1=CC=C(NC(=O)CC2)C2=C1 IFGNCVVIGAORLS-UHFFFAOYSA-N 0.000 description 1
- IIASUMRPFUOECH-UHFFFAOYSA-N 6-[4-(4-fluorophenyl)sulfinylbutoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C1=CC(F)=CC=C1S(=O)CCCCOC1=CC=C(NC(=O)CC2)C2=C1 IIASUMRPFUOECH-UHFFFAOYSA-N 0.000 description 1
- YKKCAQSYVSZODS-UHFFFAOYSA-N 6-[4-(4-phenylphenyl)sulfinylbutoxy]-1h-quinolin-2-one Chemical compound C=1C=C2NC(=O)C=CC2=CC=1OCCCCS(=O)C(C=C1)=CC=C1C1=CC=CC=C1 YKKCAQSYVSZODS-UHFFFAOYSA-N 0.000 description 1
- ZJPUSINBAIOCCC-UHFFFAOYSA-N 6-[4-(4-phenylphenyl)sulfinylbutoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C=1C=C2NC(=O)CCC2=CC=1OCCCCS(=O)C(C=C1)=CC=C1C1=CC=CC=C1 ZJPUSINBAIOCCC-UHFFFAOYSA-N 0.000 description 1
- WKFJGZJBEYTMPP-UHFFFAOYSA-N 6-[4-(4-tert-butylphenyl)sulfanylbutoxy]-1h-quinolin-2-one Chemical compound C1=CC(C(C)(C)C)=CC=C1SCCCCOC1=CC=C(NC(=O)C=C2)C2=C1 WKFJGZJBEYTMPP-UHFFFAOYSA-N 0.000 description 1
- SJSGRUSUKVLAAL-UHFFFAOYSA-N 6-[4-(4-tert-butylphenyl)sulfinylbutoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C1=CC(C(C)(C)C)=CC=C1S(=O)CCCCOC1=CC=C(NC(=O)CC2)C2=C1 SJSGRUSUKVLAAL-UHFFFAOYSA-N 0.000 description 1
- NHKIFYDGOCNNEL-UHFFFAOYSA-N 6-[4-(benzenesulfinyl)butoxy]-1h-quinolin-2-one Chemical compound C=1C=C2NC(=O)C=CC2=CC=1OCCCCS(=O)C1=CC=CC=C1 NHKIFYDGOCNNEL-UHFFFAOYSA-N 0.000 description 1
- DVHFRAJZCBPZIP-UHFFFAOYSA-N 6-[4-(benzenesulfinyl)butoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C=1C=C2NC(=O)CCC2=CC=1OCCCCS(=O)C1=CC=CC=C1 DVHFRAJZCBPZIP-UHFFFAOYSA-N 0.000 description 1
- HXCJHHPFMGSUHW-UHFFFAOYSA-N 6-[4-[4-(2-fluorophenyl)phenyl]sulfinylbutoxy]-1h-quinolin-2-one Chemical compound FC1=CC=CC=C1C1=CC=C(S(=O)CCCCOC=2C=C3C=CC(=O)NC3=CC=2)C=C1 HXCJHHPFMGSUHW-UHFFFAOYSA-N 0.000 description 1
- QOEHZEARTYEWMU-UHFFFAOYSA-N 6-[5-(3,4-dichlorophenyl)sulfinylpentoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C1=C(Cl)C(Cl)=CC=C1S(=O)CCCCCOC1=CC=C(NC(=O)CC2)C2=C1 QOEHZEARTYEWMU-UHFFFAOYSA-N 0.000 description 1
- SRSBEVMETSYHNH-UHFFFAOYSA-N 7-[4-(benzenesulfinyl)butoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C1=C2NC(=O)CCC2=CC=C1OCCCCS(=O)C1=CC=CC=C1 SRSBEVMETSYHNH-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 1
- RGVRUHWLVMDIKC-UHFFFAOYSA-N 8-[4-(benzenesulfinyl)butoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C=12NC(=O)CCC2=CC=CC=1OCCCCS(=O)C1=CC=CC=C1 RGVRUHWLVMDIKC-UHFFFAOYSA-N 0.000 description 1
- 241001552669 Adonis annua Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- MWHHJYUHCZWSLS-UHFFFAOYSA-N FC=1C=C(C=CC1C1=C2CNC(C2=C(C=C1)C=1NC(=CN1)C)=O)NC(=O)NC1=C(C=C(C=C1F)F)F Chemical compound FC=1C=C(C=CC1C1=C2CNC(C2=C(C=C1)C=1NC(=CN1)C)=O)NC(=O)NC1=C(C=C(C=C1F)F)F MWHHJYUHCZWSLS-UHFFFAOYSA-N 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 208000032109 Transient ischaemic attack Diseases 0.000 description 1
- ODUIXUGXPFKQLG-QWRGUYRKSA-N [2-(4-chloro-2-fluoroanilino)-5-methyl-1,3-thiazol-4-yl]-[(2s,3s)-2,3-dimethylpiperidin-1-yl]methanone Chemical compound C[C@H]1[C@@H](C)CCCN1C(=O)C1=C(C)SC(NC=2C(=CC(Cl)=CC=2)F)=N1 ODUIXUGXPFKQLG-QWRGUYRKSA-N 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000004931 aggregating effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- 208000007957 amaurosis fugax Diseases 0.000 description 1
- DQPBABKTKYNPMH-UHFFFAOYSA-N amino hydrogen sulfate Chemical compound NOS(O)(=O)=O DQPBABKTKYNPMH-UHFFFAOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- MXMOTZIXVICDSD-UHFFFAOYSA-N anisoyl chloride Chemical compound COC1=CC=C(C(Cl)=O)C=C1 MXMOTZIXVICDSD-UHFFFAOYSA-N 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 239000000010 aprotic solvent Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 1
- 229910001863 barium hydroxide Inorganic materials 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical class OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000005606 carbostyryl group Chemical group 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- VDQQXEISLMTGAB-UHFFFAOYSA-N chloramine T Chemical compound [Na+].CC1=CC=C(S(=O)(=O)[N-]Cl)C=C1 VDQQXEISLMTGAB-UHFFFAOYSA-N 0.000 description 1
- 125000000068 chlorophenyl group Chemical group 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 229960003887 dichlorophen Drugs 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- VRZVPALEJCLXPR-UHFFFAOYSA-N ethyl 4-methylbenzenesulfonate Chemical compound CCOS(=O)(=O)C1=CC=C(C)C=C1 VRZVPALEJCLXPR-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 125000006332 fluoro benzoyl group Chemical group 0.000 description 1
- 125000004175 fluorobenzyl group Chemical group 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 229940116364 hard fat Drugs 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 125000004464 hydroxyphenyl group Chemical group 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000005928 isopropyloxycarbonyl group Chemical group [H]C([H])([H])C([H])(OC(*)=O)C([H])([H])[H] 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 229940057948 magnesium stearate Drugs 0.000 description 1
- AUHZEENZYGFFBQ-UHFFFAOYSA-N mesitylene Substances CC1=CC(C)=CC(C)=C1 AUHZEENZYGFFBQ-UHFFFAOYSA-N 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- 125000005948 methanesulfonyloxy group Chemical group 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- 125000004458 methylaminocarbonyl group Chemical group [H]N(C(*)=O)C([H])([H])[H] 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- VJMRKWPMFQGIPI-UHFFFAOYSA-N n-(2-hydroxyethyl)-5-(hydroxymethyl)-3-methyl-1-[2-[[3-(trifluoromethyl)phenyl]methyl]-1-benzothiophen-7-yl]pyrazole-4-carboxamide Chemical compound OCC1=C(C(=O)NCCO)C(C)=NN1C1=CC=CC2=C1SC(CC=1C=C(C=CC=1)C(F)(F)F)=C2 VJMRKWPMFQGIPI-UHFFFAOYSA-N 0.000 description 1
- HFWWEMPLBCKNNM-UHFFFAOYSA-N n-[bis(hydroxyamino)methyl]hydroxylamine Chemical compound ONC(NO)NO HFWWEMPLBCKNNM-UHFFFAOYSA-N 0.000 description 1
- RRPKGUUYTHFUPN-UHFFFAOYSA-N n-hydroxy-2,4,6-trimethylbenzenesulfonamide Chemical compound CC1=CC(C)=C(S(=O)(=O)NO)C(C)=C1 RRPKGUUYTHFUPN-UHFFFAOYSA-N 0.000 description 1
- NSNPSJGHTQIXDO-UHFFFAOYSA-N naphthalene-1-carbonyl chloride Chemical compound C1=CC=C2C(C(=O)Cl)=CC=CC2=C1 NSNPSJGHTQIXDO-UHFFFAOYSA-N 0.000 description 1
- XNLBCXGRQWUJLU-UHFFFAOYSA-N naphthalene-2-carbonyl chloride Chemical compound C1=CC=CC2=CC(C(=O)Cl)=CC=C21 XNLBCXGRQWUJLU-UHFFFAOYSA-N 0.000 description 1
- 125000001038 naphthoyl group Chemical group C1(=CC=CC2=CC=CC=C12)C(=O)* 0.000 description 1
- 125000005146 naphthylsulfonyl group Chemical group C1(=CC=CC2=CC=CC=C12)S(=O)(=O)* 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 125000001402 nonanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- REEZZSHJLXOIHL-UHFFFAOYSA-N octanoyl chloride Chemical compound CCCCCCCC(Cl)=O REEZZSHJLXOIHL-UHFFFAOYSA-N 0.000 description 1
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 1
- 125000005646 oximino group Chemical group 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 150000004965 peroxy acids Chemical class 0.000 description 1
- 125000000286 phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 125000004742 propyloxycarbonyl group Chemical group 0.000 description 1
- 239000002599 prostaglandin synthase inhibitor Substances 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- AQLYZDRHNHZHIS-UHFFFAOYSA-N quinoline-2,6-diol Chemical compound N1C(=O)C=CC2=CC(O)=CC=C21 AQLYZDRHNHZHIS-UHFFFAOYSA-N 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000012262 resinous product Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- 238000005245 sintering Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical class [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 description 1
- 125000005555 sulfoximide group Chemical group 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- XTHPWXDJESJLNJ-UHFFFAOYSA-N sulfurochloridic acid Chemical compound OS(Cl)(=O)=O XTHPWXDJESJLNJ-UHFFFAOYSA-N 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 230000009424 thromboembolic effect Effects 0.000 description 1
- 201000010875 transient cerebral ischemia Diseases 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 239000011686 zinc sulphate Substances 0.000 description 1
- 235000009529 zinc sulphate Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Indole Compounds (AREA)
Description
Denne oppfinnelse angår fremstilling av nye sulfiminer med den generelle formel This invention relates to the preparation of new sulfimines with the general formula
og deres salter med sterke syrer, særlig deres fysiologisk forlikelige syreaddisjonssalter. and their salts with strong acids, especially their physiologically compatible acid addition salts.
/ De nye forbindelser med den ovenstående generelle formel I oppviser verdifulle farmakologiske egenskaper, særlig antitrombotiske virkninger. / The new compounds of the above general formula I exhibit valuable pharmacological properties, in particular antithrombotic effects.
I den ovenstående generelle formel I betyrIn the above general formula I means
n tallet 0 eller 1,n the number 0 or 1,
A betyr en eventuelt med én eller to alkylgrupper med hver 1 til 3 karbonatomer substituert metylen-, vinylen- eller etylengruppe, A means a methylene, vinylene or ethylene group optionally substituted with one or two alkyl groups with each 1 to 3 carbon atoms,
B betyr en lineær eller forgrenet alkylengruppe med 2 til 6 B means a linear or branched alkylene group of 2 to 6
karbonatomer,carbon atoms,
betyr en eventuelt med en fenylgruppe substituert alkylgruppe med 1 til 3 karbonatomer eller en fenylgruppe, hvor fenylkjernen i hvert tilfelle kan være substituert med en alkylgruppe med 1 til 4 karbonatomer, et halogenatom, en alkoksygruppe med 1 til 3 karbonatomer, en cykloheksyl-, fenyl- eller halogenfenylgruppe; en alkylgruppe med 4 til 7 karbonatomer; en cykloalkylgruppe med 3 til 7 karbonatomer; means an alkyl group with 1 to 3 carbon atoms optionally substituted with a phenyl group or a phenyl group, where the phenyl nucleus can in each case be substituted with an alkyl group with 1 to 4 carbon atoms, a halogen atom, an alkoxy group with 1 to 3 carbon atoms, a cyclohexyl, phenyl - or halophenyl group; an alkyl group of 4 to 7 carbon atoms; a cycloalkyl group of 3 to 7 carbon atoms;
en med alkylgrupper med 1 til 4 karbonatomer, alkoksygrupper med 1 til 3 karbonatomer og/eller halogenatomer di- eller tri-substituert fenyl- eller disubstituert hydroksy- eller aminofenylgruppe, hvor substituentene på fenylkjernen kan være like eller forskjellige; en eventuelt med en alkoksygruppe med 1 til 3 karbonatomer substituert naftylgruppe eller en pyridylgruppe, og one with alkyl groups of 1 to 4 carbon atoms, alkoxy groups of 1 to 3 carbon atoms and/or halogen atoms di- or tri-substituted phenyl or disubstituted hydroxy or aminophenyl group, where the substituents on the phenyl nucleus may be the same or different; a naphthyl group or a pyridyl group optionally substituted by an alkoxy group with 1 to 3 carbon atoms, and
1*2 betyr et hydrogenatom eller en acylrest av en organisk karboksylsyre, av en organisk eller uorganisk sulfonsyre eller av et karbonsyrederivat. ;Når det gjelder uttrykket "en acylrest" som er anvendt;ved definisjonen av resten , er det her særlig tale om en acylrest av en alifatisk mettet eller umettet alkansyre som eventuelt kan være substituert, av en eventuelt substituert aromatisk karboksylsyre hvor en -CH=CH-gruppe, en eller.to -CH-grupper hver kan være erstattet med et oksygen-, svovel-eller nitrogenatom, av en karbonsyreester, av en eventuelt substituert karbaminsyre, av en alifatisk eller aromatisk sulfonsyre eller en hydroksysulfonylgruppe. ;Blant halogenatomer som er nevnt under definisjonen av resten R^, skal særlig forstås et fluor-, klor- eller bromatom. ;' Blant de ved definisjonen av restene A, B, R^og R£innledningsvis angitte betydninger kommer f.eks. i betraktning ;for A betydningen en metylen-, metylmetylen-, dimetylmetylen-, dietylmetylen-, dipropylmetylen-, vinylen-, metyl-vinylen- eller etyléngruppe, ;for B betydningen en etylen-, n-propylen-, n-butylen-, n-pentylen-, n-heksylen-, 1-metyl-etylen-, 2-mety1-etylen-, 1-metyl-n-propylen-, 2-mety1-n-propylen-, 3-metyl-n-propylen-, 1- metyl-n-butylen-, 2-metyl-n-butylen-, 3-metyl-n-butylen-, 4-metyl-n-butylen-, 1-metyl-n-pentylen-, 2-metyl-n-pentylen-, 3-metyl-n-pentylen-, 4-metyl-n-pentylen-, 5-metyl-n-pentylen-, 1,1-dimety1-etylen-, 1,2-dimety1-etylen-, 2,2-dimety1-etylen-, 1,1-dimety1-n-propylen-, 2,2-dimetyl-n-propylen-, 3,3-dimetyl-n-propylen-, 1,2-dimetyl-n-propylen-, 1,3-dimety1-n-propylen-, 1,1-dimety1-n-butylen-, 2,2-dimety1-n-butylen-, 3,3-dimetyl-n-butylen-, 4,4-dimety1-n-butylen-, 1,2-dimetyl-n-butylen-, 1,3-dimety1-n-butylen-, 1,4-dimetyl-n-butylen-, 2,3-dimety1-n-butylen-, 1-etyl-etylen-, 2-ety1-etylen-, 1-etyl-n-propylen-, 2- etyl-n-propylen-, 3-ety1-n-propylen-, 1-etyl-n-butylen-, 2- etyl-n-butylen-, 3-etyl-n-butylen-, 4-ety1-n-butylen-, l-metyl-2-etyl-etylen-, l-metyl-2-ety1-n-propylen-, 1-metyl-3- etyl-n-propylen-, l-metyl-2-propyl-etylen-, 1-propy1-etylen-, . 1-buty1-etylen- eller 1-propy1-n-propylengruppe, ;for R^betydningen en metyl-, etyl-, propyl-, isopropyl-, butyl-, isobutyl-, tert.butyl-, pentyl-, neopentyl-, tert.pentyl-heksyl-, heptyl-, benzyl-, 1-fenyletyl-, 2-fenyletyl-, 1-fenylpropyl-, 3-fenylpropyl-, fluorbenzyl-, klorbenzyl-, brombenzyl-, metylbenzy1-, isopropylbenzyl-, metoksybenzy1-, etoksybenzy1-, ;cykloprcpyl-, cyklobutyl-, cyklopentyl-, cykloheksyl-, cykloheptyl-, fenyl-, fluorfenyl-, klorfenyl-, bromfenyl-, métylfenyl-, dimetylfenyl-, isopropylfenyl-, tert.butylfenyl-, : metoksyfenyl-, etoksyfenyl-, propoksyfenyl-, cykloheksylfenyl-, bifenylyl-, fluorfenyl-fenyl-, klorfenyl-fenyl-, difluorfenyl-, diklorfenyl-, dibromfeny1-, dimetoksyfenyl-, metoksyklorfenyl-, metoksy-bromfeny1-, metyl-tert.buty1-fenyl-, metyl-klorfenyl-, metylbromfenyl-, tert.butyl-bromfenyl-, dikloraminofenyl-, dibrom-aminofenyl-, dimetyl-aminofenyl-, diklor-hydroksyfenyl-, dibrom-hydroksyfenyl-, dimety1-hydroksyf enyl-, di-tert. buty 1-hydr.oksyf enyl-, trimetoksy-fenyl-, naftyl-, metoksynaftyl- eller pyridylgruppe og ;for R2betydningen et hydrogenatom, en formyl-, acetyl-, propionyl-, pivåloyl-, pentanoyl-, heksanoyl-, heptanoyl-, oktanoyl-, nonanoyl-, metoksyacetyl-, metoksypropionyl-, pinanoyl-, benzoyl-, fluorbenzoyl-, klorbenzoyl-, brom-benzoyl-, cyanobenzoyl-, metylbenzoyl-, etylbenzoyl-, isopropylbenzoy1-, tert.butylbenzoyl-, difluorbenzoyl-, diklorbenzoyl-, dimetylbenzoyl-, trimetylbenzoyl-, naftoyl-, pyridinoyl-, tenoyl-, acetoksy-benzoyl-, hydroksysulfonyl-, metylsulfony1-, etylsulfonyl-, kamfer-sulfony1-, fenylsulfonyl-, metylfenyl-sulfonyl-, fluorfenylsulfonyl-, klorfenylsulfony1-, bromfenyl-sulfony1-, pentametylfenylsulfonyl-, naftylsulfonyl-, metoksykarbonyl-, etoksykarbonyl-, propoksykarbonyl-, isopropoksykarbohyl-, benzyloksykarbonyl-, aminokarbonyl-, metylaminokarbonyl-, dimetylaminokarbonyl-, fenylaminokarbonyl-eller klorfenylaminokarbonylgruppe. ;Foretrukne forbindelser med den generelle formel I er;de hvor;n betyr tallet 0 eller 1,;A betyr en dimetylmetylen-, vinylen- eller etylengruppe,;B betyr en lineær alkylengruppe med 3 til 5 karbonatomer , ;betyr en alkylgruppe med 1 til 6 karbonatomer, en benzyl-, fenyletyl-, cykloheksyl-, naftyl-, metoksy-naftyl-eller pyridylgruppe; en eventuelt med en alkylgruppe med 1 til 4 karbonatomer, en metoksy-, cykloheksyl-, fenyl- eller fluorfenylgruppe, et fluor-, klor- eller bromatcm substituert fenylgruppe; en med alkylgrupper med 1 til 4 karbonatomer, ;metoksygrupper, klor- og/eller bromatomer disubstituert fenylgruppe, hvor substituentene på fenylkjernen kan være like eller forskjellige; eller en med to klor- eller bromatomer, to metoksygrupper eller to alkylgrupper med hver 1 til 4 karbonatomer. substituert aminofenyl-, hydroksyfenyl- eller metoksy-fenylgruppe og ;1*2betyr et hydrogenatom, en eventuelt med en metoksygruppe substituert alkanoylgruppe med 1 til 8 karbonatomer; 1*2 means a hydrogen atom or an acyl residue of an organic carboxylic acid, of an organic or inorganic sulphonic acid or of a carboxylic acid derivative. When it comes to the expression "an acyl residue" which is used in the definition of the residue, this is in particular an acyl residue of an aliphatic saturated or unsaturated alkanoic acid which may optionally be substituted, of an optionally substituted aromatic carboxylic acid where a -CH= CH group, one or two -CH groups can each be replaced by an oxygen, sulfur or nitrogen atom, by a carboxylic acid ester, by an optionally substituted carbamic acid, by an aliphatic or aromatic sulphonic acid or a hydroxysulphonyl group. Among halogen atoms mentioned under the definition of the radical R^, a fluorine, chlorine or bromine atom shall be understood in particular. ;' Among the meanings given at the beginning of the definition of the residues A, B, R^ and R£, e.g. in consideration ; for A the meaning of a methylene-, methylmethylene-, dimethylmethylene-, diethylmethylene-, dipropylmethylene-, vinylene-, methyl-vinylene- or ethylene group, ; for B the meaning of an ethylene-, n-propylene-, n-butylene-, n-pentylene-, n-hexylene-, 1-methyl-ethylene-, 2-methyl-ethylene-, 1-methyl-n-propylene-, 2-methyl-n-propylene-, 3-methyl-n-propylene- , 1- methyl-n-butylene-, 2-methyl-n-butylene-, 3-methyl-n-butylene-, 4-methyl-n-butylene-, 1-methyl-n-pentylene-, 2-methyl- n-pentylene-, 3-methyl-n-pentylene-, 4-methyl-n-pentylene-, 5-methyl-n-pentylene-, 1,1-dimethyl-ethylene-, 1,2-dimethyl-ethylene-, 2,2-dimethyl-ethylene-, 1,1-dimethyl-n-propylene-, 2,2-dimethyl-n-propylene-, 3,3-dimethyl-n-propylene-, 1,2-dimethyl-n- propylene-, 1,3-dimethyl-n-propylene-, 1,1-dimethyl-n-butylene-, 2,2-dimethyl-n-butylene-, 3,3-dimethyl-n-butylene-, 4,4 -dimethyl-n-butylene-, 1,2-dimethyl-n-butylene-, 1,3-dimethyl-n-butylene-, 1,4-dimethyl-n-butylene-, 2,3-dimethyl-n-butylene -, 1-ethyl-ethylene-, 2-ethyl-1-ethylene-, 1-ethyl-n-propylene-, 2- ethyl-n-propylene-, 3-ethyl-n-propylene-, 1-ethy l-n-butylene-, 2- ethyl-n-butylene-, 3-ethyl-n-butylene-, 4-ethyl-n-butylene-, l-methyl-2-ethyl-ethylene-, l-methyl-2-ethyl -n-propylene-, 1-methyl-3-ethyl-n-propylene-, 1-methyl-2-propyl-ethylene-, 1-propyl-1-ethylene-, . 1-butyl-1-ethylene- or 1-propy1-n-propylene group, for the R meaning a methyl-, ethyl-, propyl-, isopropyl-, butyl-, isobutyl-, tert.butyl-, pentyl-, neopentyl-, tert.pentyl-hexyl-, heptyl-, benzyl-, 1-phenylethyl-, 2-phenylethyl-, 1-phenylpropyl-, 3-phenylpropyl-, fluorobenzyl-, chlorobenzyl-, bromobenzyl-, methylbenzy1-, isopropylbenzyl-, methoxybenzy1- , ethoxybenzy1-, ;cycloprcpyl-, cyclobutyl-, cyclopentyl-, cyclohexyl-, cycloheptyl-, phenyl-, fluorophenyl-, chlorophenyl-, bromophenyl-, methylphenyl-, dimethylphenyl-, isopropylphenyl-, tert.butylphenyl-, : methoxyphenyl-, ethoxyphenyl-, propoxyphenyl-, cyclohexylphenyl-, biphenylyl-, fluorophenyl-phenyl-, chlorophenyl-phenyl-, difluorophenyl-, dichlorophenyl-, dibromophenyl-, dimethoxyphenyl-, methoxychlorophenyl-, methoxy-bromophenyl-, methyl-tert.buty1-phenyl- , methyl-chlorophenyl-, methylbromophenyl-, tert.butyl-bromophenyl-, dichloroaminophenyl-, dibromo-aminophenyl-, dimethyl-aminophenyl-, dichloro-hydroxyphenyl-, dibromo-hydroxyphenyl-, dimethyl1-hydroxyphenyl-, di-tert. buty 1-hydroxyphenyl-, trimethoxy-phenyl-, naphthyl, methoxynaphthyl or pyridyl group and; for the R2 meaning a hydrogen atom, a formyl-, acetyl-, propionyl-, pivaloyl-, pentanoyl-, hexanoyl-, heptanoyl-, octanoyl-, nonanoyl-, methoxyacetyl-, methoxypropionyl-, pinanoyl-, benzoyl-, fluorobenzoyl-, chlorobenzoyl-, bromobenzoyl-, cyanobenzoyl-, methylbenzoyl-, ethylbenzoyl-, isopropylbenzoyl-, tert.butylbenzoyl-, difluorobenzoyl-, dichlorobenzoyl -, dimethylbenzoyl-, trimethylbenzoyl-, naphthoyl-, pyridinoyl-, thenoyl-, acetoxy-benzoyl-, hydroxysulfonyl-, methylsulfonyl-, ethylsulfonyl-, camphor-sulfonyl-, phenylsulfonyl-, methylphenyl-sulfonyl-, fluorophenylsulfonyl-, chlorophenylsulfonyl-, bromophenylsulfonyl, pentamethylphenylsulfonyl, naphthylsulfonyl, methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl, isopropoxycarbonyl, benzyloxycarbonyl, aminocarbonyl, methylaminocarbonyl, dimethylaminocarbonyl, phenylaminocarbonyl or chlorophenylaminocarbonyl group. ;Preferred compounds of the general formula I are;those where;n means the number 0 or 1,;A means a dimethylmethylene, vinylene or ethylene group,;B means a linear alkylene group of 3 to 5 carbon atoms, ;means an alkyl group of 1 to 6 carbon atoms, a benzyl, phenylethyl, cyclohexyl, naphthyl, methoxy-naphthyl or pyridyl group; an optionally with an alkyl group of 1 to 4 carbon atoms, a methoxy, cyclohexyl, phenyl or fluorophenyl group, a fluorine-, chlorine- or bromate-substituted phenyl group; a disubstituted phenyl group with alkyl groups with 1 to 4 carbon atoms, methoxy groups, chlorine and/or bromine atoms, where the substituents on the phenyl nucleus may be the same or different; or one with two chlorine or bromine atoms, two methoxy groups or two alkyl groups each having 1 to 4 carbon atoms. substituted aminophenyl, hydroxyphenyl or methoxyphenyl group and ;1*2 means a hydrogen atom, an alkanoyl group with 1 to 8 carbon atoms optionally substituted with a methoxy group;
en eventuelt med et halogenatom, en cyangruppe eller en alkylgruppe med 1 til 4 karbonatomer substituert benzoyl- eller fenylsulfonylgruppe; en alkoksykarbonylgruppe med ialt 2 til 4 karbonatomer; en eventuelt med en klorfenylgruppe, a benzoyl or phenylsulfonyl group optionally substituted with a halogen atom, a cyano group or an alkyl group with 1 to 4 carbon atoms; an alkoxycarbonyl group having a total of 2 to 4 carbon atoms; one optionally with a chlorophenyl group,
med én eller to metylgrupper substituert aminokarbony1-gruppe; en naftoyl-, pinanoyl-, kamfersulfonyl-, pentametylfenylsulfonyl-, pyridinoyl- eller tenoylgruppe, with one or two methyl groups substituted aminocarbonyl group; a naphthoyl, pinanoyl, camphorsulfonyl, pentamethylphenylsulfonyl, pyridinoyl or thenoyl group,
og deres salter med sterke syrer.and their salts with strong acids.
Spesielt foretrukne forbindelser med den ovenstående generelle formel I er de hvor Particularly preferred compounds of the above general formula I are those wherein
n betyr tallet 1,n means the number 1,
A betyr en dimetylmetylen-, vinylen- eller etylengruppe,A means a dimethylmethylene, vinylene or ethylene group,
B betyr en n-butylengruppe,B means an n-butylene group,
R^betyr en metyl- eller metoksynaftylgruppe; en eventuelt med en metoksygruppe, et fluor- eller kloratom substituert fenylgruppe; en med to klor- eller bromatomer substituert fenylgruppe; en metyl-bromfenyl-, 4-amino-3,5-dibrom-fenyl-eller di-tert.buty1-hydroksy-fenylgruppe og R 2 represents a methyl or methoxynaphthyl group; a phenyl group optionally substituted with a methoxy group, a fluorine or chlorine atom; a phenyl group substituted with two chlorine or bromine atoms; a methyl-bromophenyl-, 4-amino-3,5-dibromo-phenyl or di-tert.buty1-hydroxy-phenyl group and
R2betyr et hydrogenatom, en alkanoylgruppe med 1 til 3 karbonatomer eller en eventuelt med en alkylgruppe med 1 til 4 karbonatomer substituert benzoyl- eller fenylsulfonylgruppe,. og deres fysiologisk forlikelige salter emd sterke syrer. R2 means a hydrogen atom, an alkanoyl group with 1 to 3 carbon atoms or a benzoyl or phenylsulfonyl group optionally substituted with an alkyl group with 1 to 4 carbon atoms. and their physiologically compatible salts and strong acids.
Ifølge oppfinnelsen fremstilles de nye forbindelser som følger: a) For fremstilling av en forbindelse med den generelle formel I hvor n betyr tallet 1, og R2betyr et hydrogenatom: According to the invention, the new compounds are prepared as follows: a) For the preparation of a compound with the general formula I where n means the number 1, and R2 means a hydrogen atom:
Omsetning av et sulfoksyd med den generelle formelReaction of a sulfoxide with the general formula
hvor A, B og R, er som innledningsvis angitt, med eventuelt i reaksjonsblandingen dannet hydrogenazid. where A, B and R are as stated at the outset, with hydrogen azide possibly formed in the reaction mixture.
Omsetningen utføres hensiktsmessig i et oppløsningsmiddel eller en oppløsningsmiddélblanding så som metylenklorid, dimetylformamid eller tetrahydrofuran ved temperaturer mellom 0 og 40°C, fortrinnsvis ved temperaturer mellom 10 og 35 C. Særlig fordelaktig er det å foreta omsetningen med et alkaliazid, f.eks. natriumazid, og å anvende polyfosforsyre som oppløsningsmiddel. b) For fremstilling av en forbindelse med den generelle formel I hvor betyr et hydrogenatom: The reaction is suitably carried out in a solvent or a solvent mixture such as methylene chloride, dimethylformamide or tetrahydrofuran at temperatures between 0 and 40°C, preferably at temperatures between 10 and 35°C. It is particularly advantageous to carry out the reaction with an alkali azide, e.g. sodium azide, and using polyphosphoric acid as solvent. b) For the preparation of a compound of the general formula I where a hydrogen atom means:
Omsetning av et sulfoksyd med den generelle formelReaction of a sulfoxide with the general formula
hvor A, B, n og R^er som innledningsvis angitt, med en forbindelse med den generelle formel where A, B, n and R are as initially indicated, with a compound of the general formula
hvor X betyr en karbonyl- eller sulfonylgruppe, og R^ betyr en i o-stilling disubstituert arylgruppe så som en 2,4,6-trimetylfenyl- eller 2,4,6-triisopropylfenyl-gruppe eller også en hydroksygruppe, når X betyr en sulfonylgruppe. where X means a carbonyl or sulfonyl group, and R^ means an aryl group disubstituted in the o-position such as a 2,4,6-trimethylphenyl or 2,4,6-triisopropylphenyl group or also a hydroxy group, when X means a sulfonyl group.
Omsetningen utføres hensiktsmessig i et oppløsningsmiddel eller en oppløsningsmiddélblanding så som metylenklorid, kloroform, dimetylformamid, tetrahydrofuran eller dioksan, ved temperaturer mellom 0 og 50°C, fortrinnsvis ved temperaturer mellom 5 og 40°C. Særlig fordelaktig utføres omsetningen ved at en forbindelse med den generelle formel III anvendes uten forutgående isolering, resp. fremstilles i reaksjonsblandingen. c) For fremstilling av en forbindelse med den generelle formel I hvor n betyr tallet 1: Oksydasjon av en merkaptoforbindelse med den generelle formel The reaction is conveniently carried out in a solvent or solvent mixture such as methylene chloride, chloroform, dimethylformamide, tetrahydrofuran or dioxane, at temperatures between 0 and 50°C, preferably at temperatures between 5 and 40°C. The reaction is particularly advantageously carried out by using a compound of the general formula III without prior isolation, resp. is produced in the reaction mixture. c) For the preparation of a compound of the general formula I where n means the number 1: Oxidation of a mercapto compound of the general formula
hvor A, B, R^og R2er som innledningsvis angitt. where A, B, R 2 and R 2 are as indicated at the outset.
Oksydasjonen foretas fortrinnsvis i et oppløsningsmiddel eller en oppløsningsmiddélblanding, f.eks. i vann, vann/pyridin, metanol, etanol, aceton, maursyre, iseddik, trifluoreddiksyre eller fortynnet svovelsyre, alt efter det anvendte oksydasjonsmiddel ved temperaturer mellom -80 og 1C0°C. Særlig fordelaktig utføres omsetningen med en ekvivalent av det anvendte oksydasjonsmiddel, f.eks. med hydrogenperoksyd i iseddik eller maursyre ved 0 til 20°C eller i aceton ved 0 til 60°C, med en persyre så som permaursyre i iseddik eller trifluoreddiksyre ved 0 til 50°C, eller med natriummetaperjodat i vandig metanol eller etanol ved 15 til 25°C. d) For fremstilling.av en forbindelse med den generelle formel I hvor R2ikke betyr et hydrogenatom: Acylering av en forbindelse med den generelle formel hvor n, A, B og R^er som innledningsvis angitt. Omsetningen utføres hensiktsmessig i et oppløsningsmiddel eller en oppløsningsmiddélblanding så som vann, metylenklorid, kloroform, eter, tetrahydrofuran, dioksan eller dimetylformamid, med et passende acyleringsmiddel, f.eks. med en syre i nærvær av et syreaktiverende eller vanntiltrekkende middel så som tionylklorid, med dens anhydrider så som eddiksyreanhydrid, med dens estere så som p-toluensulfonsyreetylester eller karbonsyredietylester, med dens halogenider så som acetyl-klorid, klormaursyreetylester eller p-toluensulfonsyreklorid, eller med et passende isocyanat, idet disse eventuelt også kan tjene som oppløsningsmiddel, eventuelt i nærvær av en uorganisk eller tertiær organisk base så som natriumhydroksyd, kaliumkarbonat, trietylamin eller pyridin, idet sistnevnte . samtidig også kan tjene som oppløsningsmiddel, ved temperaturer mellom -25 og 100°C, fortrinnsvis ved temperaturer mellom -10 og 80°C. e) Omsetning av en hydroksyforbindelse med den generelle formel The oxidation is preferably carried out in a solvent or a solvent mixture, e.g. in water, water/pyridine, methanol, ethanol, acetone, formic acid, glacial acetic acid, trifluoroacetic acid or dilute sulfuric acid, depending on the oxidizing agent used, at temperatures between -80 and 1C0°C. The reaction is particularly advantageously carried out with an equivalent of the oxidizing agent used, e.g. with hydrogen peroxide in glacial acetic acid or formic acid at 0 to 20°C or in acetone at 0 to 60°C, with a peracid such as permauric acid in glacial acetic acid or trifluoroacetic acid at 0 to 50°C, or with sodium metaperiodate in aqueous methanol or ethanol at 15 to 25°C. d) For the preparation of a compound of the general formula I where R 2 does not mean a hydrogen atom: Acylation of a compound of the general formula where n, A, B and R 1 are as indicated at the outset. The reaction is conveniently carried out in a solvent or solvent mixture such as water, methylene chloride, chloroform, ether, tetrahydrofuran, dioxane or dimethylformamide, with a suitable acylating agent, e.g. with an acid in the presence of an acid-activating or water-attracting agent such as thionyl chloride, with its anhydrides such as acetic anhydride, with its esters such as p-toluenesulfonic acid ethyl ester or carboxylic acid diethyl ester, with its halides such as acetyl chloride, ethyl chloroformate or p-toluenesulfonic acid chloride, or with a suitable isocyanate, since these can optionally also serve as a solvent, optionally in the presence of an inorganic or tertiary organic base such as sodium hydroxide, potassium carbonate, triethylamine or pyridine, the latter being . at the same time can also serve as a solvent, at temperatures between -25 and 100°C, preferably at temperatures between -10 and 80°C. e) Reaction of a hydroxy compound with the general one formula
hvor A er som innledningsvis angitt, eller dens salter med uorganiske eller tertiære organiske baser, med en forbindelse med den generelle formel where A is as initially indicated, or its salts with inorganic or tertiary organic bases, with a compound of the general formula
hvor n, R^, R2og B er som innledningsvis angitt, og Z betyr en nukleofil utskiftbar gruppe så som et halogenatom eller en sulfonsyreesterrest, f.eks. et klor-, brom- eller jod-atom, en p-toluensulfonyloksy- eller metansulfonyloksygruppe. where n, R 1 , R 2 and B are as indicated at the outset, and Z means a nucleophilic replaceable group such as a halogen atom or a sulphonic acid ester residue, e.g. a chlorine, bromine or iodine atom, a p-toluenesulfonyloxy or methanesulfonyloxy group.
Omsetningen utføres hensiktsmessig i et egnet opp-løsningsmiddel eller en oppløsningsmiddélblanding så som dioksan, tetrahydrofuran, kloroform eller toluen, fortrinnsvis, i et vannfritt, aprotisk oppløsningsmiddel så som aceton, dimetylformamid eller dimetylsulfoksyd, eventuelt i nærvær av en alkalibase så som natriumkarbonat, kaliumkarbonat eller natriumhydroksyd, ved temperaturer mellom Q°C og det anvendte oppløsningsmiddels koketemperatur, f.eks. ved temperaturer mellom 0 og 100°C, fortrinnsvis ved temperaturer mellom 10 og 50°C. Omsetningen kan imidlertid også utføres uten oppløsningsmiddel. f) For fremstilling av en forbindelse med den generelle formel I hvor n betyr tallet 0: The reaction is conveniently carried out in a suitable solvent or a solvent mixture such as dioxane, tetrahydrofuran, chloroform or toluene, preferably in an anhydrous, aprotic solvent such as acetone, dimethylformamide or dimethylsulfoxide, optionally in the presence of an alkali base such as sodium carbonate, potassium carbonate or sodium hydroxide, at temperatures between Q°C and the boiling temperature of the solvent used, e.g. at temperatures between 0 and 100°C, preferably at temperatures between 10 and 50°C. However, the reaction can also be carried out without a solvent. f) For the preparation of a compound of the general formula I where n means the number 0:
Omsetning av en tioeter med den generelle formelReaction of a thioether with the general formula
hvor A, B og R, er som innledningsvis angitt, med et amid med den generelle formel where A, B and R are, as indicated at the outset, with an amide of the general formula
hvor Hal betyr et klor- eller bromatom, og R^<1>har de for R2innledningsvis angitte betydninger med unntagelse av hydrogen, eller med dets alkalisalt og eventuelt påfølgende hydrolyse. where Hal means a chlorine or bromine atom, and R^<1> has the meanings given for R2 at the beginning with the exception of hydrogen, or with its alkali salt and possibly subsequent hydrolysis.
Omsetningen utføres fortrinnsvis med et alkalisalt av en forbindelse med den generelle formel IX, f.eks. natriumsaltet, eventuelt i nærvær av en uorganisk base så som en alkalibase, i et oppløsningsmiddel eller en oppløsningsmiddélblanding så The reaction is preferably carried out with an alkali salt of a compound of the general formula IX, e.g. the sodium salt, optionally in the presence of an inorganic base such as an alkali base, in a solvent or a solvent mixture such
som metanol, metanol/vann eller etanol, hensiktsmessig ved temperaturer mellom 0 og 80°C, fortrinnsvis ved temperaturer mellom 5 og 50°C. such as methanol, methanol/water or ethanol, suitably at temperatures between 0 and 80°C, preferably at temperatures between 5 and 50°C.
Den eventuelt påfølgende hydrolyse utføres i nærvær av en syre eller base/fortrinnsvis i nærvær av en base så som natronlut, i et oppløsningsmiddel eller en oppløsningsmiddél-blanding så som vann, metanol, vann/metanol eller tetrahydrofuran/vann, ved temperaturer opp til det anvendte oppløsnings-middels koketemperatur. The optionally subsequent hydrolysis is carried out in the presence of an acid or base/preferably in the presence of a base such as caustic soda, in a solvent or a solvent mixture such as water, methanol, water/methanol or tetrahydrofuran/water, at temperatures up to used solvent boiling temperature.
De fremstilte forbindelser med den generelle formel I kan eventuelt derefter overføres til sine salter med sterke syrer. Egnede syrer er f.eks. saltsyre, svovelsyre eller mesitylensulfonsyre. The prepared compounds of the general formula I can optionally then be transferred to their salts with strong acids. Suitable acids are e.g. hydrochloric acid, sulfuric acid or mesitylene sulphonic acid.
De som utgangsstoffer anvendte forbindelser med de generelle formler II til IX er delvis kjent fra litteraturen eller kan fremstilles ved vanlige metoder. The compounds with the general formulas II to IX used as starting materials are partly known from the literature or can be prepared by usual methods.
De som utgangsstoffer anvendte forbindelser med de generelle formler II eller Ila er f.eks. beskrevet i EP-A1-0.003.771 The compounds with the general formulas II or IIa used as starting materials are e.g. described in EP-A1-0.003.771
og tysk patentansøkning P 30 42 632.5 av 12. november 1980 eller kan fremstilles ifølge de fremgangsmåter som er beskrevet i EP-Al-O.003.771. and German patent application P 30 42 632.5 of 12 November 1980 or can be produced according to the methods described in EP-A1-0.003.771.
De som utgangsstoffer anvendte forbindelser med den generelle formel III får man fortrinnsvis ved omsetning av en passende 0-karbonyl- eller 0-sulfony1-acethydroksam-syreester med svovelsyre og påfølgende ekstraksjon efter tilsetning av en base. The compounds of the general formula III used as starting materials are preferably obtained by reacting a suitable O-carbonyl or O-sulphonyl-acethydroxamic acid ester with sulfuric acid and subsequent extraction after addition of a base.
De som utgangsstoffer anvendte merkaptoforbindelser med den generelle formel IV får man f.eks. ved omsetning av en passende tioeter med et kloramin eller med 0-mesitylensulfonyl-hydroksylamin. The mercapto compounds with the general formula IV used as starting materials are obtained, for example by reaction of a suitable thioether with a chloramine or with O-mesitylenesulfonyl-hydroxylamine.
En som utgangsstoff anvendt forbindelse med den generelle formel V får man f.eks. ved oksydasjon av en passende merkapto-forbindelse, som oppnås ved omsetning av en passende tioeter med et kloramin og påfølgende hydrolyse, eller ved omsetning av en passende merkapto- eller sulfinylforbindelse med 0-mesitylensulfony1-hydroksylamin. A compound with the general formula V used as a starting material gives, for example, by oxidation of a suitable mercapto compound, which is obtained by reaction of a suitable thioether with a chloramine and subsequent hydrolysis, or by reaction of a suitable mercapto or sulfinyl compound with O-mesitylenesulfony1-hydroxylamine.
En som utgangsmateriale anvendt forbindelse med den generelle formel VII får man f.eks. ved omsetning av en passende sulfinylforbindelse, som man oppnår ved oksydasjon av en passende tioeter, med et passende O-mesitylensulfonyl-hydroksylamin og eventuelt påfølgende acylering. A compound with the general formula VII used as starting material gives, for example, by reaction of a suitable sulfinyl compound, which is obtained by oxidation of a suitable thioether, with a suitable O-mesitylenesulfonyl-hydroxylamine and optionally subsequent acylation.
En som utgangsmateriale anvendt forbindelse med den generelle formel VIII får man f.eks. ved omsetning av en passende hydroksy- resp. merkaptoforbindelse med et passende halogenid i nærvær av en base. A compound with the general formula VIII used as starting material gives, for example, by conversion of a suitable hydroxy- or mercapto compound with an appropriate halide in the presence of a base.
En som utgangsmateriale anvendt forbindelse med den generelle formel IX får man f.eks. ved omsetning av et passende amid med et hypohalogenitt. A compound with the general formula IX used as starting material gives, for example, by reacting an appropriate amide with a hypohalide.
Som nevnt innledningsvis oppviser de nye forbindelserAs mentioned at the beginning, they show new connections
med den generelle formel I verdifulle farmakologiske egenskaper, særlig antitrombotiske virkninger. Forbindelsene øker syntesen av det aggregas"jonshemmende prostaglandin with the general formula I valuable pharmacological properties, especially antithrombotic effects. The compounds increase the synthesis of the aggregation-inhibiting prostaglandin
(prostacyklin). Dessuten representerer forbindelsene med(prostacyclin). Moreover, the connections with represent
den generelle formel I, hvor n betyr tallet 0, verdifulle mellomprodukter for fremstilling av de nye forbindelser med den generelle formel I hvor n betyr tallet 1. the general formula I, where n means the number 0, valuable intermediates for the preparation of the new compounds with the general formula I where n means the number 1.
Videre oppviser forbindelsene med den generelle formel I en hemmende virkning på tumormetastasedannelsen, og dette beror på de følgende egenskaper hos de fremstilte forbindelser: 1. De er hemmere av blodplate-fos fodiesterase, som er kjent som hemmer for tumormetastasedannelsen (H. Gastpar, Thrombosis Research 5, 277-289 (1974) og K.V. Honn, Furthermore, the compounds of the general formula I exhibit an inhibitory effect on tumor metastasis formation, and this is due to the following properties of the compounds produced: 1. They are inhibitors of platelet phosphodiesterase, which is known to inhibit tumor metastasis formation (H. Gastpar, Thrombosis Research 5, 277-289 (1974) and K. V. Honn,
Science 212, 1270-1272 (1981)). Science 212, 1270-1272 (1981)).
2. Forbindelsene forårsaker en sterk forlengelse av blødningstiden, dvs. de hemmer den primære hemostase, den første festing av trombocytter til skadede kar under dannelse av en ren blodplatetrombe, allerede ved meget lav dosering. Dette'kan for forbindelsene med formel I ikke alene forklares ved en begrensning av blodplatefunksjonen, men også ved én forhøyet prostacyklin-frigjøring fra endotelcellene i karene. En bekreftelse er uteblivelse av blødningstidforlengelse 2. The compounds cause a strong prolongation of the bleeding time, i.e. they inhibit the primary hemostasis, the first attachment of platelets to damaged vessels during the formation of a pure platelet thrombus, already at a very low dosage. For the compounds of formula I, this can not only be explained by a limitation of platelet function, but also by an elevated prostacyclin release from the endothelial cells in the vessels. A confirmation is the absence of bleeding time extension
når man avbryter prostacyklin-syntesen i endotelcellene ved hjelp av tilførsel av cyklooksygenase-hemmere på forhånd. Forbindelsene representerer, således en hittil ukjent, optimal kombinasjon av to virkningsprinsipper, nemlig forhøyet cAMP-speil ved stimulering av dannelsen (prostacyklin) og samtidig hemning av nedbrytningen (PDE-hemning). Den således oppnådde økning av prostacyklinaktiviteten resp. prostacyklinsyntesen i karveggen er ifølge Honn (K. v. Honn, Science 212, 1270-1272 when prostacyclin synthesis in the endothelial cells is interrupted by prior administration of cyclooxygenase inhibitors. The compounds thus represent a hitherto unknown, optimal combination of two principles of action, namely elevated cAMP level by stimulating the formation (prostacyclin) and simultaneous inhibition of the breakdown (PDE inhibition). The thus achieved increase in prostacyclin activity resp. prostacyclin synthesis in the vessel wall is, according to Honn (K. v. Honn, Science 212, 1270-1272
(1981)) likeledes årsak til hemning av tumormetastasedannelsen. (1981)) likewise cause inhibition of tumor metastasis formation.
Som eksempler ble forbindelseneAs examples were the compounds
A = 6-(4-metylsulfoksimino-butoksy)-3,4-dihydrokarbostyril-mesitylensulfonat, A = 6-(4-methylsulfoximino-butoxy)-3,4-dihydrocarbostyryl mesitylene sulfonate,
B = 6-(4-fenylsulfoksimino-butoksy)-3,4-dihydrokarbostyril,B = 6-(4-phenylsulfoximino-butoxy)-3,4-dihydrocarbostyryl,
C = 6-[ 4-(4-fluorfenylsulfoksimino)-butoksy]-3,4-dihydrokarbostyril, C = 6-[4-(4-fluorophenylsulfoximino)-butoxy]-3,4-dihydrocarbostyryl,
D = 6-[4-(4-klorfenylsulfoksimino)-butoksy]-3,4-dihydro- . D = 6-[4-(4-chlorophenylsulfoximino)-butoxy]-3,4-dihydro- .
karbostyril,carbostyril,
E =(6-[4-(N-acety1-3,4-diklorfenylsulfoksimino)-butoksy]-3,4-dihydrokarbostyri 1, E =(6-[4-(N-acety1-3,4-dichlorophenylsulfoximino)-butoxy]-3,4-dihydrocarbostyri 1,
F = 6-[4-(N-p-toluensulfonyl-3,4-diklorfenylsulfoksimino)-butoksy]-3,4-dihydrokarbostyril, F = 6-[4-(N-p-toluenesulfonyl-3,4-dichlorophenylsulfoximino)-butoxy]-3,4-dihydrocarbostyryl,
G = 6-[4-(4-fluorfenylsulfoksimino)-butoksy]-karbostyril,G = 6-[4-(4-fluorophenylsulfoximino)-butoxy]-carbostyryl,
H = 6-[4-(4-klorfenylsulfoksimino)-butoksy]-karbostyril,H = 6-[4-(4-chlorophenylsulfoximino)-butoxy]-carbostyryl,
I ■=' 6-[4-(3-metyl-4-bromfenylsulfoksimino)-butoksy]-karbostyril, I ■=' 6-[4-(3-methyl-4-bromophenylsulfoximino)-butoxy]-carbostyril,
K = 6-[ A-(4-tert.but<y>lfen<y>1-sulfoksimino)-butoksy]-3,4-dihydrokarbostyril, K = 6-[ A -(4-tert.but<y>lphen<y>1-sulfoximino)-butoxy]-3,4-dihydrocarbostyryl,
L = 6-[4-(4-cykloheksylfeny1-sulfoksimino)-butoksy]-3,4-dihydrokarbostyril, L = 6-[4-(4-cyclohexylphenyl-sulfoximino)-butoxy]-3,4-dihydrocarbostyryl,
M = 6-[4-(4-tert.butylfenyl-sulfoksimino)-butoksy]-karbostyril, M = 6-[4-(4-tert.butylphenyl-sulfoximino)-butoxy]-carbostyryl,
N = 6-(4-cykloheksy1-sulfoksimino-butoksy)-karbostyril,N = 6-(4-cyclohexy1-sulfoximino-butoxy)-carbostyryl,
0 = 6-[4-(N-butyry1-3,4-diklorfeny1-sulfoksimino)-butoksy]-3,4-dihydrokarbostyril, 0 = 6-[4-(N-butyryl-3,4-dichlorophenyl-sulfoximino)-butoxy]-3,4-dihydrocarbostyril,
P = 5-[4-(N-acety1-4-klorfenyl-sulfoksimino)-butoksy]-3,3-dimetyl-indolin-2-on, P = 5-[4-(N-acety1-4-chlorophenyl-sulfoximino)-butoxy]-3,3-dimethyl-indolin-2-one,
Q = 6-[4-(N-(4-tert.butylbenzoyl)-3,4-dimetoksyfenyl-sulfoksimino ) -butoksy]-3,4-dihydrokarbostyril, og Q = 6-[4-(N-(4-tert.butylbenzoyl)-3,4-dimethoxyphenyl-sulfoximino)-butoxy]-3,4-dihydrocarbostyryl, and
R 6-[4-(3,4-dimetoksyfeny1-sulfoksimino)-butoksy]-3,4-dihydrokarbostyril R 6-[4-(3,4-dimethoxyphenyl-sulfoximino)-butoxy]-3,4-dihydrocarbostyryl
undersøkt med hensyn til sine biologiske egenskaper som følger: examined for its biological properties as follows:
1. PDE- hemnlng:1. PDE inhibition:
Prinsipp:Principle:
cAMP hydrolyseres til AMP av fosfodiesterase (PDE) fra forskjellige kilder, også fra blodplater. Denne hydrolyse hemmes konsentrasjonsavhengig av PDE-hemmere. cAMP is hydrolyzed to AMP by phosphodiesterase (PDE) from various sources, including platelets. This hydrolysis is inhibited concentration-dependently by PDE inhibitors.
Metode:Method:
Som fosfodiesterase anvendes 10.000 x g toppskiktet fra menneskeblodplater som er frosset med vann og igjen tint opp. 0,3 ml av en blanding inneholdende 0,1 mol/l trishydroksy-aminometan (pH 7,4), 3 mmol/1 magnesiumklorid, 1 mmol/1 AMP, 1 nmol/1 H-cAMP (spesifikk aktivitet ca. 10 MBq/pmol), PDE og prøveforbindelsen resp. vann for kontrollene, inkuberes i As phosphodiesterase, 10,000 x g of the top layer from human platelets that have been frozen with water and thawed again is used. 0.3 ml of a mixture containing 0.1 mol/l trishydroxyaminomethane (pH 7.4), 3 mmol/1 magnesium chloride, 1 mmol/1 AMP, 1 nmol/1 H-cAMP (specific activity approx. 10 MBq /pmol), PDE and the test compound resp. water for the controls, are incubated in
15 minutter ved 37°C.15 minutes at 37°C.
Inkuberingen stanses ved tilsetning av 0,5 ml sinksulfat (0,266 mol/l) og 0,5 ml bariumhydroksyd (0,226 mol/l), bunn-fallet frasentrifugeres, og aktiviteten av det uomsatte<3>"H-cAMP som er tilbake i toppskiktet, bestemmes. På grunnlag av sammenligningen mellom prøveforbindelsen og kontrollforbindelsen ble konsentrasjonen for en 50%ig hemmende virkning (IC<-q) for den aktuelle forbindelse beregnet: The incubation is stopped by adding 0.5 ml zinc sulphate (0.266 mol/l) and 0.5 ml barium hydroxide (0.226 mol/l), the precipitate is centrifuged off, and the activity of the unreacted<3>"H-cAMP that is back in On the basis of the comparison between the test compound and the control compound, the concentration for a 50% inhibitory effect (IC<-q) for the compound in question was calculated:
Den hemmende virkning på tumormetastasedannelsen kan også fastlegges ifølge Gastpar et al. (se Thrombosis Research 5, 277-289 (1974)) som en virkning som hindrer tumorcelle-emboli. Her tilføres prøveforbindelsen før tumorcelle-transplantasjonen, og overlevelsesgraden for forsøksdyrene, f.eks. rotter, bestemmes sammenlignet med kontrollene. 2. Bestemmelse av- forlengningen av blødningstiden: The inhibitory effect on the formation of tumor metastasis can also be determined according to Gastpar et al. (see Thrombosis Research 5, 277-289 (1974)) as an effect that prevents tumor cell embolism. Here, the test compound is added before the tumor cell transplantation, and the survival rate for the test animals, e.g. rats, is determined compared to the controls. 2. Determination of the prolongation of the bleeding time:
Forhåndsbemerkning:Advance notice:
Den menneskelige organisme og også organismen hos andre varmblodige dyr er i besittelse av en sinnrik mekanisme som The human organism and also the organism of other warm-blooded animals is in possession of an ingenious mechanism which
skal beskytte den mot blodtap i tilfelle av skader. Dette system består av blodplatene (trombocytter), som ved hjelp av sine klebeegenskaper raskt skal tilstoppe en kardefekt og således medføre den primære hemostase. Ved siden av denne rent cellulære blodstillingsmekanismen har kroppen også et blodkoagulasjonssystem. I dette system bringes plasma-faktorer (eggehvitestoffer) i en virksom form, slik at det flytende plasmafibrinogen til slutt kan overføres til et fibrinkoagulat. Systemet med den primære hemostase, som hovedsakelig reguleres av trombocyttene, men også av should protect it from blood loss in case of injuries. This system consists of the platelets (thrombocytes), which, with the help of their adhesive properties, will quickly plug a cardiac defect and thus bring about the primary hemostasis. In addition to this purely cellular blood status mechanism, the body also has a blood coagulation system. In this system, plasma factors (egg white substances) are brought into an active form, so that the liquid plasma fibrinogen can finally be transferred to a fibrin coagulum. The system of the primary hemostasis, which is mainly regulated by the platelets, but also by
prostacyklin-aktiviteten i karveggene, og koagulasjonssystemet utfyller hverandre med henblikk på det samme mål, nemlig å beskytte kroppen mot blodtap. the prostacyclin activity in the vessel walls and the coagulation system complement each other with a view to the same goal, namely to protect the body against blood loss.
Ved mange sykdommer kan det også i et intakt karsystem oppstå koagulasjonsprosesser eller sammenklumpning av trombocytter. En svekkelse av blodkoagulasjonssystemet ved hjelp av kumarin eller heparin er kjent og kan lett måles ved hjelp av kjente blodkoagulasjonsmetoder, som viser en forlengelse under preparatinnvirkning (plasmarecalcif.-tid, Quick-bestemmelse, trombintid osv.). In many diseases, coagulation processes or clumping of platelets can also occur in an intact vascular system. A weakening of the blood coagulation system by means of coumarin or heparin is known and can be easily measured using known blood coagulation methods, which show a prolongation under the influence of the preparation (plasma recalcif. time, Quick determination, thrombin time, etc.).
I tilfelle av en skade skjer den første, raske blod-stilling ved at trombocyttene heftes og aggregeres på karveggen, og ved påføring av en standardisert skade kan man således lett. bestemme funksjonen av trombocyttene resp. prostacyklin-aktiviteten i karveggen ved å måle blødnings-tiden. Den normale blødningstid utgjør hos mennesker ca. In the event of an injury, the first, rapid blood position occurs by the platelets adhering and aggregating on the vessel wall, and by applying a standardized injury one can thus easily. determine the function of the platelets or the prostacyclin activity in the vessel wall by measuring the bleeding time. The normal bleeding time in humans is approx.
1 til 3 minutter, men forutsetter at det er til stede trombocytter i aktiv form og i tilstrekkelig antall. Ved et normalt trombocytt-tall viser således en forlenget blødningstid at det forekommer en forstyrret funksjon av trombocyttene og/eller en forhøyet prostacyklinaktivitet i karveggen. Dette forekommer f.eks. ved noen medfødte trombocytt-funksjonsforstyrrelser. Hvis man på den annen side ved hjelp av medikamenter vil forhindre tilbøyeligheten til spontan sammenklumpning av trombocyttene, hvilket fører til kar-tilstopninger i det arterielle system, må ved en vellykket terapi som er virksom overfor trombocyttene eller karveggen, blødningstiden forlenges under innvirkning av forbindelsene. 1 to 3 minutes, but presupposes that platelets are present in active form and in sufficient numbers. With a normal platelet count, an extended bleeding time thus shows that there is a disturbed function of the platelets and/or an increased prostacyclin activity in the vessel wall. This occurs e.g. in some congenital platelet function disorders. If, on the other hand, by means of drugs one wants to prevent the tendency to spontaneous clumping of the platelets, which leads to vessel blockages in the arterial system, in a successful therapy which is effective against the platelets or the vessel wall, the bleeding time must be prolonged under the influence of the compounds.
Med en antitrombotisk aktiv forbindelse venter man således en forlengelse av blødningstiden, og da det plasmatiske koagulasjons system ikke berøres, en normal blodkoagulasjonstid. With an antithrombotic active compound, one therefore expects an extension of the bleeding time, and since the plasmatic coagulation system is not affected, a normal blood coagulation time.
Litteratur: W.D. Keidel: Kurzgefa3tes Lehrbuch derLiterature: W.D. Keidel: Kurzgefa3tes Lehrbuch der
Physiologie, Georg Thi.eme Verlag Stuttgart 1967, side 31: Der Blutstillungsvorgang. Physiologie, Georg Thi.eme Verlag Stuttgart 1967, page 31: Der Blutstillungsvorgang.
For å bestemme blødningstiden tilføres prøveforbindelsene til våkne mus i en dose på 2,5 mg/kg p.o. Efter 1 time ble det fra halespissen hos hvert dyr avkuttet ca. 0,5 mm, og det blod. som kom ut ble tørket forsiktig av med 30 sekunders mellomrom ved hjelp av et filtrerpapir. Antall således oppnådde bloddråper ga et mål for blødningstiden (5 dyr pr. forsøk). De følgende tallangivelser betyr prosentvis forlengelse sammenlignet med kontrollene: To determine the bleeding time, the test compounds are administered to awake mice at a dose of 2.5 mg/kg p.o. After 1 hour approx. was cut off from the tip of the tail of each animal. 0.5 mm, and that blood. that came out was gently wiped off at 30 second intervals using a filter paper. The number of blood drops thus obtained gave a measure of the bleeding time (5 animals per experiment). The following figures represent percentage elongation compared to controls:
2. • Akutt toksisitet: 2. • Acute toxicity:
Den akutte toksisitet av prøveforbindelsene ble bestemt orienterende på grupper på hver 10 mus efter oral admini-strering av en enkeltdose (observasjonstid: 14 dager): The acute toxicity of the test compounds was determined approximately in groups of 10 mice each after oral administration of a single dose (observation time: 14 days):
De nye forbindelser fremstilt ifølge oppfinnelsen The new compounds produced according to the invention
er på grunn av sine ovennevnte farmakologiske egenskaper egnet til forebyggelse av trombo-emboliske lidelser så som hjerteinfarkt, cerebralinfarkt, såkalt forbigående ischemiske angrep, Amaurosis fugax, til forebyggelse av arteriosklerose og til metastaseforebyggelse. is, due to its above-mentioned pharmacological properties, suitable for the prevention of thromboembolic disorders such as myocardial infarction, cerebral infarction, so-called transient ischemic attacks, Amaurosis fugax, for the prevention of arteriosclerosis and for metastasis prevention.
Den dosering som er nødvendig for å oppnå én passende virkning, er hensiktsmessig 2 til 4 ganger daglig 0,1 til 4 mg/kg kroppsvekt, fortrinnsvis 0,2 til 3 mg/kg kroppsvekt. De fremstilte forbindelser med den generelle formel I og deres fysiologisk forlikelige syreaddisjonssalter med sterke syrer, eventuelt i kombinasjon med andre virke-stoffer, sammen med ett eller flere inerte, vanlige bære-materialer og/eller fotynningsmidler, f.eks. maisstivelse, melkesukker, rørsukker, mikrokrystallinsk cellulose, magnesium-stearat, polyvinylpyrrolidon, sitronsyre, vinsyre, vann, vann/etanol, vann/glycerol, vann/sorbitol, ikke-ioniske tensider så som polyoksyetylen-fettsyreestere, vann/polyetylen-glykol, propylenglykol, cetylstearylalkohol, karboksymety1-cellulose eller fettholdige stoffer så som hardt fett eller egnede blandinger derav, kan innarbeides i vanlige galeniske preparater så som tabletter, dragéer, kapsler, pulvere, The dosage necessary to achieve one suitable effect is suitably 2 to 4 times a day 0.1 to 4 mg/kg body weight, preferably 0.2 to 3 mg/kg body weight. The prepared compounds of the general formula I and their physiologically compatible acid addition salts with strong acids, optionally in combination with other active substances, together with one or more inert, common carrier materials and/or foot thinners, e.g. corn starch, milk sugar, cane sugar, microcrystalline cellulose, magnesium stearate, polyvinylpyrrolidone, citric acid, tartaric acid, water, water/ethanol, water/glycerol, water/sorbitol, non-ionic surfactants such as polyoxyethylene fatty acid esters, water/polyethylene glycol, propylene glycol , cetylstearyl alcohol, carboxymethyl-cellulose or fatty substances such as hard fat or suitable mixtures thereof, can be incorporated into usual galenic preparations such as tablets, dragées, capsules, powders,
. suspensjoner, dråper, ampuller, safter eller stikkpiller.. suspensions, drops, ampoules, juices or suppositories.
De følgende eksempler skal tjene til å illustrere oppfinnelsen ytterligere: Eksempel 1 The following examples shall serve to further illustrate the invention: Example 1
6-( 4- fenylsulfoksimino- butoksy)- 3, 4- dihydrokarbostyril6-(4-phenylsulfoximino-butoxy)-3,4-dihydrocarbostyril
3,4 g (0,01 mol) 6-(4-fenylsulfiny1-butoksy)-3,4-dihydrokarbostyril innrøres ved 45°C i 50 ml polyfosforsyre. Efter at praktisk talt alt er oppløst, tilsetter man i løpet av 30 minutter 0,98 g (0,015 mol) natriumazid i små porsjoner. Det oppstår en svak utvikling av nitrogengass. Man omrører den beige-farvede, kremaktige masse i 3 timer ved 45-50°G og tilsetter derefter 150 g is. Den dannede uklare oppløsning innstiller man på pH 8 med konsentrert ammoniakk og ekstraherer det utfelte, harpiksaktige produkt med kloroform. Den olje-aktige inndampningsrest omkrystalliseres fra etylacetat. 3.4 g (0.01 mol) of 6-(4-phenylsulfinyl-butoxy)-3,4-dihydrocarbostyril is stirred at 45°C in 50 ml of polyphosphoric acid. After practically everything has dissolved, 0.98 g (0.015 mol) of sodium azide are added in small portions over the course of 30 minutes. A slight evolution of nitrogen gas occurs. The beige-coloured, creamy mass is stirred for 3 hours at 45-50°G and then 150 g of ice is added. The cloudy solution formed is adjusted to pH 8 with concentrated ammonia and the precipitated, resinous product is extracted with chloroform. The oily evaporation residue is recrystallized from ethyl acetate.
Man får hvite krystaller.You get white crystals.
Smeltepunkt: 127-129°CMelting point: 127-129°C
Utbytte: 1,6 g (44,6% av det teoretiske).Yield: 1.6 g (44.6% of the theoretical).
Eksempel- 2 Example- 2
6- [ 4-( 3, 4-d iklorfenylsulfoksimino)- butoksy]- 3x4- dihydrokarbostyril 6- [ 4-( 3, 4-dichlorophenylsulfoximino)-butoxy]- 3x4- dihydrocarbostyril
24,0 g (0,84 mol) 0-mesitylensulfonyl-acethydroksamsyre-etylester oppløses i 3'5 ml dioksan og tilsettes dråpevis 17 ml 90%ig svovelsyre ved 20-23°C i løpet av 20 minutter under 24.0 g (0.84 mol) 0-mesitylenesulfonyl-acethydroxamic acid ethyl ester is dissolved in 3.5 ml of dioxane and 17 ml of 90% sulfuric acid is added dropwise at 20-23°C during 20 minutes under
god omrøring. Man efterrører i ytterligere 10 minutter ved den samme temperatur, heller derefter i 300 ml isvann og ekstraherer det dannede O-mesitylensulfonyl-hydroksylamin med 100 ml metylenklorid, vasker ytterligere to ganger med isvann<p>g tørrer over magnesiumsulfat. I den oppnådde oppløsning inn-fører man 12,4 g (0,03 mol) 6- [4-(3,4-diklorfenylsulfinyl)-butoksy]-3,4-dihydrokarbostyril og omrører i 18 timer ved romtemperatur. Den knapt rørbare krystallgrøt fortynnes med 120 ml etylacetat, og derefter avsuges det krystallinske 6- [4-(3,4-diklorfenyl-sulfoksimino)-butoksy]-3,4-dihydro-karbostyri1-mesitylensulfonat. For å oppnå den frie base suspenderer' man i 60 ml metanol og utrører med 17 ml 2N natronlut hvorved alt går i oppløsning. Efter kort tid faller det ut et hvitt bunnfall av 6-[4-(3,4-diklorfenylsulfoksimino)-butoksy]-3,4-dihydrokarbostyril. good stirring. The mixture is stirred for a further 10 minutes at the same temperature, then poured into 300 ml of ice water and the O-mesitylenesulfonyl hydroxylamine formed is extracted with 100 ml of methylene chloride, washed twice more with ice water and dried over magnesium sulphate. 12.4 g (0.03 mol) of 6-[4-(3,4-dichlorophenylsulfinyl)-butoxy]-3,4-dihydrocarbostyril are introduced into the resulting solution and stirred for 18 hours at room temperature. The barely stirrable crystal slurry is diluted with 120 ml of ethyl acetate, and then the crystalline 6-[4-(3,4-dichlorophenyl-sulfoximino)-butoxy]-3,4-dihydro-carbostyryl-mesitylenesulfonate is filtered off with suction. To obtain the free base, suspend in 60 ml of methanol and stir with 17 ml of 2N caustic soda, whereby everything dissolves. After a short time, a white precipitate of 6-[4-(3,4-dichlorophenylsulfoximino)-butoxy]-3,4-dihydrocarbostyril falls out.
Smeltepunkt: 160-161°C,Melting point: 160-161°C,
Utbytte: 10,4 g (81,1% av det teoretiske).Yield: 10.4 g (81.1% of theoretical).
Eksempel 3 Example 3
6- [ 4-( 4- tert. buty1fenylsulfoksimino)- butoksy]- 3, 4- dihydrokarbostyril 6- [ 4-( 4- tert. buty1phenylsulfoximino)-butoxy]- 3, 4- dihydrocarbostyril
Fremstilt analogt med eksempel 2 fra 6-[4-(4-tert.butyl-fenylsulfinyl)-butoksy]-3,4-dihydrokarbostyril og 0-mesitylen-sulf ony lhydroksy lamin. Prepared analogously to example 2 from 6-[4-(4-tert.butyl-phenylsulfinyl)-butoxy]-3,4-dihydrocarbostyril and 0-mesitylene-sulfonylhydroxylamine.
Smeltepunkt: 201-203°C.Melting point: 201-203°C.
Utbytte: 44% av det teoretiske.Yield: 44% of the theoretical.
Eksempel 4 Example 4
6-[ 4-( 3, 5- di- tert. butyl- 4- hydro ksy- fenylsulfoksimino)-b utoksy]-3, 4- dihydrokarbostyril 6-[ 4-( 3, 5- di- tert. butyl- 4- hydroxy- phenylsulfoximino)-butoxy]-3, 4- dihydrocarbostyril
Fremstilt analogt med eksempel 2 fra 6-[4-(3,5-di-tert.-butyl-4-hydroksyfenylsulfinyl)-butoksy]-3,4-dihydrokarbostyril og Q-mesitylensulfonylhydroksylamin. Prepared analogously to example 2 from 6-[4-(3,5-di-tert-butyl-4-hydroxyphenylsulfinyl)-butoxy]-3,4-dihydrocarbostyril and Q-mesitylenesulfonylhydroxylamine.
Smeltepunkt: 110-112°CMelting point: 110-112°C
Utbytte: 52% av det teoretiske.Yield: 52% of the theoretical.
Eksempel 5 Example 5
6-[ 4-( 4- cykloheksylfenylsulfoksimino)- butoksy]- 3, 4- dihydrokarbostyril 6-[ 4-( 4- cyclohexylphenylsulfoximino)- butoxy]- 3, 4- dihydrocarbostyril
'Fremstilt analogt med eksempel 2 fra 6-[4-(4-cykloheksyl-fenylsulfinyl)-butoksy]-3,4-dihydrokarbostyril og O-mesitylensulfonylhydroksylamin. Prepared analogously to example 2 from 6-[4-(4-cyclohexyl-phenylsulfinyl)-butoxy]-3,4-dihydrocarbostyril and O-mesitylenesulfonylhydroxylamine.
Smeltepunkt: 17 4-17 6°C.Melting point: 17 4-17 6°C.
Utbytte: 65% av det teoretiske.'Yield: 65% of the theoretical.'
Eksempel 6 Example 6
6-[ 4-( 4- bifenylylsulfoksimino)- butoksy]- 3, 4- dihydrokarbostyril 6-[ 4-( 4- biphenylylsulfoximino)- butoxy]- 3, 4- dihydrocarbostyril
Fremstilt analogt med eksempel 2 fra 6-[ 4-(4-bifenylyl-sulfinyl)-butoksy]-3,4-dihydrokarbostyril og O-mesitylen-sulf onylhydroksylamin. Prepared analogously to example 2 from 6-[4-(4-biphenylyl-sulfinyl)-butoxy]-3,4-dihydrocarbostyril and O-mesitylene-sulfonylhydroxylamine.
Smeltepunkt: 184-186°C.Melting point: 184-186°C.
Utbytte: 64% av det teoretiske.Yield: 64% of the theoretical.
Eksempel 7 Example 7
6- [ 4-( naftyl-( 2)- sulfoksimino)- butoksy]- 3, 4- dihydrokarbostyril: Fremstilt analogt med eksempel 2 fra 6-[4-(nafty1-2-sulfiny1)-butoksy]-3,4-dihydrokarbostyril og 0-mesitylensulfony1-hydroksylamin. 6-[4-(naphthyl-(2)-sulfoximino)-butoxy]-3,4-dihydrocarbostyryl: Prepared analogously to example 2 from 6-[4-(naphthy1-2-sulfiny1)-butoxy]-3,4- dihydrocarbostyril and O-mesitylenesulfony1-hydroxylamine.
Smeltepunkt: 151-152°C.Melting point: 151-152°C.
Utbytte: 71% av det teoretiske.Yield: 71% of the theoretical.
Eksempel 8 Example 8
6-[ 4-( 4- fluorfenylsulfoksimino)- butoksy]-3, 4- dihydrokarbostyril 6-[ 4-( 4- fluorophenylsulfoximino)-butoxy]-3, 4- dihydrocarbostyril
Fremstilt analogt med eksempel 1 fra 6-[4-(4-fluorfenyl-sulfinyl)-butoksy]-3,4-dihydrokarbostyril og natriumazid i polyfosforsyre. Prepared analogously to example 1 from 6-[4-(4-fluorophenyl-sulfinyl)-butoxy]-3,4-dihydrocarbostyril and sodium azide in polyphosphoric acid.
Smeltepunkt: 170-173°C.Melting point: 170-173°C.
Utbytte: 7 8% av det teoretiske.Yield: 7 8% of the theoretical.
Eksempel' 9 Example' 9
6-[ 4-( 4- klorfe nylsulfoksimino)- butoksy]- 3, 4- dihydrokarbos tyril 6-[ 4-( 4- chlorophenylsulfoximino)- butoxy]- 3, 4- dihydrocarbostyryl
Fremstilt analogt med eksempel 2 fra 6-[4-(4-klorfenyl-sulf inyl)-butoksy ]-3 , 4-dihydrokarbostyril og O-mesitylen-sulf onylhydroksylamin . Prepared analogously to example 2 from 6-[4-(4-chlorophenyl-sulfinyl)-butoxy]-3,4-dihydrocarbostyril and O-mesitylene-sulfonylhydroxylamine.
Smeltepunkt: 150-151°C.Melting point: 150-151°C.
Utbytte: 60% av det teoretiske.Yield: 60% of the theoretical.
Eksempel 10 Example 10
6-[ 4-( 3- metyl- 4- brom- fenylsulfoksimino)- butoksy]- 3, 4- dihydrokarbostyril 6-[ 4-( 3- methyl- 4- bromo- phenylsulfoximino)- butoxy]- 3, 4- dihydrocarbostyril
; Fremstilt analogt med eksempel 2 fra 6-[4-( S-met<y>l^-bromf enylsulf inyl)-butoksy ]-3 , 4-dihydrokarbostyril og O-mesitylensulfonylhydroksylamin. ; Prepared analogously to example 2 from 6-[4-(S-meth<y>1^-bromophenylsulfinyl)-butoxy]-3,4-dihydrocarbostyril and O-mesitylenesulfonylhydroxylamine.
Smeltepunkt: 150-152°C,Melting point: 150-152°C,
Utbytte: 60% av det teoretiske.Yield: 60% of the theoretical.
Eksempel 11 Example 11
6-[ 4-( 3, 5- dibrom- 4- aminofenylsulfoksimino)- butoksy]-3, 4- dihydrokarbostyril 6-[ 4-( 3, 5- dibromo- 4- aminophenylsulfoximino)- butoxy]-3, 4- dihydrocarbostyril
Fremstilt analogt med eksempel 2 fra 6-[4-(3,4-dibrom-4-aminofenylsulfinyl)-butoksy]-3,4-dihydrokarbostyril og O-mesitylensulfonylhydroksylamin. Prepared analogously to example 2 from 6-[4-(3,4-dibromo-4-aminophenylsulfinyl)-butoxy]-3,4-dihydrocarbostyril and O-mesitylenesulfonylhydroxylamine.
Smeltepunkt: 110-113°C,Melting point: 110-113°C,
Utbytte: 55% av det teoretiske.Yield: 55% of the theoretical.
Eksempel 12Example 12
6-( 4- fenylsulfoksimino- butoksy)- karbostyril6-(4-phenylsulfoximino-butoxy)-carbostyryl
Fremstilt analogt med eksempel 2 fra 6-(4-fenylsulfinyl-butoksy)-karbostyril og 0-mesitylensulfonylhydroksylamin. Smeltepunkt: 161-162°C. Prepared analogously to example 2 from 6-(4-phenylsulfinyl-butoxy)-carbostyril and 0-mesitylenesulfonylhydroxylamine. Melting point: 161-162°C.
Utbytte: 60% av det teoretiske.Yield: 60% of the theoretical.
Eksempel 13 Example 13
6- [ 4-( 4- tert. butylfenylsulfoksimino)- butoksy]- karbos tyril 6- [ 4-( 4- tert. butylphenylsulfoximino)- butoxy]- carbostyryl
Fremstilt analogt med eksempel 1 fra 6-[4-(4-tert.butyl-fenylsulfinyl)-butoksy]-karbostyril og natriumazid i polyfosforsyre. Prepared analogously to example 1 from 6-[4-(4-tert.butyl-phenylsulfinyl)-butoxy]-carbostyryl and sodium azide in polyphosphoric acid.
Smeltepunkt: 208-210°C,Melting point: 208-210°C,
Utbytte: 45% av det teoretiske.Yield: 45% of the theoretical.
Eksempel 14 Example 14
6-[ 4-( 3, 5- di- tert. butyl- 4- hydroksy- fenylsulfoksimino)- buto ksy]-karbostyril 6-[ 4-( 3, 5- di- tert. butyl- 4- hydroxy- phenylsulfoximino)-butoxy]- carbostyryl
Fremstilt analogt med eksempel 2 fra 6-[4-(3,4-di-tert.-butyl-4-hydroksy-fenylsulfinyl)-butoksy]-karbostyril og O-mesitylensulfonylhydroksylamin. Prepared analogously to example 2 from 6-[4-(3,4-di-tert-butyl-4-hydroxy-phenylsulfinyl)-butoxy]-carbostyril and O-mesitylenesulfonylhydroxylamine.
Smeltepunkt: 205-207°C.Melting point: 205-207°C.
Utbytte: 59% av det teoretiske.Yield: 59% of the theoretical.
Eksempel 15 Example 15
6- L4-( 4- cykloheksylfenylsulfoksimino)- butoksy]- karbostyril 6- L4-(4-cyclohexylphenylsulfoximino)-butoxy]-carbostyryl
Fremstilt analogt med eksempel 1 fra 6-[4-(4-cykloheksyl-fenylsulfinyl)-butoksy]-karbostyril og natriumazid i polyfosforsyre. Prepared analogously to example 1 from 6-[4-(4-cyclohexyl-phenylsulfinyl)-butoxy]-carbostyril and sodium azide in polyphosphoric acid.
Smeltepunkt: 195-197°C,Melting point: 195-197°C,
Utbytte: 52% av det teoretiske.Yield: 52% of the theoretical.
Eksempel 16Example 16
6-[ 4-( 4- bifenylylsulfoksi mino)- butoksy]- karbostyril6-[ 4-( 4-biphenylylsulfoximino)-butoxy]- carbostyryl
Fremstilt analogt med eksempel 2 fra 6-[4-(4-bifenylyl-sulf inyl) -butoksy]-karbostyril og O-mesitylensulfonylhydroksylami Smeltepunkt: 2 3 6-2 3 8°C. Prepared analogously to example 2 from 6-[4-(4-biphenylyl-sulfinyl)-butoxy]-carbostyril and O-mesitylenesulfonylhydroxylami Melting point: 2 3 6-2 3 8°C.
Utbytte:76% av det teoretiske.Yield: 76% of the theoretical.
Eksempel 17Example 17
6- ( 4- cykloheksylsul foksi mino- butoksy)- karbostyril6-(4-cyclohexylsulfoxyminobutoxy)- carbostyryl
Fremtilt analogt med eksempel 1 fra 6-(4-cykloheksyl-sulfinyl-butoksy-karbostyril og natriumazid i polyfosforsyre. Smeltepunkt: 145-147°C. Prepared analogously to example 1 from 6-(4-cyclohexyl-sulfinyl-butoxy-carbostyryl and sodium azide in polyphosphoric acid. Melting point: 145-147°C.
Utbytte: 47% av det teoretiske.Yield: 47% of the theoretical.
Eksempel 18Example 18
6- [ 4-( 4- fluorfenylsulfoksimino)- butoksy]- karbostyril6- [ 4-( 4- fluorophenylsulfoximino)-butoxy]- carbostyryl
Fremstilt analogt med eksempel 2 fra 6-[4-(4-fluorfenyl-sulfinyl)-butoksy]-karbostyril og O-mesitylensulfonylhydroksylami Smeltepunkt: 177-179°C. Prepared analogously to example 2 from 6-[4-(4-fluorophenyl-sulfinyl)-butoxy]-carbostyryl and O-mesitylenesulfonyl hydroxylami Melting point: 177-179°C.
Utbytte: 70% av det teoretiske.Yield: 70% of the theoretical.
Eksempel- 19 Example- 19
6--[ 4- ( 4- klorfenylsulfoksiminc) - butoksy] - karbostyril6-[4-(4-chlorophenylsulfoximinc)-butoxy]-carbostyryl
Fremstilt analogt med eksempel 2 fra 6-[4-(4-klorfenyl-sulf inyl) -butoksy ] -karbostyril og O-mesitylensulfonylhydroksylamj Smeltepunkt: 201-203°C. Utbytte: 7 9% av det teoretiske. Prepared analogously to example 2 from 6-[4-(4-chlorophenyl-sulfinyl)-butoxy]-carbostyryl and O-mesitylenesulfonylhydroxylamj Melting point: 201-203°C. Yield: 7 9% of the theoretical.
Eksempel 20 Example 20
6-[ 4-( 4- bromfenylsulfoksim ino)- butoksy]-karbostyril6-[4-(4-bromophenylsulfoximine)-butoxy]-carbostyryl
Fremstilt analogt med eksempel 2. fra 6- [4-(4-bromf enylsulf inyl)-butoksy]-karbostyril og O-mesitylensulfonyl-hydroksylamin . Prepared analogously to example 2. from 6-[4-(4-bromophenylsulfinyl)-butoxy]-carbostyril and O-mesitylenesulfonyl-hydroxylamine.
Smeltepunkt: 211-213°C,Melting point: 211-213°C,
Utbytte: 63% av det teoretiske.Yield: 63% of the theoretical.
Eksempel 21 Example 21
6- [ 4- (- 3-, 4- diklorfeny lsulfoksimino) - butoksy] -karbostyril Fremstilt analogt med eksempel 2 fra 6-[4-(3,4-diklor-fenylsulfinyl)-butoksy]-karbostyril og O-mesitylensulfonyl-hydroksylamin. 6-[4-(-3-,4-dichlorophenylsulfoximino)-butoxy]-carbostyril Prepared analogously to example 2 from 6-[4-(3,4-dichloro-phenylsulfinyl)-butoxy]-carbostyril and O-mesitylenesulfonyl- hydroxylamine.
Smeltepunkt: 214-216°C.Melting point: 214-216°C.
Utbytte: 73% av det teoretiske.Yield: 73% of the theoretical.
Eksempel 22 Example 22
6-[ 4-( 3- metyl- 4- bromfenylsulfoksimino)- butoksy]- karbostyril 6-[ 4-( 3- methyl- 4- bromophenylsulfoximino)- butoxy]- carbostyryl
Fremstilt analogt med eksempel 1 fra 6-[4-(3-metyl-4-bromfenylsulfinyl)-butoksy]-karbostyril og natriumazid i polyfosforsyre. Prepared analogously to example 1 from 6-[4-(3-methyl-4-bromophenylsulfinyl)-butoxy]-carbostyril and sodium azide in polyphosphoric acid.
Smeltepunkt: 193-194°C,Melting point: 193-194°C,
Utbytte: 54% av det teoretiske.Yield: 54% of the theoretical.
Eksempel 2 3 Example 2 3
6-[ 4-( 2'- fluor- 4- bifenylylsulfoksimino)- butoksy]-k arbostyril 6-[4-(2'-Fluoro-4-biphenylylsulfoximino)-butoxy]-carbostyryl
Fremstilt analogt med eksempel 2 fra 6-[4-(2'-fluor-4-bifenylylsulfinyl)-butoksy]-karbostyril og 0-mesitylensulfonyl-hydroksylamin. Prepared analogously to example 2 from 6-[4-(2'-fluoro-4-biphenylylsulfinyl)-butoxy]-carbostyril and 0-mesitylenesulfonyl-hydroxylamine.
Smeltepunkt: 191-193°C.Melting point: 191-193°C.
Utbytte: 74% av det teoretiske.Yield: 74% of the theoretical.
Eksempel 24 Example 24
6-[ 4—( 3, 5- dibrom- 4- aminofenylsulfoksimino)- butoksy]- karbostyril Fremstilt analogt med eksempel 2 fra 6-[4-(3,5-dibrom-4-aminofenylsulfinyl)-butoksy]-karbostyril og O-mesitylensulfonyl-hydroksylamin . 6-[4-(3,5-dibromo-4-aminophenylsulfoximino)-butoxy]-carbostyril Prepared analogously to example 2 from 6-[4-(3,5-dibromo-4-aminophenylsulfinyl)-butoxy]-carbostyril and O -mesitylenesulfonyl-hydroxylamine .
Smeltepunkt: 130-135°C.Melting point: 130-135°C.
Utbytte: 51% av det teoretiske.Yield: 51% of the theoretical.
Eksempel 2 5 Example 2 5
3/ 3- dimety1- 5-[ 4-( 4- metylfen ylsulfoksimino)- butok sy]- indolinon- 2 3/ 3- dimethyl- 5-[ 4-( 4- methylphenylsulfoximino)-butoxy]- indolinone- 2
Fremstilt analogt med eksempel 2 fra 3,3-dimety1-5-[4-(4-metylfenylsulfinyl)-butoksy]-indolinon-2 og O-mesitylensulfonylhydroksylamin. Prepared analogously to example 2 from 3,3-dimethyl-5-[4-(4-methylphenylsulfinyl)-butoxy]-indolinone-2 and O-mesitylenesulfonylhydroxylamine.
Smeltepunkt: 146-147°C.Melting point: 146-147°C.
Utbytte:84% av det teoretiske.Yield: 84% of the theoretical.
Eksempel 2 6 Example 2 6
3, 3- dimety1- 5-[ 4-( 4- tert. butylfenylsulfoksimino)- butoksy]-indolin- on- 2 3, 3- dimethyl- 5-[ 4-( 4- tert. butylphenylsulfoximino)-butoxy]-indolin-one- 2
Fremstilt analogt med eksempel 2 fra 3,3-dimetyl-5-[4-(4-tert.buty1fenylsulfinyl)-butoksy]-indolinon-2 og O-mesitylensulfonylhydroksylamin. Prepared analogously to example 2 from 3,3-dimethyl-5-[4-(4-tert.butylphenylsulfinyl)-butoxy]-indolinone-2 and O-mesitylenesulfonylhydroxylamine.
Smeltepunkt: 195-197°C.Melting point: 195-197°C.
Utbytte: 85% av det teoretiske.Yield: 85% of the theoretical.
Eksempel 27 Example 27
3, 3- dimety1- 5-[ 4-( 2- mety1- 4- tert. buty1fenylsulfoksimino)-butoksy]- indolinon- 2• 3, 3- dimethyl- 5-[ 4-( 2- methyl- 4- tert. buty1-phenylsulfoximino)-butoxy]- indolinone- 2•
Fremstilt analogt med eksempel 2 fra 3,3-dimetyl-5-[4-(2-metyl-4-tert.butylsulfinyl)-butoksy]-indolinon-2 og 0-mesitylensulfonylhydroksylamin. Prepared analogously to example 2 from 3,3-dimethyl-5-[4-(2-methyl-4-tert.butylsulfinyl)-butoxy]-indolinone-2 and 0-mesitylenesulfonylhydroxylamine.
Smeltepunkt: 149-150°CMelting point: 149-150°C
Utbytte: 26% av det teoretiske.Yield: 26% of the theoretical.
Eksempel 28 Example 28
3, 3- dimety1- 5-[ 4-( 3, 5- di- tert.but y1- 4- hydroksyfenylsulfoksimino)-b utoksy]- indolinon- 2 3, 3- dimethyl- 5-[ 4-( 3, 5- di- tert.but y1- 4- hydroxyphenylsulfoximino)-butoxy]- indolinone- 2
Fremstilt analogt med eksempel 2 fra 3,3-dimetyl-5-[4-(3,5-di-tert.buty1-4-hydroksyfenylsulfoksimino)-butoksy]-indolinon-2 og O-mesitylensulfonylhydroksylamin. Prepared analogously to example 2 from 3,3-dimethyl-5-[4-(3,5-di-tert.butyl1-4-hydroxyphenylsulfoximino)-butoxy]-indolinone-2 and O-mesitylenesulfonylhydroxylamine.
Glassaktig stoff. R^-verdi: 0,25 (silikagelplate, utviklingsmiddel: etylacetat/metylenklorid 1:1), Vitreous substance. R^ value: 0.25 (silica gel plate, developer: ethyl acetate/methylene chloride 1:1),
Utbytte: 42% av det teoretiske.Yield: 42% of the theoretical.
Eksempel 2 9 Example 2 9
3, 3- dimety l- 5-( 4- cykloheksylfen ylsulf oksimino- butoksy)-indolinon- 2 3, 3- dimethyl- 5-(4- cyclohexylphenylsulfoximinobutoxy)-indolinone- 2
Fremstilt analogt med eksempel 1 fra 3,3-dimetyl-5-(4-cykloheksylfenylsulfinyl-butoksy)-indolinon-2 og natriumazid i polyfosforsyre. Prepared analogously to example 1 from 3,3-dimethyl-5-(4-cyclohexylphenylsulfinyl-butoxy)-indolinone-2 and sodium azide in polyphosphoric acid.
Smeltepunkt: 162-163°CMelting point: 162-163°C
Utbytte: 39% av det teoretiske.Yield: 39% of the theoretical.
Eksempel 30 Example 30
3, 3- dimétyl- 5-[ 4-( 2- naftylsulfoksimi no)- butoksy]- indolinon-2 3, 3- dimethyl- 5-[ 4-( 2- naphthylsulfoximino)- butoxy]- indolinone-2
Fremstilt analogt med eksempel 2 fra 3,3-dimetyl-5-[4-(2-naftylsulfinyl)-butoksy]-indolinon-2 og O-mesitylen-sulf ony lhydroksy lamin . Prepared analogously to example 2 from 3,3-dimethyl-5-[4-(2-naphthylsulfinyl)-butoxy]-indolinone-2 and O-mesitylene-sulfonylhydroxylamine.
Smeltepunkt: 120-121°C.Melting point: 120-121°C.
Utbytte: 6 4% av det teoretiske.Yield: 6 4% of the theoretical.
Eksempel 31 Example 31
3, 3- dimetyl- 5-( 4- cykloheksylsulfoksimino- butoksy)- indolinon- 2 3, 3- dimethyl- 5-( 4- cyclohexylsulfoximino- butoxy)- indolinone- 2
Fremstilt analogt med eksempel 2 fra 3,3-dimetyl-5-(4-cykloheksylsulfinyl-butoksy)-indolinon-2 og O-mesitylen-sulf onylhydroksylamin. Prepared analogously to example 2 from 3,3-dimethyl-5-(4-cyclohexylsulfinyl-butoxy)-indolinone-2 and O-mesitylene-sulfonylhydroxylamine.
Smeltepunkt: 108-109°C.Melting point: 108-109°C.
Utbytte: 77% av det teoretiske.Yield: 77% of the theoretical.
Eksempel 32 Example 32
3, 3- dimetyl- 5-( 4- benzylsulfoks imino- butoksy)- indolinon-2 3, 3- dimethyl- 5-( 4- benzyl sulfox imino-butoxy)- indolinone-2
Fremstilt analogt med eksempel 2 fra 3,3-dimety1-5-(4-benzylsulfinyl-butoksy)-indolinon-2 og O-mesitylensulfony1-hydroksylamin. Prepared analogously to example 2 from 3,3-dimethyl-5-(4-benzylsulfinyl-butoxy)-indolinone-2 and O-mesitylenesulfonyl-1-hydroxylamine.
Smeltepunkt: 98-99°C,Melting point: 98-99°C,
Utbytte: 82% av det teoretiske.Yield: 82% of the theoretical.
Eksempel 33 Example 33
• 3/ 3- dimety1- 5-[ 4-( 4- fluorfenylsulfoksimi no)- butoksy]-i ndolinon- 2 • 3/ 3- dimethyl- 5-[ 4-( 4- fluorophenylsulfoximino)-butoxy]-indolinone- 2
Fremstilt analogt med eksempel 2 fra 3,3-dimety1-5-[4-(4-fluorfenylsulfinyl)-butoksy]-indolinoh-2 og 0-mesitylensulfonylhydroksylamin. Prepared analogously to example 2 from 3,3-dimethyl-5-[4-(4-fluorophenylsulfinyl)-butoxy]-indolino-2 and 0-mesitylenesulfonylhydroxylamine.
Smeltepunkt: 101-102°C.Melting point: 101-102°C.
Utbytte: 90% av det teoretiske.Yield: 90% of the theoretical.
Eksempel 34 3, 3- dimetyl- 5-[ 4-( 4- klorf enylsulfoksimino)- butoksy]- indolinon- 2 Example 34 3,3-dimethyl-5-[4-(4-chlorophenylsulfoximino)-butoxy]-indolinone-2
/Fremstilt analogt med eksempel 2 fra 3,3-dimety1-5-[4-(4-klorfenylsulfinyl)-butoksy]-indolinon-2 og 0-mesitylensulfonylhydroksylamin. ■ /Prepared analogously to example 2 from 3,3-dimethyl-5-[4-(4-chlorophenylsulfinyl)-butoxy]-indolinone-2 and 0-mesitylenesulfonylhydroxylamine. ■
Smeltepunkt: 136-137°C.Melting point: 136-137°C.
Utbytte: 76% av det teoretiske.Yield: 76% of the theoretical.
Eksempel 35 Example 35
3, 3- dimetyl- 5-[ 4-( 4- bromfenylsulfoksimino)- butoksy]- indolinon- 2 3, 3- dimethyl- 5-[ 4-( 4- bromophenylsulfoximino)- butoxy]- indolinone- 2
Fremstilt analogt med eksempel 2 fra 3,3-dimetyl-5-[4-. (4-bromfenylsulfinyl)-butoksy]-indolinon-2 og O-mesitylen-sulf ony lhydroksy lamin. Prepared analogously to example 2 from 3,3-dimethyl-5-[4-. (4-bromophenylsulfinyl)-butoxy]-indolinone-2 and O-mesitylene-sulfonylhydroxylamine.
Smeltepunkt: 160-161°C.Melting point: 160-161°C.
Utbytte: 88% av det teoretiske.Yield: 88% of the theoretical.
Eksempel 36 Example 36
3, 3- dimety1- 5-[ 4-( 3, 4- diklorfeny lsulfoks imino)- butoksy]-indolinon- 2 3, 3- dimethyl- 5-[ 4-( 3, 4- dichlorophenylsulfoximino)-butoxy]-indolinone- 2
Fremstilt analogt med eksempel 2 fra 3,3-dimety1-5-[4-(3,4-diklorfenylsulfinyl)-butoksy]-indolinon-2 og O-mesitylensulfonylhydroksylamin. Prepared analogously to example 2 from 3,3-dimethyl-5-[4-(3,4-dichlorophenylsulfinyl)-butoxy]-indolinone-2 and O-mesitylenesulfonylhydroxylamine.
Smeltepunkt: 147-148°C.Melting point: 147-148°C.
Utbytte: 68% av det teoretiske.Yield: 68% of the theoretical.
Eksempel 37 Example 37
3, 3- dimetyl- 5-[ 4-( 2, 5- diklorfenylsulfo ksimino)- butoksy]-indolinon- 2 3, 3- dimethyl- 5-[ 4-( 2, 5- dichlorophenylsulfoximino)- butoxy]-indolinone- 2
Fremstilt analogt med eksempel 2 fra 3,3-dimety1-5-[4-(2,5-diklorfenylsulfinyl)-butoksy]-indolinon-2 og O-mesitylensulfonylhydroksylamin. Prepared analogously to example 2 from 3,3-dimethyl-5-[4-(2,5-dichlorophenylsulfinyl)-butoxy]-indolinone-2 and O-mesitylenesulfonylhydroxylamine.
R^-verdi: 0,3 (silikagelplate, utviklingsmiddel: R^ value: 0.3 (silica gel plate, developer:
etylacetat/metylenklorid 1:1).ethyl acetate/methylene chloride 1:1).
Utbytte: 18% av det teoretiske.Yield: 18% of the theoretical.
Eksempel 3 8 Example 3 8
3, 3- dimety1- 5-[ 4-( 3- metyl- 4- brom- fenyls ulfoksimino)-but oksy]-i ndolinon- 2 3, 3- dimethyl- 5-[ 4-( 3- methyl- 4- bromo- phenylsulfoximino)-butoxy]-indolinone- 2
Fremstilt analogt med eksempel 2 fra 3,3-dimety1-5-[4-(3-metyl-4-brom-fenylsulfinyl)-butoksy]-indolinon-2 og O-mesitylensulfonylhydroksylamin. Prepared analogously to example 2 from 3,3-dimethyl-5-[4-(3-methyl-4-bromo-phenylsulfinyl)-butoxy]-indolinone-2 and O-mesitylenesulfonylhydroxylamine.
Smeltepunkt: 131-132°C,Melting point: 131-132°C,
Utbytte: 84% av det teoretiske.Yield: 84% of the theoretical.
■ Eksempel 3 9 ■ Example 3 9
3, 3- dimetyl- 5-[ 4-( 2'- fluor- 4- bifenylylsulfoksimi no)- butoksy]-indolinon- 2 3, 3- dimethyl- 5-[ 4-( 2'- fluoro- 4- biphenylylsulfoximino)- butoxy]-indolinone- 2
Fremstilt analogt med eksempel 2 fra 3,3-dimetyl-5-[4-(2'-fluor-4-bifenylylsulfinyl)-butoksy]-indolinon-2 og O-mesitylensulfonylhydroksylamin. Prepared analogously to example 2 from 3,3-dimethyl-5-[4-(2'-fluoro-4-biphenylylsulfinyl)-butoxy]-indolinone-2 and O-mesitylenesulfonylhydroxylamine.
Smeltepunkt: 177-178°C.Melting point: 177-178°C.
Utbytte: 90% av det teoretiske.Yield: 90% of the theoretical.
Eksempel 40 Example 40
3, 3- dimétyl- 5-[ 4-( 3, 5- dibro m- 4- aminofenylsulfoksimino)-butoksy]- indolinon- 2 3, 3- dimethyl- 5-[ 4-( 3, 5- dibrom- 4- aminophenylsulfoximino)-butoxy]- indolinone- 2
Fremstilt analogt med eksempel 2 fra 3,3-dimety1-5-[4-(3,5-dibrom-4-aminofenylsulfinyl)-butoksy]-indolinon-2 og O-mesitylensulfonylhydroksylamin. Prepared analogously to example 2 from 3,3-dimethyl-5-[4-(3,5-dibromo-4-aminophenylsulfinyl)-butoxy]-indolinone-2 and O-mesitylenesulfonylhydroxylamine.
Smeltepunkt: 202-204°C.Melting point: 202-204°C.
Utbytte: 76% av det teoretiske.Yield: 76% of the theoretical.
Eksempel 41 Example 41
3, 3- dimetyl- 5-[ 4-( 4- metoksyf enylsulfoksimino)-but oksy]-indolinon- 2 3, 3- dimethyl- 5-[ 4-( 4- methoxyphenylsulfoximino)-butoxy]-indolinone- 2
Fremstilt analogt med eksempel 2 fra 3,3-dimety1-5-[4-(4-metoksyfenylsulfinyl)-butoksy]-indolinon og O-mesitylen-sulf ony lhydroksy lamin . Prepared analogously to example 2 from 3,3-dimethyl-5-[4-(4-methoxyphenylsulfinyl)-butoxy]-indolinone and O-mesitylene-sulfonylhydroxylamine.
Smeltepunkt: 140-141°C.Melting point: 140-141°C.
Utbytte: 71% av det teoretiske.Yield: 71% of the theoretical.
Eksempel 42 . 3 , 3- dimetyl- 5- [ 4- ( 2- m. etoksyf enylsulfoksimino) - butoksy] indolinon- 2 Example 42. 3 , 3- dimethyl- 5- [ 4- ( 2- m. ethoxy enylsulfoximino) - butoxy] indolinone- 2
Fremstilt analogt med eksempel 2 fra 3,3-dimety1-5-[4-(2-metoksyfenylsulfinyl)-butoksy]-indolinon-2 pg 0-mesitylensulfonylhydroksylamin. Prepared analogously to example 2 from 3,3-dimethyl-5-[4-(2-methoxyphenylsulfinyl)-butoxy]-indolinone-2pg O-mesitylenesulfonylhydroxylamine.
Farveløst, harpiksaktig stoff. R^-verdi: 0,35Colorless, resinous substance. R^ value: 0.35
(silikagel, utviklingsmiddel: etylenklorid/etanol = 9:1). Utbytte: 52% av det teoretiske. (silica gel, developer: ethylene chloride/ethanol = 9:1). Yield: 52% of the theoretical.
Eksempel 43 Example 43
3, 3- dimety1- 5-[ 4-( 3, 4- dimetoksyfeny lsulfoksimino)- butoksy]-indolinon- 2 3, 3- dimethyl- 5-[ 4-( 3, 4- dimethoxyphenylsulfoximino)-butoxy]-indolinone- 2
Fremstilt analogt med eksempel 2 fra 3,3-dimetyl-5-[4-(3,4-dimetoksy-fenylsulfinyl)-butoksy]-indolinon-2 og O-mesitylensulfonylhydroksylamin. Prepared analogously to example 2 from 3,3-dimethyl-5-[4-(3,4-dimethoxy-phenylsulfinyl)-butoxy]-indolinone-2 and O-mesitylenesulfonylhydroxylamine.
Smeltepunkt: 108-109°C.Melting point: 108-109°C.
Utbytte: 79% av det teoretiske.Yield: 79% of the theoretical.
Eksempel 44 Example 44
3 , 3- dimetyl- 5- [ 4- ( 6- metoks y.- naft- 2- yl- sulf oksimi n o) - butoksy] - indolinon- 2 3 , 3- dimethyl- 5- [ 4- ( 6- methox y.- naphth- 2- yl- sulf oximi n o) - butoxy] - indolinone- 2
Fremstilt analogt med eksempel 2 fra 3,3-dimetyl-5-[4-(6-metoksy-naft-2-yl-sulfinyl)-butoksy]-indolinon-2 og 0-mesitylensulfonylhydroksylamin. Prepared analogously to example 2 from 3,3-dimethyl-5-[4-(6-methoxy-naphth-2-yl-sulfinyl)-butoxy]-indolinone-2 and 0-mesitylenesulfonylhydroxylamine.
Smeltepunkt: 174-175°C.Melting point: 174-175°C.
Utbytte:88% av det teoretiske.Yield: 88% of the theoretical.
Eksempel 4 5 Example 4 5
6-( 4- metylsulfoksimino- butoksy)- 3, 4-di hydrokarbostyril-mesitylensulfonat 6-(4-methylsulfoximinobutoxy)-3,4-dihydrocarbostyryl mesitylene sulfonate
Fremstilt analogt med eksempel 2 fra 6-(4-metylsulfinyl-butoksy) -3 , 4-dihydrokarbostyril og O-mesitylensulfonyl-hydroksylamin . Prepared analogously to example 2 from 6-(4-methylsulfinyl-butoxy)-3,4-dihydrocarbostyril and O-mesitylenesulfonyl-hydroxylamine.
Smeltepunkt: 130-133°C,Melting point: 130-133°C,
Utbytte: 87% av det teoretiske.Yield: 87% of the theoretical.
Eksempel 46 3. 3- dimetyl- 5-(4-fen ylsulfoksimino-b utoksy)- indolinon- 2 Example 46 3. 3-dimethyl-5-(4-phenylsulfoximino-butoxy)-indolinone-2
Fremstilt analogt med eksempel 2 fra 3,3-dimetyl-5-(4-fenylsulfinyl-butoksy)-indolinon-2 og O-mesitylensulfonyl-hydroksylamin. Prepared analogously to example 2 from 3,3-dimethyl-5-(4-phenylsulfinyl-butoxy)-indolinone-2 and O-mesitylenesulfonyl-hydroxylamine.
Smeltepunkt: 111-112°C.Melting point: 111-112°C.
Utbytte:86% av det teoretiske.Yield: 86% of the theoretical.
Eksempel 47 Example 47
6-[ 4-( N- acetyl-3, 4- diklorfenylsulfoks imino)- butoksy]-3. 4- dihydrokarbostyril 6-[ 4-( N-acetyl-3, 4-dichlorophenylsulfoximino)-butoxy]-3. 4- dihydrocarbostyril
( I en blanding av 70 ml iseddik og 70 ml eddiksyreanhydrid suspenderes 1,40 g 6-[4-(3,4-diklorfenylsulfoksimino)-butoksy]-3,4-dihydrokarbostyril og omrøres i 2,5 timer. Til den dannede oppløsning settes under kraftig omrøring 300 ml . isvann. Efter 10 minutter begynner hvite krystaller å (In a mixture of 70 ml of glacial acetic acid and 70 ml of acetic anhydride, 1.40 g of 6-[4-(3,4-dichlorophenylsulfoximino)-butoxy]-3,4-dihydrocarbostyril are suspended and stirred for 2.5 hours. To the solution formed Place under vigorous stirring 300 ml of ice water After 10 minutes, white crystals begin to form
skille seg ut. Efter 1 time avsuger man, eftervasker med vann og omkrystalliserer fra 140 ml etanol under tilsetning av litt aktivt kull. Man får et hvitt, krystallinsk stand out. After 1 hour, suction is applied, the mixture is washed with water and recrystallized from 140 ml of ethanol while adding a little activated charcoal. You get a white, crystalline
stoff, som man tørrer i luftsirkulasjonsskap ved 80°C. Smeltepunkt: 150-152°C. fabric, which is dried in an air circulation cabinet at 80°C. Melting point: 150-152°C.
Utbytte: 12,9 g (84% av det teoretiske).Yield: 12.9 g (84% of the theoretical).
Eksempel 4 8 Example 4 8
6-[ 4-( N- karbamoyl-3,4- diklorfenylsulfoksi mino)- butoksy]-3, 4- dihydrokarbostyril 6-[ 4-( N- carbamoyl-3,4- dichlorophenylsulfoximino)- butoxy]-3, 4- dihydrocarbostyril
I 70 ml iseddik oppløser man 1,49 g (0,0035 mol) 6-[4-(3,4-diklor-fenylsulfoksimino)-butoksy]-3,4-dihydrokarbostyril og tilsetter 2,8 g (0,035 mol) kaliumcyanat og omrører i 3 timer ved romtemperatur. Derefter tilsetter man 40 ml vann under omrøring, hvorved den først utfelte olje gjennomkrystalliserer. Man avsuger, omkrystalliserer fra 65 ml etanol og tørrer det hvite, krystallinske stoff i luftsirkulasjonsskap ved 50°C. 1.49 g (0.0035 mol) of 6-[4-(3,4-dichloro-phenylsulfoximino)-butoxy]-3,4-dihydrocarbostyryl are dissolved in 70 ml of glacial acetic acid and 2.8 g (0.035 mol) of potassium cyanate are added and stir for 3 hours at room temperature. 40 ml of water is then added while stirring, whereby the first precipitated oil crystallizes through. The mixture is filtered off with suction, recrystallized from 65 ml of ethanol and the white, crystalline substance is dried in an air circulation cabinet at 50°C.
Smeltepunkt: 14 8-150°C,Melting point: 14 8-150°C,
Utbytte: 1,2 g (73% av det teoretiske).Yield: 1.2 g (73% of the theoretical).
Eksempel 4 9 Example 4 9
6-[ 4-( N- butyryl- 3, 4- diklorfen y1sulfoksimino)- butoks y]-3, 4- dihydrokarbostyril 6-[ 4-( N- butyryl- 3, 4- dichlorophen y1sulfoximino)-butox y]-3, 4- dihydrocarbostyril
3,0 g (0,007 mol) 6- [4- (3,4-diklorfenylsulfoksimino)-butoksy]-3,4-dihydrokarbostyril suspenderes i 15 ml pyridin og tilsettes 0,9 g (1,2 x 0,007 mol) n-smørsyreklorid. 3.0 g (0.007 mol) of 6-[4-(3,4-dichlorophenylsulfoximino)-butoxy]-3,4-dihydrocarbostyryl is suspended in 15 ml of pyridine and 0.9 g (1.2 x 0.007 mol) of n- butyric acid chloride.
Under oppvarmning til 40°C dannes en lysegul oppløsning.During heating to 40°C, a pale yellow solution is formed.
Efter ytterligere 90 minutters henstand inndamper man til tørrhet i vannstrålevakuum i en rotasjonsinndamper, opptar residuet i metylenklorid og utrister to ganger med 0,5N saltsyre og en gang med vann. Efter tørring over magnesiumsulfat avdestillerer man oppløsningsmidlet i eri rotasjonsinndamper og omkrystalliserer residuet fra 15 ml etanol. Man får farveløse krystaller. After standing for a further 90 minutes, the mixture is evaporated to dryness in a water jet vacuum in a rotary evaporator, the residue is taken up in methylene chloride and decanted twice with 0.5N hydrochloric acid and once with water. After drying over magnesium sulfate, the solvent is distilled off in a rotary evaporator and the residue is recrystallized from 15 ml of ethanol. Colorless crystals are obtained.
Smeltepunkt: 133-135°C,Melting point: 133-135°C,
Utbytte: 2,4 g (69% av det teoretiske).Yield: 2.4 g (69% of theoretical).
Eksempel 50 Example 50
6-[ 4-( N- pivaloyl- 3, 4- diklorfenylsulfoksimino)- butoksy]-3, 4- dihydrokarbostyril1 6-[ 4-( N- pivaloyl- 3, 4- dichlorophenylsulfoximino)- butoxy]-3, 4- dihydrocarbostyril1
Fremstilt analogt med eksempel 49 fra 6-[4-(3,4-diklorfenylsulfoksimino)-butoksy]-3,4-dihydrokarbostyril og pivalinsyreklorid. Prepared analogously to Example 49 from 6-[4-(3,4-dichlorophenylsulfoximino)-butoxy]-3,4-dihydrocarbostyril and pivalic acid chloride.
Smeltepunkt: 158-160°C.Melting point: 158-160°C.
Utbytte: 81% av det teoretiske.Yield: 81% of the theoretical.
Eksempel 51 Example 51
6-[ 4-( N-( 2-m etoksyacetyl)-3, 4- diklorfenylsulfoksimi no)-butoksy]- 3, 4- dihydrokarbostyril 6-[ 4-( N-(2-Methoxyacetyl)-3, 4- dichlorophenylsulfoximini)-butoxy]- 3, 4- dihydrocarbostyril
Fremstilt analogt med eksempel 49 fra 6-[4-(3,4-diklorfenylsulfoksimino)-butoksy]-3,4-dihydrokarbostyril og 2-metoksyacetylklorid. Prepared analogously to example 49 from 6-[4-(3,4-dichlorophenylsulfoximino)-butoxy]-3,4-dihydrocarbostyril and 2-methoxyacetyl chloride.
Smeltepunkt: 103-105°C,Melting point: 103-105°C,
Utbytte: 50% av det teoretiske.Yield: 50% of the theoretical.
Eksempel 52 6-[ 4-( N- benzoyl- 3, 4- diklorfenyisulfoksimi no)- butoksy]-3, 4- dihydrokarbostyril Example 52 6-[4-(N-benzoyl-3,4-dichlorophenysulfoximini)-butoxy]-3,4-dihydrocarbostyril
Fremstilt analogt med.eksempel 49 fra 6-[ 4-(3,4-diklorfenylsulfoksimino)-butoksy]-3,4-dihydrokarbostyril og benzoy1-klorid. Prepared analogously to Example 49 from 6-[4-(3,4-dichlorophenylsulfoximino)-butoxy]-3,4-dihydrocarbostyril and benzoyl chloride.
Smeltepunkt: 100-111°CMelting point: 100-111°C
Utbytte: 68% av det teoretiske.Yield: 68% of the theoretical.
Eksempel 5 3 Example 5 3
6-[ 4-( N-( 4- metoksybenzoyl)- 3, 4- diklorf enylsulfoksimino)-butoksy]- 3, 4- dihydrokarbostyril 6-[ 4-( N-( 4- methoxybenzoyl)- 3, 4- dichlorophenylsulfoximino)-butoxy]- 3, 4- dihydrocarbostyril
Fremstilt analogt med eksempel 49 fra 6-[4-( 3,4-diklorfenylsulfoksimino)-butoksy]-3,4-dihydrokarbostyril og 4-metoksy-benzoylklorid. Prepared analogously to example 49 from 6-[4-(3,4-dichlorophenylsulfoximino)-butoxy]-3,4-dihydrocarbostyril and 4-methoxy-benzoyl chloride.
Smeltepunkt: 186-188°C.Melting point: 186-188°C.
Utbytte: 70% av det teoretiske.Yield: 70% of the theoretical.
Eksempel 5 4 Example 5 4
6- [ 4- ( N- nikotinoyl- 3, 4- diklorfenylsulfoksimino)- butoksy]-3, 4- dihydr okarbostyril 6- [ 4- ( N- nicotinoyl- 3, 4- dichlorophenylsulfoximino)- butoxy]-3, 4- dihydro carbostyryl
Fremstilt analogt med eksempel 49 fra 6-[4-(3,4-diklorfenyl-sulfoksimino)-butoksy]-3,4-dihydrokarbostyril og nikotinsyreklorid-hydroklorid. Prepared analogously to Example 49 from 6-[4-(3,4-dichlorophenyl-sulfoximino)-butoxy]-3,4-dihydrocarbostyril and nicotinic acid chloride hydrochloride.
Smeltepunkt: 101-103°C.Melting point: 101-103°C.
Utbytte:94% av det teoretiske.Yield: 94% of the theoretical.
Eksempel 55 Example 55
6- [ 4-(N-( 4- metylfenyls ulf onyl)- 3, 4- diklorfe nylsulfoksimino)-butoksy] -3, 4- dihydrokarbostyri. l 6- [ 4-(N-( 4- methylphenylsulfonyl)-3, 4- dichlorophenylsulfoximino)-butoxy] -3, 4- dihydrocarbostyri. l
Fremstilt analogt med eksempel 49 fra 6-[4-(3,4-diklorfenylsulfoksimino)-butoksy]-3,4-dihydrokarbostyril og p-toluensulfoklorid. Prepared analogously to example 49 from 6-[4-(3,4-dichlorophenylsulfoximino)-butoxy]-3,4-dihydrocarbostyril and p-toluenesulfochloride.
Smeltepunkt: 154-156°C.Melting point: 154-156°C.
Utbytte:84% av det teoretiske.Yield: 84% of the theoretical.
Eksempel 56 Example 56
6-[ 4-( N-( 2- acetoksy- fenylacetyl)- 3, 4- diklorfenylsulfoksimino)-butoksy]- 3, 4- dihydrokarbostyril 6-[ 4-( N-( 2- acetoxy- phenylacetyl)- 3, 4- dichlorophenylsulfoximino)- butoxy]- 3, 4- dihydrocarbostyril
Fremstilt fra 6-[4-(3,4-diklorfenylsulfoksimino)-butoksy]-3,4-dihydrokarbostyri1 og 0-acety1-D,L-mandélsyreklorid analogt med eksempel 49. Efter rensning over en silikagelkolonne med etylenklorid får man forbindelsen som ikke-krystalliserende, glassaktig harpiks. Prepared from 6-[4-(3,4-dichlorophenylsulfoximino)-butoxy]-3,4-dihydrocarbostyri1 and 0-acety1-D,L-mandelic acid chloride analogously to example 49. After purification over a silica gel column with ethylene chloride, the compound is obtained which does not -crystallizing, vitreous resin.
R^-verdi: 0,2 (silikagelplate, etylenklorid),R^-value: 0.2 (silica gel plate, ethylene chloride),
Utbytte: 50% av det teoretiske.Yield: 50% of the theoretical.
Eksempel 57 Example 57
5-[ 4-( N- acetyl- 3, 4-di klorfenylsulfoksimino)- butoksy]- 3, 3- dimety 1- indolinon- 2 ■ 5-[ 4-( N- acetyl- 3, 4-dichlorophenylsulfoximino)- butoxy]- 3, 3- dimethyl 1- indolinone- 2 ■
Fremstilt analogt med eksempel 47 fra 5-[4-(3,4-diklorfenylsulfoksimino)-butoksy]-3,3-dimetyl-indolinon-2 og eddiksyreanhydrid. Prepared analogously to example 47 from 5-[4-(3,4-dichlorophenylsulfoximino)-butoxy]-3,3-dimethyl-indolinone-2 and acetic anhydride.
Smeltepunkt: 145-146°c.Melting point: 145-146°c.
Utbytte: 6 4% av det teoretiske.Yield: 6 4% of the theoretical.
Eksempel 58 Example 58
5-[ 4-( N- butyryl- 3, 4- diklorfenylsulfoksimin o)- butoksy]- 3, 3-dimety1- indolinon- 2 5-[ 4-( N- butyryl- 3, 4- dichlorophenylsulfoximine o)- butoxy]- 3, 3- dimethyl- indolinone- 2
Fremstilt analogt med eksempel 4 9 fra 5- [4-(3,4-diklorfenylsulfoksimino)-butoksy]-3,3-dimetyl-indolinon-2 og smørsyre-klorid. Prepared analogously to example 4 9 from 5-[4-(3,4-dichlorophenylsulfoximino)-butoxy]-3,3-dimethyl-indolinone-2 and butyric acid chloride.
Smeltepunkt: 120-122°C.Melting point: 120-122°C.
Utbytte: 81% av det teoretiske.Yield: 81% of the theoretical.
Eksempel 5 9 Example 5 9
5-[ 4-( N-( 2- metoksy- acetyl)- 3, 4- diklorfen ylsulfoksimino)-butoksy]- indolinon- 2 5-[ 4-( N-( 2- methoxy-acetyl)- 3, 4- dichlorophenylsulfoximino)-butoxy]- indolinone- 2
Fremstilt analogt med eksempel 49 fra 3,3-dimetyl-5-[4-(3,4-diklorfenylsulfoksimino)-butoksy]-indolinon-2 og 2-metoksyacetylklorid. Prepared analogously to Example 49 from 3,3-dimethyl-5-[4-(3,4-dichlorophenylsulfoximino)-butoxy]-indolinone-2 and 2-methoxyacetyl chloride.
Smeltepunkt: 126-128°C.Melting point: 126-128°C.
Utbytte: 72% av det teoretiske.Yield: 72% of the theoretical.
Eksempel 60 Example 60
5-[ 4-( N- etoksykarbonyl- 3, 4- diklorfenylsulfoksimino)- butoksy]-3, 3- dimetyl- indolinon- 2 5-[ 4-( N- ethoxycarbonyl- 3, 4- dichlorophenylsulfoximino)- butoxy]-3, 3- dimethyl- indolinone- 2
Fremstilt analogt med eksempel 49 fra 5-[4-(4-klorfenyl-sulfoksimino)-butoksy]-3,3-dimetyl-indolinon-2 og.klor-karbonsyre-etylester. Prepared analogously to example 49 from 5-[4-(4-Chlorophenyl-sulfoximino)-butoxy]-3,3-dimethyl-indolinone-2 and .chloro-carbonic acid ethyl ester.
Smeltepunkt:102-104°C,Melting point: 102-104°C,
Utbytte: 7 9% av det teoretiske.Yield: 7 9% of the theoretical.
Eksemp el' 61 Example or' 61
5-[ 4-( N- acety1- 4- klorfenylsulfoksimincQ - butoksy]- 3, 3- diroet yl-indolinon- 2 5-[ 4-( N- acety1- 4- chlorophenylsulfoximincQ - butoxy]- 3, 3- diroetyl-indolinone- 2
Fremstilt analogt med eksempel 47 fra 5- [4-(4-klorfeny1^ sulfoksimino)-butoksy]-3,3-dimetyl-indolinon-2 og eddiksyreanhydrid. Prepared analogously to example 47 from 5-[4-(4-chlorophenyl-sulfoximino)-butoxy]-3,3-dimethyl-indolinone-2 and acetic anhydride.
Smeltepunkt: 138-140°C.Melting point: 138-140°C.
Utbytte: 75% av det teoretiske.Yield: 75% of the theoretical.
Eksempel 62 Example 62
5- [ 4-( N- butyry1- 4- klorfenylsulfoksimino)- butoksy]- 3, 3- dimety1-indolinon- 2 5- [ 4-( N- butyry1- 4- chlorophenylsulfoximino)- butoxy]- 3, 3- dimethyl-indolinone- 2
Fremstilt analogt med eksempel 49 fra 5-[4-(4-klorfenyl-sulfoksimino) -butoksy]-3,3-dimetyl-indolinon-2 og smørsyre-klorid. Prepared analogously to example 49 from 5-[4-(4-chlorophenyl-sulfoximino)-butoxy]-3,3-dimethyl-indolinone-2 and butyric acid chloride.
Smeltepunkt: 166-168°C.Melting point: 166-168°C.
Utbytte: 38% av det teoretiske.Yield: 38% of the theoretical.
Eksempel 6 3 Example 6 3
5-[ 4-( N- pivaloy1- 4- klorfenylsulfoksimino)- butoksy]- 3, 3-dimetyl- indolinon-2 5-[ 4-( N- pivaloy1- 4- chlorophenylsulfoximino)- butoxy]- 3, 3-dimethyl- indolinone-2
Fremstilt analogt med eksempel 49 fra 5-[4-(4-klorfeny1-sulfoksimino)-butoksy]-3,3-dimetyl-indolinon-2 og pivalinsyreklorid. Prepared analogously to example 49 from 5-[4-(4-chlorophenyl-sulfoximino)-butoxy]-3,3-dimethyl-indolinone-2 and pivalic acid chloride.
Smeltepunkt: 95-97°C.Melting point: 95-97°C.
Utbytte: 76% av det teoretiske.Yield: 76% of the theoretical.
Eksempel 64 Example 64
5-[ 4-( N- kapry l-4- klorfenylsulfoksi mino)- but oksy]- 3, 3- dimety1-indolinon-2 5-[ 4-( N- capryl-4- chlorophenylsulfoximino)- butoxy]- 3, 3- dimethyl-indolinone-2
Fremstilt analogt med eksempel 49 fra 5-[4-(4-klorfeny1-sulfoksimino)-butoksy]-3,3-dimetyl-indolinon-2 og kaprylsyre-klorid. Harpiks. Prepared analogously to example 49 from 5-[4-(4-chlorophenyl-sulfoximino)-butoxy]-3,3-dimethyl-indolinone-2 and caprylic acid chloride. Resin.
R^-verdi: 0,5 (silikagelplate, etylacetat/metylenklorid = 1:1). Utbytte: 95% av det teoretiske. R^ value: 0.5 (silica gel plate, ethyl acetate/methylene chloride = 1:1). Yield: 95% of the theoretical.
Eksempel- 65 Example- 65
5-[ 4-( N- karbamoyl- 4- klorfenylsulfoksimino)- butoksy]-3, 3- dimetyl- indolinon- 2 5-[ 4-( N- carbamoyl- 4- chlorophenylsulfoximino)- butoxy]-3, 3- dimethyl- indolinone- 2
Fremstilt analogt med eksempel 48 fra 5- [4-(4-klorfenyl-sulf oksimino.) -butoksy ]-3 , 3-dimety l-indolinon-2 og kaliumcyanat. Prepared analogously to example 48 from 5-[4-(4-chlorophenyl-sulfoximino.)-butoxy]-3,3-dimethyl-indolinone-2 and potassium cyanate.
Farveløs harpiks.Colorless resin.
R^-verdi: 0,4 (silikagelplate, etylenklorid/etanol =9:1), Utbytte: 75% av det teoretiske. R^-value: 0.4 (silica gel plate, ethylene chloride/ethanol =9:1), Yield: 75% of the theoretical.
Eksempel 6 6 Example 6 6
5- [ 4-( N- dimetylaminokarbonyl- 4- klorfenylsulfoksimino)- butoksy]-3. 3- dimetyl- indolinon- 2 5- [ 4-( N-dimethylaminocarbonyl-4-chlorophenylsulfoximino)-butoxy]-3. 3- dimethyl- indolinone- 2
Fremstilt analogt med eksempel 49 fra 5-[4-(4-klorfenyl-sulfoksimino) -butoksy] -3 , 3-dimetyl-indolinon-2 og dimety1-karbamylklorid. Prepared analogously to example 49 from 5-[4-(4-chlorophenyl-sulfoximino)-butoxy]-3,3-dimethyl-indolinone-2 and dimethyl-carbamyl chloride.
Smeltepunkt: 170-172°C,Melting point: 170-172°C,
Utbytte: 64% av det teoretiske.Yield: 64% of the theoretical.
Eksempel 67 Example 67
6- [ 4-( N- acety1- 3, 4- dimetoks yfenylsulfoksimino)-bu toksy]-3. 4- dihydrokarbostyril 6-[4-(N-acety1-3,4-dimethoxyphenylsulfoximino)-butoxy]-3. 4- dihydrocarbostyril
Fremstilt analogt med eksempel 47 fra 6-[4-(3,4-dimetoksy-fenylsulfoksimino)-butoksy]-3,4-dihydrokarbostyril og eddiksyreanhydrid. Prepared analogously to Example 47 from 6-[4-(3,4-dimethoxy-phenylsulfoximino)-butoxy]-3,4-dihydrocarbostyril and acetic anhydride.
Smeltepunkt: 8 9-92°C.Melting point: 8 9-92°C.
Utbytte: 60% av det teoretiske.Yield: 60% of the theoretical.
Eksempel 6 8 Example 6 8
6-[ 4-( N- butyry1- 3, 4- dimetoksyfenylsulfoksimi no)- butoksy]-3, 4- dihydrokarbostyril 6-[ 4-( N- butyry1- 3, 4- dimethoxyphenylsulfoximini)- butoxy]-3, 4- dihydrocarbostyril
Fremstilt analogt med eksempel 4 9 fra 6-[4-(3,4-dimetoksy-fenylsulfoksimino)-butoksy]-3,4-dihydrokarbostyril og smørsyre-klorid. Glassaktig, farveløs harpiks. R^-verdi: 0,35 (silikagelplate, etylenklorid/etanol =9:1). Prepared analogously to example 4 9 from 6-[4-(3,4-dimethoxy-phenylsulfoximino)-butoxy]-3,4-dihydrocarbostyril and butyric acid chloride. Glassy, colorless resin. R^ value: 0.35 (silica gel plate, ethylene chloride/ethanol =9:1).
Utbytte: 41% av det teoretiske.Yield: 41% of the theoretical.
■ Eksempel 6 9 ■ 6- [ 4-( N- benzoy1- 3, 4- dim etoksyfenylsulfoksimino)- butoksy]-3, 4- dihydrokarbostyril ■ Example 6 9 ■ 6- [ 4-( N- benzoyl- 3, 4- dimethoxyphenylsulfoximino)- butoxy]-3, 4- dihydrocarbostyril
Fremstilt analogt med eksempel 49 fra 6-[4-(3,4-dimetoksy-fenylsulfoksimino)-butoksy]-3,4-dihydrokarbostyril og benzoyl-. klorid. Prepared analogously to example 49 from 6-[4-(3,4-dimethoxy-phenylsulfoximino)-butoxy]-3,4-dihydrocarbostyryl and benzoyl-. chloride.
Smeltepunkt: 7 8-80°C.Melting point: 7 8-80°C.
Utbytte: 50% av det teoretiske.Yield: 50% of the theoretical.
Eksempel 70 Example 70
6- [ 4-( N-( 4- klorben zoyl)- 3, 4- dimetoksyfenylsulfoksimino)-butoksy]- 3, 4- dihydrokarbostyril■ 6- [ 4-( N-( 4- chlorobenzoyl)- 3, 4- dimethoxyphenylsulfoximino)-butoxy]- 3, 4- dihydrocarbostyril■
Fremstilt analogt med eksempel 49 fra 6-[4-(3,4-dimetoksy-fenylsulfoksimino)-butoksy]-3,4-dihydrokarbostyril og 4-klor-benzoylklorid. Prepared analogously to example 49 from 6-[4-(3,4-dimethoxy-phenylsulfoximino)-butoxy]-3,4-dihydrocarbostyryl and 4-chloro-benzoyl chloride.
Smeltepunkt: 134-137°C.Melting point: 134-137°C.
Utbytte: 61% av det teoretiske.Yield: 61% of the theoretical.
Eksempel 71 Example 71
6-[ 4-( N-( 4- tert. butylbenzoyl)-3,4-dimet oksyfenylsulfoksimino)-butoksy]-3,4- dihydrokarbostyril 6-[ 4-( N-( 4- tert. butylbenzoyl)-3,4-dimethoxyphenylsulfoximino)-butoxy]-3,4- dihydrocarbostyryl
Fremstilt analogt med eksempel 49 fra 6-[4-(3,4-dimetoksy-fenylsulfoksimino)-butoksy]-3,4-dihydrokarbostyril og Prepared analogously to example 49 from 6-[4-(3,4-dimethoxy-phenylsulfoximino)-butoxy]-3,4-dihydrocarbostyril and
4-tert.buty1-benzoylklorid.4-tert.Buty1-benzoyl chloride.
Smeltepunkt: 98-101°C.Melting point: 98-101°C.
Utbytte: 87% av det teoretiske.Yield: 87% of the theoretical.
Eksempel 7 2 6-[ 4-( N- nikotinoyl- 3, 4- dimetoksyfenylsulfoksimino)- butoksy]-3, 4- dihydrokarbostyril Example 7 2 6-[4-(N-nicotinoyl-3,4-dimethoxyphenylsulfoximino)-butoxy]-3,4-dihydrocarbostyril
Fremstilt analogt med eksempel 49 fra 6-[4-(3,4-dimetoksy-fenylsulfoksimino)-butoksy]-3,4-dihydrokarbostyril og nikotinsyreklorid-hydroklorid. Prepared analogously to Example 49 from 6-[4-(3,4-dimethoxy-phenylsulfoximino)-butoxy]-3,4-dihydrocarbostyril and nicotinic acid chloride hydrochloride.
Smeltepunkt:90-93°C,Melting point: 90-93°C,
Utbytte: 75% av det teoretiske.Yield: 75% of the theoretical.
Eksempel 7 3 Example 7 3
6-[ 4-( N- pmtametylfenylsulfonyl- 3, 4- dimetoksyfenylsulfoks imino)-butoksy]- 3, 4- dihydrokarbostyril 6-[ 4-( N- pmtamethylphenylsulfonyl- 3, 4- dimethoxyphenylsulfoximino)-butoxy]- 3, 4- dihydrocarbostyril
Fremstilt analogt med eksempel 4 9 fra 6-[4-(3,4-dimetoksy-fenylsulfoksimino)-butoksy]-3,4-dihydrokarbostyril og penta- Prepared analogously to example 4 9 from 6-[4-(3,4-dimethoxy-phenylsulfoximino)-butoxy]-3,4-dihydrocarbostyryl and penta-
metylbenzen-sulfonsyreklorid.methylbenzene sulfonic acid chloride.
Smeltepunkt: 186-188°C.Melting point: 186-188°C.
Utbytte: 75% av det teoretiske.Yield: 75% of the theoretical.
Eksempel 7 4 Example 7 4
5-[ 4-( N- acetyl- 3, 4- dimetoksyfenylsulfoksimino)- but oksy]-3, 3- dimetylindolin- 2- on 5-[ 4-( N- acetyl- 3, 4- dimethoxyphenylsulfoximino)- butoxy]-3, 3- dimethylindolin- 2- one
Fremstilt analogt med eksempel 47 fra 5-[4-(3,4-dimetoksy-fenylsulfoksimino)-butoksy]-3,3-dimetylindolin-2-on og eddiksyreanhydrid. Prepared analogously to example 47 from 5-[4-(3,4-dimethoxy-phenylsulfoximino)-butoxy]-3,3-dimethylindolin-2-one and acetic anhydride.
Glassaktig harpiks.Glassy resin.
R^-verdi: C,3 (silikagelplate, etylenklorid/etanol = 9:1), Utbytte: 99% av det teoretiske. R^-value: C.3 (silica gel plate, ethylene chloride/ethanol = 9:1), Yield: 99% of the theoretical.
Eksempel- 7 5 Example- 7 5
5-[ 4-( N- butyryl- 3, 4- dimetoksyfenyls ulfoksimino)- butoksy]-3, 3- dimetylindolin- 2- on 5-[ 4-( N- butyryl- 3, 4- dimethoxyphenyls ulfoximino)- butoxy]-3, 3- dimethylindolin- 2- one
Fremstilt analogt med eksempel 49 fra 5-[4-(3,4-dimetoksy-fenylsulfoksimino)-butoksy]-3,3-dimetylindolin-2-on og smøresyreklorid. Harpiks. Prepared analogously to example 49 from 5-[4-(3,4-dimethoxy-phenylsulfoximino)-butoxy]-3,3-dimethylindolin-2-one and butyric acid chloride. Resin.
R^-verdi: 0,35 (silikagelplate, etylacetat/metylenklorid = 1:1), Utbytte: 92% av det teoretiske. R^ value: 0.35 (silica gel plate, ethyl acetate/methylene chloride = 1:1), Yield: 92% of the theoretical.
Eksempel 7 6 Example 7 6
5-[ 4-( N- piavl oy1- 3, 4- dimetoksyfenylsulfoksimino)- butoksy]-3, 3- dimétyl- indolinon- 2 5-[ 4-( N- piavl oy1- 3, 4- dimethoxyphenylsulfoximino)- butoxy]-3, 3- dimethyl- indolinone- 2
Fremstilt analogt med eksempel 49 fra 5-[4-(3,4-dimetoksy-fenylsulfoksimino)-butoksy]-3,3-dimetyl-indolinon-2 og pivalinsyreklorid. Harpiks. Prepared analogously to example 49 from 5-[4-(3,4-dimethoxy-phenylsulfoximino)-butoxy]-3,3-dimethyl-indolinone-2 and pivalic acid chloride. Resin.
Rf-verdi: 0,45 (silikagelplate, etylacetat/metylenklorid =1:1), Utbytte: 88% av det teoretiske. Rf value: 0.45 (silica gel plate, ethyl acetate/methylene chloride = 1:1), Yield: 88% of the theoretical.
Eksempel 7 7 Example 7 7
5-[ 4-( N- karbamoyl- 3, 4- dimetoksyfenylsulfoksimino)- butoksy]-3, 3- dimetyl- indolinon- 2 5-[ 4-( N- carbamoyl- 3, 4- dimethoxyphenylsulfoximino)- butoxy]-3, 3- dimethyl- indolinone- 2
Fremstilt analogt med eksempel 48 fra 5-[4-(3,4-dimetoksy-fenylsulfoksimino)-butoksy]-3,3-dimetyl-indolinon-2 og kaliumcyanat. Harpiks. Prepared analogously to example 48 from 5-[4-(3,4-dimethoxy-phenylsulfoximino)-butoxy]-3,3-dimethyl-indolinone-2 and potassium cyanate. Resin.
Rf-verdi: 0,25 (silikagelplate, etylnklorid/etanol = 9:1), Utbytte: 75% av det teoretiske. Rf value: 0.25 (silica gel plate, ethylene chloride/ethanol = 9:1), Yield: 75% of the theoretical.
Eksempel 7 8 Example 7 8
5- [ 4-( N- dimetylaminokarbonyl-3, 4- dimetoksyfenylsulfoksimino)-butoksy]- 3, 3- dimetylin doTinon- 2 5- [ 4-( N- dimethylaminocarbonyl-3, 4- dimethoxyphenylsulfoximino)-butoxy]- 3, 3- dimethylin doTinon- 2
Fremstilt analogt med eksempel 49 fra 5-[4-(3,4-dimetoksy-fenylsulfoksimino)-butoksy]-3,3-dimetyl-indolinon-2 og dimetylkarbamylklorid. Harpiks. Prepared analogously to Example 49 from 5-[4-(3,4-dimethoxy-phenylsulfoximino)-butoxy]-3,3-dimethyl-indolinone-2 and dimethylcarbamyl chloride. Resin.
Rf-verdi: 0,3 (silikagelplate, etylenklorid/etanol = 9:1), Utbytte: 98% av det teoretiske. Rf value: 0.3 (silica gel plate, ethylene chloride/ethanol = 9:1), Yield: 98% of the theoretical.
Eksempel 7 9 5- [ 4-( N-( 4- klorben zoyl)- 3, 4- dimetoksyfenylsul foksimino)-butoksy]- 3, 3- dimet yl- indolinon- 2 Example 7 9 5- [ 4-( N -( 4- chlorobenzoyl)- 3, 4- dimethoxyphenylsulfoximino)- butoxy]- 3, 3- dimethyl indolinone- 2
Fremstilt analogt med eksempel 49 fra 5-[4-(3,4-dimetoksy-fenylsulfoksimino)-butoksy]-3,3-dimetyl-indolinon-2 og 4-klor-benzoylklorid. Prepared analogously to Example 49 from 5-[4-(3,4-dimethoxy-phenylsulfoximino)-butoxy]-3,3-dimethyl-indolinone-2 and 4-chloro-benzoyl chloride.
Smeltepunkt: 174-177°C,Melting point: 174-177°C,
Utbytte: 74% av det teoretiske.Yield: 74% of the theoretical.
Eksempel 80 Example 80
5- [ 4-( N- nikotinoyl- 3, 4- dimetoksyfenylsulfoksimino)- butoksy]-3. 3- dimetyl- indolinon-2 5-[4-(N-nicotinoyl-3,4-dimethoxyphenylsulfoximino)-butoxy]-3. 3-dimethyl-indolinone-2
Fremstilt analogt med eksempel 49 fra 5-[4-(3,4-dimetoksy-fenylsulfoksimino)-butoksy]-3,3-dimety1-indolinon-2 og nikotinsyreklorid-hydroklorid. Harpiks. Prepared analogously to Example 49 from 5-[4-(3,4-dimethoxy-phenylsulfoximino)-butoxy]-3,3-dimethyl-indolinone-2 and nicotinic acid chloride hydrochloride. Resin.
R^-verdi: 0,25 (silikagelplate, etylenklorid/etanol = 9:1), Utbytte: 76% av det teoretiske. R^ value: 0.25 (silica gel plate, ethylene chloride/ethanol = 9:1), Yield: 76% of the theoretical.
Eksem pel 81 Example number 81
6 - [ 4-( 2- naftoyl)- 3, 4- dimetoksyfenylsulfoksimino)- butoksy]-3. 4- di hydrokarbostyril 6 - [4-(2-naphthoyl)-3,4-dimethoxyphenylsulfoximino)-butoxy]-3. 4- dihydrocarbostyril
Fremstilt analogt med eksempel 49 fra 6- [4-(3,4-dimetoksy-fenylsulfoksimino)-butoksy]-3,4-dihydrokarbostyril og 2-naftoesyreklorid. Harpiks. Prepared analogously to Example 49 from 6-[4-(3,4-dimethoxy-phenylsulfoximino)-butoxy]-3,4-dihydrocarbostyril and 2-naphthoic acid chloride. Resin.
R^-verdi: 0,45 (silikagelplate, etylacetat/metylenklorid = 1:1), Utbytte: 93% av det teoretiske. R^-value: 0.45 (silica gel plate, ethyl acetate/methylene chloride = 1:1), Yield: 93% of the theoretical.
Eksempel 82 Example 82
6- [ 4-( N-(1- naftoyl)- 3,4-dimet oksyfenylsulfoksimino)-but oksy]-3, 4- dihydrokarbostyril 6- [ 4-( N -(1- naphthoyl)- 3,4-dimethoxyphenylsulfoximino)-butoxy]-3, 4- dihydrocarbostyril
Fremstilt analogt med eksempel 49 fra 6-[4-(3,4-dimetoksy fenyl-sulfoksimino)-butoksy]-3,4-dihydrokarbostyril og 1-naftoesyreklorid. Harpiks. Prepared analogously to example 49 from 6-[4-(3,4-dimethoxy phenyl-sulfoximino)-butoxy]-3,4-dihydrocarbostyryl and 1-naphthoic acid chloride. Resin.
R^-verdi: 0,3 (silikagelplate, etylacetat/metylenklorid = 1:1), Utbytte: 83% av det teoretiske. R^ value: 0.3 (silica gel plate, ethyl acetate/methylene chloride = 1:1), Yield: 83% of the theoretical.
Eksempel 8 3 Example 8 3
6-[ 4-( N-( 2- tienoyl)- 3, 4- dimetoksyfenyl sulfoksimino)- butoksy]-3, 4- dihydrokarbostyril 6-[ 4-( N-( 2- thienoyl)- 3, 4- dimethoxyphenyl sulfoximino)- butoxy]-3, 4- dihydrocarbostyril
Fremstilt analogt med eksempel 49 fra 6-[4-(3,4-dimetoksy-fenylsulfoksimino)-butoksy]-3,4-dihydrokarbostyril og tiofen-2-karboksylsyreklorid. Harpiks. Prepared analogously to Example 49 from 6-[4-(3,4-dimethoxy-phenylsulfoximino)-butoxy]-3,4-dihydrocarbostyril and thiophene-2-carboxylic acid chloride. Resin.
Rf-verdi: 0,3 (silikagelplate, etylacetat/metylenklorid = 1:1), Utbytte: 88% av det teoretiske. Rf value: 0.3 (silica gel plate, ethyl acetate/methylene chloride = 1:1), Yield: 88% of the theoretical.
Eksempel 84 Example 84
6-[ 4-( 3, 4- dimetoksyfen ylsulfoksimino)- butoksy]-3, 4- dihydrokarbostyril 6-[ 4-( 3, 4- dimethoxyphenylsulfoximino)- butoxy]-3, 4- dihydrocarbostyril
Fremstilt analogt med eksempel 2 fra 6-[4-(3,4-dimetoksy-fenylsulfinyl) ^butoksy]-3,4-dihydrokarbostyril og O-mesitylensulfonylhydroksylamin. Prepared analogously to example 2 from 6-[4-(3,4-dimethoxy-phenylsulfinyl)-butoxy]-3,4-dihydrocarbostyril and O-mesitylenesulfonylhydroxylamine.
Smeltepunkt: 154-156°C.Melting point: 154-156°C.
Utbytte: 64% av det teoretiske..Yield: 64% of the theoretical..
Eksempel 85 Example 85
6- [ 4-( N- benzoyl- 4- fluorfenylsulfoksimino)- butoksy]-3, 4- dihydrokarbostyril 6- [ 4-( N- benzoyl- 4- fluorophenylsulfoximino)- butoxy]-3, 4- dihydrocarbostyril
Fremstilt analogt med eksempel 49 fra 6-[4-(4-fluorfenyl-sulf oksimino) -butoksy]-3,4-dihydrokarbostyril og benzoylklorid. Smeltepunkt: 64- 68°C. Prepared analogously to Example 49 from 6-[4-(4-fluorophenyl-sulfoximino)-butoxy]-3,4-dihydrocarbostyril and benzoyl chloride. Melting point: 64-68°C.
Utbytte: 87% av det teoretiske.Yield: 87% of the theoretical.
Eksempel 86 Example 86
6- [ 4-( N-( 4- klorbenzoyl)- 4- fluorfenylsulfoksimino)- butoksy]-3, 4- dihydrokarbostyril 6- [ 4-( N-( 4- chlorobenzoyl)- 4- fluorophenylsulfoximino)- butoxy]-3, 4- dihydrocarbostyril
Fremstilt analogt med eksempel 49 fra 6-[4-(4-fluorfenyl-sulf oksimino) -butoksy ] -3 , 4-dihydrokarbostyril og 4-klor-benzoylklorid. Prepared analogously to example 49 from 6-[4-(4-fluorophenyl-sulfoximino)-butoxy]-3,4-dihydrocarbostyryl and 4-chloro-benzoyl chloride.
Smeltepunkt: 134-138°C,Melting point: 134-138°C,
Utbytte: 78% av det teoretiske.Yield: 78% of the theoretical.
Eksempel 87 Example 87
6- [ 4- ( 3, 4- diklorfenylsulf oksimino)- butoksy]-3, 4- dihyd ro-k arbostyril 6- [ 4- ( 3, 4- dichlorophenylsulfoximino)- butoxy]-3, 4- dihydro-carbostyril
Man oppløser 145,5 g p-toluensulfonsyre under omrøring145.5 g of p-toluenesulfonic acid are dissolved while stirring
i 350 ml dimetylformamid og innrører 70,1 g 6-[4-(3,4-diklor-fenylsulfinyl)-butoksy]-3,4-dihydrokarbostyril. Derefter tilsetter man 106,7 g O-mesitylensulfonylhydroksamsyre-etylester. Reaksjonen er svakt eksoterm, og ved leilighetsvis avkjøling sørger man for at reaksjonsblandingens temperatur ikke overstiger 20°C. Efter 46 timer tilsetter man under god omrøring 350 ml vann til den første svak uklarhet oppstår. in 350 ml of dimethylformamide and stir in 70.1 g of 6-[4-(3,4-dichloro-phenylsulfinyl)-butoxy]-3,4-dihydrocarbostyril. 106.7 g of O-mesitylenesulfonyl hydroxamic acid ethyl ester is then added. The reaction is slightly exothermic, and by occasional cooling it is ensured that the temperature of the reaction mixture does not exceed 20°C. After 46 hours, add 350 ml of water with good stirring until the first slight cloudiness appears.
Efter tilsetning av en suspensjon av podekrystaller begynner krystallisasjonen av en stor andel av produktet i løpet av 30 minutter under ytterligere omrøring. For fullførelse innrører man ytterligere 300 ml vann. Man efterrører i ytterligere 30 minutter, avsuger derefter krystallene av det dannede 0-mesitylensulfonsure salt og eftervasker med vann. After addition of a suspension of seed crystals, crystallization of a large proportion of the product begins within 30 minutes under further stirring. For completion, a further 300 ml of water is stirred in. The mixture is stirred for a further 30 minutes, then the crystals of the formed 0-mesitylene sulphonic acid salt are filtered off and washed with water.
Den ennu vannfuktige filterkake suspenderes i 500 ml metanolThe still water-moist filter cake is suspended in 500 ml of methanol
og man innrører 100 ml 2N natronlut, alt på én gang. Forbindelsen går efter kort tid i oppløsning, men derefter følger krystallisasjon av det frie sulfoksimin. Man omrører i ytterligere 1/2 time ved romtemperatur, avsuger og vasker med iskald metanol. Man tørrer i luftsirkulasjonsskap ved 80°C. Smeltepunkt: 160-162°C. and stir in 100 ml of 2N caustic soda, all at once. The compound dissolves after a short time, but then crystallization of the free sulfoximine follows. The mixture is stirred for a further 1/2 hour at room temperature, filtered off with suction and washed with ice-cold methanol. It is dried in an air circulation cabinet at 80°C. Melting point: 160-162°C.
Utbytte: 61,7 g (84,9% av det teoretiske).Yield: 61.7 g (84.9% of the theoretical).
Eksempel 88 Example 88
6-[ 4-( 3, 4- diklorfeny1- N-( 4- toluensulfonyl)- sul foksi mino)-b utoksy]- 3, 4- dihydrokarbostyril 6-[ 4-( 3, 4- dichlorophenyl- N-( 4- toluenesulfonyl)- sulfoximino)-butoxy]- 3, 4- dihydrocarbostyril
200 mg 6-[4-(3,4-diklorfenyl-N-(4-toluensulfony1)-sulfimino) butoksy]-3,4-dihydrokarbostyril [fremstilt fra 6-[4-(3,4-diklor-fenylmerkapto)-butoksy]-3,4-dihydrokarbostyril og N-klor-4-toluensulfonamid-natrium (kloramin T)] suspenderes i metanol, tilsettes 0,35 ml 2N natronlut og 0,06 ml hydrogenperoksyd-oppløsning (397,4 mg/ml) og oppvarmes til kokning under tilbakelø kjøling i 4 timer. I begynnelsen av kokningen dannes en klar oppløsning, og efter en time utfelles krystaller.. Efter ytterligere oppvarmning avsuger man krystallene i varm tilstand og tørrer dem i luft. 200 mg 6-[4-(3,4-dichlorophenyl-N-(4-toluenesulfonyl)sulfimino)butoxy]-3,4-dihydrocarbostyril [prepared from 6-[4-(3,4-dichloro-phenylmercapto)- butoxy]-3,4-dihydrocarbostyril and N-chloro-4-toluenesulfonamide sodium (chloramine T)] are suspended in methanol, 0.35 ml of 2N caustic soda and 0.06 ml of hydrogen peroxide solution (397.4 mg/ml) are added and heated to boiling under reflux cooling for 4 hours. At the beginning of boiling, a clear solution is formed, and after an hour crystals precipitate. After further heating, the crystals are sucked off while still hot and dried in air.
Smeltepunkt: 155-157°CMelting point: 155-157°C
Utbytte: 59% av det teoretiskeYield: 59% of the theoretical
Eksempel 89 Example 89
6- [ 3-( 3, 4-d ikl orfenylsulfoksimino)- propoks y]- 3, 4- dihydrokarbostyril 6- [ 3-( 3, 4-dichlorophenylsulfoximino)- propoxy]- 3, 4- dihydrocarbostyril
Fremstilt analogt med eksempel 2 fra 6-[3-(3,4-diklor-fenylsulfinyl)-propoksy]-3,4-dihydrokarbostyril og O-mesitylen-sulf onylhydroksylamin . Prepared analogously to example 2 from 6-[3-(3,4-dichloro-phenylsulfinyl)-propoxy]-3,4-dihydrocarbostyril and O-mesitylene-sulfonylhydroxylamine.
Smeltepunkt: 144-146°CMelting point: 144-146°C
Utbytte: 67% av det teoretiske.Yield: 67% of the theoretical.
Eksempel 90 Example 90
6-[ 5-( 3, 4- diklorfenylsulfoksimino)- pentoksy]- 3, 4- dihydrokarbostyril 6-[ 5-( 3, 4- dichlorophenylsulfoximino)- pentoxy]- 3, 4- dihydrocarbostyril
Fremstilt analogt med eksempel 2 fra 6-[5-(3,4-diklor-fenylsulfinyl)-pentoksy]-3,4-dihydrokarbostyril og O-mesitylensulfonylhydroksylamin. Prepared analogously to example 2 from 6-[5-(3,4-dichloro-phenylsulfinyl)-pentoxy]-3,4-dihydrocarbostyril and O-mesitylenesulfonylhydroxylamine.
Smeltepunkt: 154-155°C,Melting point: 154-155°C,
Utbytte: 29% av det teoretiske.Yield: 29% of the theoretical.
Eksempel 91 Example 91
6- ( 3- etylsulf oksimino- propoksy) - 3 ,' 4- dihydrokarbostyril 6-(3-ethylsulfoximinopropoxy)-3,'4-dihydrocarbostyril
Fremstilt analogt med eksempel 2 fra 6-(3-etylsulfinyl-propoksy)-3,4-dihydrokarbostyril og O-mesitylensulfony1-hydroksylamin. Prepared analogously to example 2 from 6-(3-ethylsulfinyl-propoxy)-3,4-dihydrocarbostyril and O-mesitylenesulfonyl-1-hydroxylamine.
Smeltepunkt: 107-109°C,Melting point: 107-109°C,
Utbytte: 61% av det teoretiske.Yield: 61% of the theoretical.
Eksempel 9 2 Example 9 2
' 6- [ 4-( N- 4- cyanobenzoyl- 3, 4- diklorfenylsulfoksimino)- butoksy]-3, 4- dihydrokarbostyril ' 6- [ 4-( N- 4- cyanobenzoyl- 3, 4- dichlorophenylsulfoximino)- butoxy]-3, 4- dihydrocarbostyril
Fremstilt analogt med eksempel 49 fra 6-[4-(3,4-diklorfenylsulfoksimino)-butoksy]-3,4-dihydrokarbostyril og 4-cyano-benzoylklorid. Prepared analogously to Example 49 from 6-[4-(3,4-dichlorophenylsulfoximino)-butoxy]-3,4-dihydrocarbostyril and 4-cyano-benzoyl chloride.
Smeltepunkt: 200-202°C,Melting point: 200-202°C,
Utbytte: 79% av det teoretiske.Yield: 79% of the theoretical.
Eksempel 93 Example 93
6-[ 4-( N- 2- tenoyl- 3, 4- diklorfenylsulfoksimino)- butoksy]-3, 4- dihydrokarbostyril 6-[ 4-( N- 2- thenoyl- 3, 4- dichlorophenylsulfoximino)- butoxy]-3, 4- dihydrocarbostyril
Fremstilt analogt med eksempel 49 fra 6-[4-(3,4-diklorfenylsulfoksimino)-butoksy]-3,4-dihydrokarbostyril og Prepared analogously to example 49 from 6-[4-(3,4-dichlorophenylsulfoximino)-butoxy]-3,4-dihydrocarbostyril and
2-tiofenkarboksylsyreklorid.2-thiophenecarboxylic acid chloride.
Smeltepunkt:. 100-102°CMelting point:. 100-102°C
Utbytte: 61% av det teoretiske.Yield: 61% of the theoretical.
Eksempel 94 Example 94
6-[ 4-( N-(+)- pinanoyl- 3, 4- diklorfenylsulfoksimino)- butoksy]-3, 4-.- dihydrokarbostyril 6-[ 4-( N-(+)- pinanoyl- 3, 4- dichlorophenylsulfoximino)- butoxy]-3, 4-.- dihydrocarbostyril
Fremstilt analogt med eksempel 49 fra 6-[4-(3,4-diklorfenylsulfoksimino)-butoksy]-3,4-dihydrokarbostyril og (+)-pinansyreklorid. Prepared analogously to example 49 from 6-[4-(3,4-dichlorophenylsulfoximino)-butoxy]-3,4-dihydrocarbostyril and (+)-pinanoic acid chloride.
Smeltepunkt: 69-74°C,Melting point: 69-74°C,
Utbytte: 94% av det teoretiske..Yield: 94% of the theoretical..
Eksempel 9 5 Example 9 5
6-[ 4-( N-(-)- pinanoyl- 3, 4- diklorfenylsulfoksimino)- butoksy]-3, 4- dihydrokarbostyril 6-[ 4-( N-(-)- pinanoyl- 3, 4- dichlorophenylsulfoximino)- butoxy]-3, 4- dihydrocarbostyril
Fremstilt analogt med eksempel 49 fra 6-[4-(3,4-diklorfenylsulfoksimino)-butoksy]-3,4-dihydrokarbostyril og Prepared analogously to example 49 from 6-[4-(3,4-dichlorophenylsulfoximino)-butoxy]-3,4-dihydrocarbostyryl and
(-)-pinansyreklorid.(-)-Pinanoic acid chloride.
Smeltepunkt: 69-74°C,Melting point: 69-74°C,
Utbytte: 91% av det teoretiske.Yield: 91% of the theoretical.
Eksempel 96 Example 96
6-[ N- pentametylfenylsulfonyl- 3, 4- diklorfenylsulfoksimino) - butoksy]— 3, 4- dihydrokarbostyril 6-[ N- pentamethylphenylsulfonyl- 3, 4- dichlorophenylsulfoximino) - butoxy]— 3, 4- dihydrocarbostyril
Fremstilt analogt med eksempel '49 fra 6-[ 4-(3 , 4-diklorfenylsulfoksimino)-butoksy]-3,4-dihydrokarbostyril og penta-metylfenylsulfoklorid. Prepared analogously to Example '49 from 6-[4-(3,4-dichlorophenylsulfoximino)butoxy]-3,4-dihydrocarbostyril and pentamethylphenylsulfochloride.
Smeltepunkt: 149-151°C.Melting point: 149-151°C.
Utbytte: 83% av det teoretiske.Yield: 83% of the theoretical.
Eksemepel 97 Example 97
6-[ 4-( N- metansulfony1- 3, 4- diklorfenylsulfoksimino)- butoksy]-3, 4- dihydrokarbostyril 6-[ 4-( N- methanesulfony1- 3, 4- dichlorophenylsulfoximino)- butoxy]-3, 4- dihydrocarbostyril
Fremstilt analogt med eksempel 49 fra 6-[4-(3,4-diklorfenylsulfoksimino)-butoksy]-3,4-dihydrokarbostyril og metan-sulfonylklorid. Prepared analogously to Example 49 from 6-[4-(3,4-dichlorophenylsulfoximino)-butoxy]-3,4-dihydrocarbostyryl and methanesulfonyl chloride.
Smeltepunkt: 172-174°C,Melting point: 172-174°C,
Utbytte: 37% av det teoretiske.Yield: 37% of the theoretical.
Eksempel 98 6-[ 4-( N- acetyl- 4- cykloheksylfenyl- sulfoksimino)- butoksy]-3, 4- dihydrokårbostyril Example 98 6-[4-(N-acetyl-4-cyclohexylphenyl-sulfoximino)-butoxy]-3,4-dihydrocarbostyril
Fremstilt analogt med eksempel 47 fra 6-[4-(4-cyklo-heksylfenylsulfoksimino)-butoksy]-3,4-dihydrokarbostyril og eddiksyreanhydrid. Prepared analogously to example 47 from 6-[4-(4-cyclohexylphenylsulfoximino)-butoxy]-3,4-dihydrocarbostyryl and acetic anhydride.
Smeltepunkt: 135-136°C,Melting point: 135-136°C,
Utbytte: 92% av det teoretiske.Yield: 92% of the theoretical.
Eksempel 99 6-[ 4-( N- pivaloyl- 4- cykloheksylfenylsulfoksimino)- butoksy]-3, 4- dihydrokarbostyril Example 99 6-[4-(N-pivaloyl-4-cyclohexylphenylsulfoximino)-butoxy]-3,4-dihydrocarbostyril
Fremstilt analogt med eksempel 49 fra 6-[4-(4-cykloheksyl-fenylsulfoksimino)-butoksy]-3,4-dihydrokarbostyril og pivaloyl-klorid. Prepared analogously to example 49 from 6-[4-(4-cyclohexyl-phenylsulfoximino)-butoxy]-3,4-dihydrocarbostyril and pivaloyl chloride.
Smeltepunkt: 170-172°C,Melting point: 170-172°C,
Utbytte: 95% av det teoretiske.Yield: 95% of the theoretical.
Eksempel 100 Example 100
6-[ 4-( N- benzoyl- 4- cykloheksylfenylsulfoksimino)- butoksy]-3, 4- dihydrokarbostyril 6-[ 4-( N- benzoyl- 4- cyclohexylphenylsulfoximino)- butoxy]-3, 4- dihydrocarbostyril
Fremstilt analogt med eksempel 49 fra 6-[4-(4-cyklo-heksylfeny1-sulfoksimino)-butoksy]-3,4-dihydrokarbostyril og benzoylklorid. Prepared analogously to Example 49 from 6-[4-(4-cyclohexylphenyl-sulfoximino)-butoxy]-3,4-dihydrocarbostyril and benzoyl chloride.
Smeltepunkt: 187-189°C.Melting point: 187-189°C.
Utbytte: 92% av det teoretiske.Yield: 92% of the theoretical.
Eksempel 101 6-[ 4-( N- acety1- 4- fluorfenylsulfoksimino)- butoksy]- 3, 4- dihydrokarbostyril Example 101 6-[4-(N-acetyl-4-fluorophenylsulfoximino)-butoxy]-3,4-dihydrocarbostyril
Fremstilt analogt med eksempel 47 fra 6-[4-(4-fluorfenyl-sulf oksimino)-butoksy]-3,4-dihydrokarbostyril (R^-verdi: 0,60) og eddiksyreanhydrid. Prepared analogously to example 47 from 6-[4-(4-fluorophenyl-sulfoximino)-butoxy]-3,4-dihydrocarbostyril (R^-value: 0.60) and acetic anhydride.
R^-verdi: 0,65 (silikagel, utviklingsmiddel: etylenklorid/ etanol = 85:15). R^ value: 0.65 (silica gel, developer: ethylene chloride/ ethanol = 85:15).
Utbytte: 54% av det teoretiske.Yield: 54% of the theoretical.
Eksempel■ 102 Example■ 102
6- [ Ar - ( N- butyroyl- 4- f luorf enylsulf oksimino) - butoksy] - 3, 4-dihydrokarbostyril 6- [ Ar - ( N- butyroyl- 4- fluoro enylsulf oximino) - butoxy] - 3, 4-dihydrocarbostyril
Fremstilt analogt med eksempel 49 fra 6-[4-(4-fluor-f enylsulf oksimino) -butoksy] -3., 4-dihydrokarbostyril (R^-verdi 0, 6i og smørsyreklorid. Prepared analogously to example 49 from 6-[4-(4-fluoro-phenylsulfoximino)-butoxy]-3.,4-dihydrocarbostyril (R^-value 0.6i and butyric acid chloride.
R^-verdi: 0,70 (silikagel, utviklingsmiddel: etylenklorid/etanol 85:15). R^ value: 0.70 (silica gel, developer: ethylene chloride/ethanol 85:15).
Utbytte: 78% av det teoretiske.Yield: 78% of the theoretical.
Eksempel 103 Example 103
6-[ 4-( N- 2- metoksyacetyl- 4- fluorfenylsulfoksimino)- butoksy]-3, 4- dihydrokarbostyril 6-[ 4-( N- 2- methoxyacetyl- 4- fluorophenylsulfoximino)- butoxy]-3, 4- dihydrocarbostyril
Fremstilt analogt med eksempel 49 fra 6-[4-(4-fluorfenyl-sulf oksimino) -butoksy]-3,4-dihydrokarbostyril (R^-verdi: 0,60) og 2-metoksyacetylklorid. Prepared analogously to example 49 from 6-[4-(4-fluorophenyl-sulfoximino)-butoxy]-3,4-dihydrocarbostyril (R^-value: 0.60) and 2-methoxyacetyl chloride.
R^-verdi: 0,66 (silikagel, utviklingsmiddel: etylenklorid/ etanol = 85/15). R^ value: 0.66 (silica gel, developer: ethylene chloride/ ethanol = 85/15).
Utbytte: 67% av det teoretiske.Yield: 67% of the theoretical.
Eksempel 104 Example 104
6-[ 4-( N-(+)- pinanoyl- 4- fluorfenylsulfoksimino)- butoksy]-3, 4- dihydrokarbostyril 6-[ 4-( N-(+)- pinanoyl- 4- fluorophenylsulfoximino)- butoxy]-3, 4- dihydrocarbostyril
Fremstilt fra 6-[4-(4-fluorfenylsulfoksimino)-butoksy]-3,4-dihydrokarbostyril og (+)-pinansyreklorid analogt med eksempel 49. Prepared from 6-[4-(4-fluorophenylsulfoximino)-butoxy]-3,4-dihydrocarbostyril and (+)-pinanoic acid chloride analogously to Example 49.
Smeltepunkt: 116-120°C,Melting point: 116-120°C,
Utbytte: 61% av det teoretiske.Yield: 61% of the theoretical.
Eksempel 105 Example 105
6- [. 4- ( N- (-) - pinanoyl- 4- f luorf enylsulf oksimino) - butoksy] - 3, 4- dihydrokarbostyril 6- [. 4-(N-(-)-pinanoyl-4-fluorophenylsulfoximino)-butoxy]-3,4-dihydrocarbostyril
Fremstilt analogt med eksempel 49 fra 6-[4-(4-fluor-fenylsulfoksimino)-butoksy]-3,4-dihydrokarbostyril og Prepared analogously to example 49 from 6-[4-(4-fluoro-phenylsulfoximino)-butoxy]-3,4-dihydrocarbostyril and
(-)-pinansyreklorid.(-)-Pinanoic acid chloride.
Smeltepunkt: 122-123°C,Melting point: 122-123°C,
Utbytte: 45% av det teoretiske.Yield: 45% of the theoretical.
Eksempel 106 Example 106
6-[ 4-( N- 4- toluensulfonyl- 4- fluorfenylsulfoksimino)- butoksy]-3, 4- dihydrokarbostyril 6-[ 4-( N- 4- toluenesulfonyl- 4- fluorophenylsulfoximino)- butoxy]-3, 4- dihydrocarbostyril
Fremstilt analogt med eksempel 49 fra 6-[4-(4-fluorfenyl-sulfoksimino)-butoksy]-3,4-dihydrokarbostyril og 4-toluensulfoklorid. Prepared analogously to example 49 from 6-[4-(4-fluorophenyl-sulfoximino)-butoxy]-3,4-dihydrocarbostyril and 4-toluene sulfochloride.
Smeltepunkt: 67-70°C,Melting point: 67-70°C,
Utbytte: 57% av det teoretiske.Yield: 57% of the theoretical.
Eksempel 107 Example 107
6- [ 4-( N-( + )- 10- kamfersulfonyl- 4- fluorfenylsulfoksimino)-butoksy]- 3, 4- dihydrokarbostyril 6- [ 4-( N-( + )- 10- camphorsulfonyl- 4- fluorophenylsulfoximino)-butoxy]- 3, 4- dihydrocarbostyril
Fremstilt analogt med eksempel 49 fra 6-[4-(4-fluorfenyl-sulf oksimino)-butoksy]-3,4-dihydrokarbostyril og (+)-10-kamfer-sulfoklorid. Prepared analogously to Example 49 from 6-[4-(4-fluorophenyl-sulfoximino)-butoxy]-3,4-dihydrocarbostyril and (+)-10-camphor sulfochloride.
Smeltepunkt: 81-100°C,Melting point: 81-100°C,
Utbytte: 61% av det teoretiske.Yield: 61% of the theoretical.
Eksempel 108 Example 108
6-[ 4- ( N- 4- klorbenzoy1- 4- metylsulfoksimino)- butoksy]- 3, 4- dihydrokarbostyril 6-[ 4- ( N- 4- chlorobenzoyl- 4- methylsulfoximino)- butoxy]- 3, 4- dihydrocarbostyril
Fremstilt analogt med eksempel 49 fra 6-(4-metylsulf oksimino) -butoksy)-3,4-dihydrokarbostyril og 4-klorbenzoyl-klorid. Prepared analogously to example 49 from 6-(4-methylsulfoximino)-butoxy)-3,4-dihydrocarbostyril and 4-chlorobenzoyl chloride.
Smeltepunkt: 176-178°C,Melting point: 176-178°C,
Utbytte: 87% av det teoretiske.Yield: 87% of the theoretical.
Eksempel 109 Example 109
6-( 4- n- heksylsulfoksimino- butoksy)- 3, 4- dihydrokarbostyril 6-( 4- n- hexylsulfoximino- butoxy)- 3, 4- dihydrocarbostyril
Fremstilt analogt med eksempel 2 fra 6-(4-n-heksylsulfinyl-butoksy)-3 , 4-dihydrokarbostyril og O-mesitylensulfonyl-hydroksylamin . Prepared analogously to example 2 from 6-(4-n-hexylsulfinyl-butoxy)-3,4-dihydrocarbostyril and O-mesitylenesulfonyl-hydroxylamine.
Smeltepunkt: 111-113°C,Melting point: 111-113°C,
Utbytte: 59% av det teoretiske.Yield: 59% of the theoretical.
Eksempel 110 Example 110
6-( N- acetyl- 4- n- heksylsulfoksimino- butoksy)- 3, 4- dihydrokarbostyril 6-( N- acetyl- 4- n- hexyl sulfoximino- butoxy)- 3, 4- dihydrocarbostyril
Fremstilt analogt med eksempel 47 fra 6-(4-n-heksyl-sulf oksimino-butoksy ) -3,4-dihydrokarbostyril og eddiksyreanhydri Smeltepunkt: 119-121°C, Prepared analogously to example 47 from 6-(4-n-hexyl-sulfoximino-butoxy)-3,4-dihydrocarbostyril and acetic anhydride Melting point: 119-121°C,
Utbytte: 90% av det teoretiske.Yield: 90% of the theoretical.
Eksempel 111 Example 111
6- ( N- benzoyl- 4- n- heks' ylsulf oksimino- butoksy) - 3 , 4- dihydrokarbostyril 6-(N-benzoyl-4-n-hex'ylsulfoximino-butoxy)-3,4-dihydrocarbostyril
Fremstilt analogt med eksempel 49 fra 6-(4-n-heksyl-sulf oksimino-butoksy ) -3 , 4-dihydrokarbostyril og benzoylklorid. Smeltepunkt: 112-114°C, Prepared analogously to example 49 from 6-(4-n-hexyl-sulfoximino-butoxy)-3,4-dihydrocarbostyryl and benzoyl chloride. Melting point: 112-114°C,
Utbytte: 75% av det teoretiske.Yield: 75% of the theoretical.
Eksempel 112 Example 112
6- [ 4- ( 2- f enyletylsulfoksimino.) - butoksy] - 3 , 4- dihydrokarbostyril 6-[4-(2-phenylethylsulfoximino.)-butoxy]-3,4-dihydrocarbostyril
Fremstilt analogt med eksempel 2 fra 6-[4-(2-fenyletyl-sulf inyl ) -butoksy ] -3 , 4-dihydrokarbostyril og O-mesitylen-hydroksylamin. Prepared analogously to example 2 from 6-[4-(2-phenylethylsulfinyl)-butoxy]-3,4-dihydrocarbostyril and O-mesitylene-hydroxylamine.
Smeltepunkt: 158-159°C,Melting point: 158-159°C,
Utbytte: 69% av det teoretiske.-Yield: 69% of the theoretical.-
Eksempel 113 Example 113
5-( 4~ fenylsulfoksimino- butoksy)- 3, 4- dihydrokarbostyril 5-(4~ phenylsulfoximinobutoxy)-3, 4- dihydrocarbostyril
Fremstilt analogt med eksempel 2 fra 5-(4-fenylsulfinyl-butoksy ) -3,4-dihydrokarbostyril og O-mesitylensulfonylhydroksylamin. Prepared analogously to example 2 from 5-(4-phenylsulfinyl-butoxy)-3,4-dihydrocarbostyril and O-mesitylenesulfonylhydroxylamine.
Smeltepunkt: 159-160°C,Melting point: 159-160°C,
Utbytte: 76% av det teoretiske.Yield: 76% of the theoretical.
Eksempel 114 5-( N- acetyl- 4- fenylsulfoksimino- butoksy)- 3, 4- dihydrokarbostyril Example 114 5-(N-acetyl-4-phenylsulfoximino-butoxy)-3,4-dihydrocarbostyril
Fremstilt analogt med eksempel 47 fra 5-(4-fenylsulfoksimino-butoksy )-3,4-dihydrokarbostyril og eddiksyreanhydrid. Smeltepunkt: 134-137°C, Prepared analogously to example 47 from 5-(4-phenylsulfoximino-butoxy)-3,4-dihydrocarbostyril and acetic anhydride. Melting point: 134-137°C,
Utbytte: 61% av det teoretiske.Yield: 61% of the theoretical.
Eksempel 115 Example 115
7-( 4- fenylsulfoksimino- butoksy)- 3, 4- dihydrokarbostyril 7-(4-phenylsulfoximino-butoxy)-3,4-dihydrocarbostyril
Fremstilt analogt med eksempel 87 fra 7-(4-fenylsulfinyl-butoksy ) -3,4-dihydrokarbostyril,. O-mesitylensulfonylhydroksamsyre-etylester og p-toluensulfonsyre. Prepared analogously to example 87 from 7-(4-phenylsulfinyl-butoxy)-3,4-dihydrocarbostyril,. O-mesitylenesulfonylhydroxamic acid ethyl ester and p-toluenesulfonic acid.
Smeltepunkt: 137-139°C,Melting point: 137-139°C,
Utbytte: 81% av det teoretiske.Yield: 81% of the theoretical.
Eksempel 116 Example 116
7- ( N- acetyl- 4- fenylsulfoksimino- butoksy)- 3, 4- dihydrokarbostyril 7- ( N- acetyl- 4- phenylsulfoximino- butoxy)- 3, 4- dihydrocarbostyril
Fremstilt analogt med eksempel 47 fra 7-(4-fenylsulfoksimino-butoksy)-3,4-dihydrokarbostyril og eddiksyreanhydrid. Prepared analogously to example 47 from 7-(4-phenylsulfoximino-butoxy)-3,4-dihydrocarbostyril and acetic anhydride.
Smeltepunkt: 111-113°C,Melting point: 111-113°C,
Utbytte: 78% av det teoretiske.Yield: 78% of the theoretical.
Eksempel 117 Example 117
8- ( 4- f enylsulf oksimino- butoksy).- 3 , 4- dihydrokarbostyril 8- ( 4-phenylsulfoximino-butoxy).- 3 , 4- dihydrocarbostyril
Fremstilt analogt med eksempel 2 fra 8-(4-fenylsulfinyl-butoksy ) -3,4-dihydrokarbostyril og mesitylensulfonylhydroksylamin. Prepared analogously to example 2 from 8-(4-phenylsulfinyl-butoxy)-3,4-dihydrocarbostyril and mesitylenesulfonylhydroxylamine.
Smeltepunkt: 78-80°C,Melting point: 78-80°C,
Utbytte: 96% av det teoretiske.Yield: 96% of the theoretical.
Eksempel 118 Example 118
8- ( N- acety1- 4- fenylsulfoksimino- butoksy)- 3, 4- dihydrokarbostyril 8-( N- acety1- 4- phenylsulfoximino- butoxy)- 3, 4- dihydrocarbostyril
Fremstilt analogt med eksempel 47 fra 8-(4-fenylsulfoksimino-butoksy)-3,4-dihydrokarbostyril og eddiksyreanhydrii Smeltepunkt: 116-118°C Prepared analogously to example 47 from 8-(4-phenylsulfoximino-butoxy)-3,4-dihydrocarbostyril and acetic anhydride Melting point: 116-118°C
Utbytte: 82% av det teoretiske.Yield: 82% of the theoretical.
Eksempel 119Example 119
6- ( 3- etylsulfoksimino- propoksy)- karbostyril6-(3-ethylsulfoximino-propoxy)-carbostyryl
Fremstilt analogt med eksempel 2 fra 6-(3-etylsulfinyl-propoksy)-karbostyril og 0-mesitylensulfonylhydroksylamin. Smeltepunkt: 166-167°C, Prepared analogously to example 2 from 6-(3-ethylsulfinyl-propoxy)-carbostyril and 0-mesitylenesulfonylhydroxylamine. Melting point: 166-167°C,
Utbytte:-80% av det teoretiske.Yield: -80% of the theoretical.
Eksempel 120 Example 120
6-[ 4-( N- benzoyl- 4- fluorfenylsulfoksimino)- butoksy]- karbostyril 6-[ 4-( N- benzoyl- 4- fluorophenylsulfoximino)- butoxy]- carbostyryl
Fremstilt analogt med eksempel 49 fra 6-[4-(4-fluor-fenylsulfoksimino)-butoksy]-karbostyril og benzoylklorid. Smeltepunkt: 137-141°C, Prepared analogously to example 49 from 6-[4-(4-fluoro-phenylsulfoximino)-butoxy]-carbostyryl and benzoyl chloride. Melting point: 137-141°C,
Utbytte: 34% av det teoretiske.Yield: 34% of the theoretical.
Eksempel 121 Example 121
3, 3- dimety1- 5-[ 4-( 3, 4- dimetylfenylsulfoksimino)- butoksy]-indolinon- 2 3, 3- dimethyl- 5-[ 4-( 3, 4- dimethylphenylsulfoximino)-butoxy]-indolinone- 2
Fremstilt analogt med eksempel 87 fra 3,3-dimetyl-5-[4-(3,4-dimetylfenylsulfinyl)-butoksy]-indolinon-2, O-mesitylensulfonylhydroksamsyre-etylester og p-toluen-sulf onsyre. Prepared analogously to example 87 from 3,3-dimethyl-5-[4-(3,4-dimethylphenylsulfinyl)-butoxy]-indolinone-2, O-mesitylenesulfonylhydroxamic acid ethyl ester and p-toluenesulfonic acid.
Smeltepunkt: 153-154°C,Melting point: 153-154°C,
Utbytte: 77% av det teoretiske.Yield: 77% of the theoretical.
Eksempel 122 Example 122
3, 3- dimety1- 5-[ 4-( N- acety1- 3, 4- dimetylfenylsulfoksimino)- butoksy] indolinon- 2 3, 3- dimethyl- 5-[ 4-( N-acety1- 3, 4- dimethylphenylsulfoximino)- butoxy] indolinone- 2
Fremstilt analogt med eksempel 47 fra 3,3-dimety1-5-[4-(3,4-dimetylfenylsulfoksimino)-butoksy]-indolinon-2 og eddiksyreanhydrid. Prepared analogously to Example 47 from 3,3-dimethyl-5-[4-(3,4-dimethylphenylsulfoximino)-butoxy]-indolinone-2 and acetic anhydride.
Smeltepunkt: 150-152°C,Melting point: 150-152°C,
Utbytte: 78% av det teoretiske.Yield: 78% of the theoretical.
Eksempel 123 Example 123
3, 3- dimetyl- 5-( 4- metylsulfoksimino- butoksy)- indolinon- 2 3, 3- dimethyl- 5-( 4- methylsulfoximino- butoxy)- indolinone- 2
Fremstilt ifølge eksempel 2 fra 3,3-dimetyl-5-(4-metylsulf inyl-butoksy ) -indolinon-2 og O-mesitylensulfonylhydroksylamin. Prepared according to example 2 from 3,3-dimethyl-5-(4-methylsulfinyl-butoxy)-indolinone-2 and O-mesitylenesulfonylhydroxylamine.
Smeltepunkt: 123-124°C,Melting point: 123-124°C,
Utbytte: 98% av det teoretiske.Yield: 98% of the theoretical.
Eksempel 124 Example 124
3, 3- dimetyl- 5-[ 4-( N- 4- klorfenylaminokarbonyl- metylsulfoksimino)-butoksy]- indolinon- 2 3, 3- dimethyl- 5-[ 4-( N- 4- chlorophenylaminocarbonyl- methylsulfoximino)-butoxy]- indolinone- 2
Fremstilt fra 3,3-dimetyl-5-(4-metylsulfoksimino-butoksy)-indolinon-2 og 4-klorfenylisocyanat i absolutt dioksan ved romtemperatur i 30 minutter. Prepared from 3,3-dimethyl-5-(4-methylsulfoximino-butoxy)-indolinone-2 and 4-chlorophenyl isocyanate in absolute dioxane at room temperature for 30 minutes.
Smeltepunkt: 175-177°C,Melting point: 175-177°C,
Utbytte: 89% av det teoretiske.Yield: 89% of the theoretical.
Eksempel 125 Example 125
3, 3- dimety1- 5-[ 4-( N- 4- toluensulfony1- 4- metylsulfoksimino)-butoksy]- indolinon- 2 3, 3- dimethyl- 5-[ 4-( N- 4- toluenesulfonyl- 4- methylsulfoximino)-butoxy]- indolinone- 2
Fremstilt analogt med eksempel 49 fra 3,3-dimetyl-5-(4-metylsulfoksimino-butoksy)-indolinon-2 (R^-verdi: 0,45) Prepared analogously to example 49 from 3,3-dimethyl-5-(4-methylsulfoximino-butoxy)-indolinone-2 (R^ value: 0.45)
og 4-toluensulfoklorid.and 4-toluene sulfochloride.
R^-verdi: 0,70 (silikagel, utviklingsmiddel: etylacetat/ metylenklorid = 1:1), R^-value: 0.70 (silica gel, developer: ethyl acetate/ methylene chloride = 1:1),
Utbytte: 63% av det teoretiske.Yield: 63% of the theoretical.
Eksempel 126 Example 126
3 , 3- dimetyl- 5- [ 4- ( N- 4-. klorbenzoyl- 4- metylsulfoksimino) - butoksy]- indolinon- 2 3 , 3- dimethyl- 5- [ 4- ( N- 4-. chlorobenzoyl- 4- methylsulfoximino) - butoxy]- indolinone- 2
Fremstilt analogt med eksempel 49 fra 3,3-dimety1-5-(4-metylsulfoksimino-butoksy)-indolinon-2 og 4-klorbenzoyl-klorid. Prepared analogously to Example 49 from 3,3-dimethyl-5-(4-methylsulfoximino-butoxy)-indolinone-2 and 4-chlorobenzoyl chloride.
Smeltepunkt:. 176-178°C,Melting point:. 176-178°C,
Utbytte: 73% av det teoretiske.Yield: 73% of the theoretical.
Eksempel 127 Example 127
6-[ 4-( N- acetyl- 3, 4- diklorfenylsulfoksimino)- butoksy]- 3, 4-dihydrokarbostyril 6-[ 4-( N- acetyl- 3, 4- dichlorophenylsulfoximino)- butoxy]- 3, 4-dihydrocarbostyril
3,4-diklorfénylsulfinyl-4-brombutan omsettes analogt med eksempel 2 med O-mesitylensulfonylhydroksylamin til 3,4-diklorfenylsulfoksimino-4-brombutan og overføres derefter analogt med eksempel 47 med eddiksyreanhydrid til 3,4-diklorfenyl-(N-acetyl-sulfoksimino)-4-brombutan. 3,4-dichlorophenylsulfinyl-4-bromobutane is reacted analogously to example 2 with O-mesitylenesulfonylhydroxylamine to 3,4-dichlorophenylsulfoximino-4-bromobutane and then transferred analogously to example 47 with acetic anhydride to 3,4-dichlorophenyl-(N-acetyl-sulfoximino )-4-bromobutane.
Smeltepunkt: 170-173°G,Melting point: 170-173°G,
Utbytte: 98% av det teoretiske.Yield: 98% of the theoretical.
163,2 mg (0,001 mol) 6-hydroksykarbostyril, oppløst i 2 ml dimetylsulfoksyd, tilsettes 448 mg (0,0013 mol) 3,4-diklorfenyl-(N-acetyl-sulfoksimino)-4-brombutan og 276,4 mg (0,002 mol vannfritt kaliumkarbonat og omrøres i 17 timer ved romtemperatur. Derefter tilsettes vann porsjonsvis i små porsjoner hvorefter reaksjonsproduktet utkrystalliserer i hvite nåler. Smeltepunkt: 149-151°C, 163.2 mg (0.001 mol) of 6-hydroxycarbostyril, dissolved in 2 ml of dimethyl sulfoxide, is added to 448 mg (0.0013 mol) of 3,4-dichlorophenyl-(N-acetyl-sulfoximino)-4-bromobutane and 276.4 mg ( 0.002 mol of anhydrous potassium carbonate and stirred for 17 hours at room temperature. Water is then added portionwise in small portions after which the reaction product crystallizes in white needles. Melting point: 149-151°C,
Utbytte: 267,1 mg (62,5% av det teoretiske).Yield: 267.1 mg (62.5% of the theoretical).
Eksempel 128 Example 128
6- ( 4f- metylsulf imino- butoksy) - 3 , 4- dihydrokarbostyril- hydrogen-sulfat 6- (4f- methylsulfimino-butoxy)-3, 4- dihydrocarbostyril-hydrogen-sulphate
Man oppløser 0,12 g natrium i 25 ml metanol, innfører under omrøring 1,3 g 6-(4-metylmerkapto-butoksy)-3,4-dihydrokarbostyril og tilsetter i løpet av 40 minutter ved en temperatur på 17°C 0,57 g hydroksylamin-O-sulfonsyre. Derved stiger temperaturen til 22°C. Man omrører videre natten over, avsuger derefter utskilt natriumsulfat og utfeller ved gradvis tilsetning av eter en harpiksaktig substans som efter ut-gnidning med eter krystalliserer til et noe hygroskopisk stoff. Man avsuger og tørrer i vakuumeksikator over kalsiumklorid. Smeltepunkt: 75-80°C, 0.12 g of sodium is dissolved in 25 ml of methanol, 1.3 g of 6-(4-methylmercapto-butoxy)-3,4-dihydrocarbostyril is introduced with stirring and added over the course of 40 minutes at a temperature of 17°C 0, 57 g of hydroxylamine-O-sulfonic acid. The temperature thereby rises to 22°C. Stirring is continued overnight, then the separated sodium sulphate is sucked off and, by gradual addition of ether, a resinous substance is precipitated which, after rubbing with ether, crystallizes into a somewhat hygroscopic substance. Extract and dry in a vacuum desiccator over calcium chloride. Melting point: 75-80°C,
Utbytte: 0,656 g (20% av det teoretiske).Yield: 0.656 g (20% of the theoretical).
Eksempel 129 Example 129
6- [ 4- ( 3, 4- diklorfenylsulfimino)- butoksy]- 3, 4- dihydrokarbostyril-mesitylensulfonat 6- [ 4- ( 3, 4- dichlorophenylsulfimino)- butoxy]- 3, 4- dihydrocarbostyryl mesitylene sulfonate
Fremstilt analogt med eksempel 2 fra 6-[4-(3,4-diklor-fenylmerkapto)-butoksy]-3,4-dihydrokarbostyril og O-mesitylen-sulf onylhydroksylamin . Prepared analogously to example 2 from 6-[4-(3,4-dichloro-phenylmercapto)-butoxy]-3,4-dihydrocarbostyril and O-mesitylene-sulfonylhydroxylamine.
Smeltepunkt: 82-83°C.Melting point: 82-83°C.
Utbytte: 49% av det teoretiske.Yield: 49% of the theoretical.
Eksempel 130 Example 130
6- [ 4-( 3, 4- dimetoksyfenylsulfimino)- butoksy]- 3, 4- dihydrokarbostyril- mesitylensulfonat 6- [ 4-( 3, 4- dimethoxyphenylsulfimino)-butoxy]- 3, 4- dihydrocarbostyryl- mesitylene sulfonate
Fremstilt analogt med eksempel 2 fra 6-[4-(3,4-dimetoksy- ' fenylmerkapto)-butoksy]-3,4-dihydrokarbostyril og O-mesitylen-sulf ony lhydroksy lamin . Prepared analogously to example 2 from 6-[4-(3,4-dimethoxy-'phenylmercapto)-butoxy]-3,4-dihydrocarbostyril and O-mesitylene-sulfonylhydroxylamine.
Smeltepunkt: 140-145°C,Melting point: 140-145°C,
Utbytte: 83% av det teoretiske.Yield: 83% of the theoretical.
Eksempel 131 Example 131
6-[ 4-( 2'- fluor- 4— bifenylylsulfimino)- butoksy]- karbostyril-mesitylensulfonat 6-[ 4-( 2'- fluoro- 4- biphenylylsulfimino)- butoxy]- carbostyryl mesitylene sulfonate
Fremstilt analogt med eksempel 2 fra 6-[4-(2<1->fluor-4-bifenylylmerkapto)-butoksy]-karbostyril og O-mesitylensulfonyl-hydroksylamin . Prepared analogously to example 2 from 6-[4-(2<1->fluoro-4-biphenylylmercapto)-butoxy]-carbostyril and O-mesitylenesulfonyl-hydroxylamine.
Smeltepunkt: 125-128°C,Melting point: 125-128°C,
Utbytte: 63% av det teoretiske.Yield: 63% of the theoretical.
. Eksempel 132 . Example 132
6-[ 4- ( 4- tert. butylfenylsulfimino)- butoksy]- karbostyril 6-[ 4-( 4- tert. butylphenylsulfimino)- butoxy]- carbostyryl
Fremstilt analogt med eksempel 2 fra 6-[4-(4-tert.butyl-fenylmerkapto)-butoksy]-karbostyril og O-mesitylensulfonyl-hydroksylamin . Prepared analogously to example 2 from 6-[4-(4-tert.butyl-phenylmercapto)-butoxy]-carbostyril and O-mesitylenesulfonyl-hydroxylamine.
Smeltepunkt: 145-150°C,Melting point: 145-150°C,
Utbytte: 55% av det teoretiske.Yield: 55% of the theoretical.
Eksempel' 133 Example' 133
6-[ 4-( N- 4- toluensulfonyl- 4- fluorfenylsulfimino)- butoksy]-3, 4- dihydrokarbostyril 6-[ 4-( N- 4- toluenesulfonyl- 4- fluorophenylsulfimino)- butoxy]-3, 4- dihydrocarbostyril
0,70 g 6-[4-(4-fluorfenylmerkapto)-butoksy]-3,4-dihydrokarbostyril suspenderes i 20 ml metanol og tilsettes en klar oppløsning av 1,16 g N-klor-4-toluensulfonamid-natrium. Efter omrøring natten over ved romtemperatur åvdestillerer man metanolen. Det oppnådde residuum kromatograferes på en silikagelkolonne med metylenklorid/etylacetat = 1:1. Smeltepunkt: 122-124°C, 0.70 g of 6-[4-(4-fluorophenylmercapto)-butoxy]-3,4-dihydrocarbostyril is suspended in 20 ml of methanol and a clear solution of 1.16 g of N-chloro-4-toluenesulfonamide sodium is added. After stirring overnight at room temperature, the methanol is distilled off. The obtained residue is chromatographed on a silica gel column with methylene chloride/ethyl acetate = 1:1. Melting point: 122-124°C,
Utbytte: 0,59 g (57% av det teoretiske).Yield: 0.59 g (57% of theoretical).
Eksempel 134 Example 134
6-[ 4-( N- 4- toluensulfonyl- 3, 4- diklorfenylsulfimino)- butoksy]-3, 4- dihydrokarbostyril 6-[ 4-( N- 4- toluenesulfonyl- 3, 4- dichlorophenylsulfimino)- butoxy]-3, 4- dihydrocarbostyril
Fremstilt analogt med eksempel 133 fra 6-[4-(3,4-diklor-fenylmerkapto)-butoksy]-3,4-dihydrokarbostyril og N-klor-4-toluensulfonamid-natrium. Prepared analogously to Example 133 from 6-[4-(3,4-dichloro-phenylmercapto)-butoxy]-3,4-dihydrocarbostyril and N-chloro-4-toluenesulfonamide sodium.
Smeltepunkt: 150-152°C,Melting point: 150-152°C,
Utbytte:' 62% av det teoretiske.Yield:' 62% of the theoretical.
. Eksempel 135 . Example 135
5- [ 4-( N- 4- toluensulfonyl- 4- bromfenylsulfimino)- butoksy]-3. 3- dimetyl- indolinon- 2 5- [ 4-( N- 4- toluenesulfonyl- 4- bromophenylsulfimino)- butoxy]-3. 3- dimethyl- indolinone- 2
Fremstilt analogt med eksempel 133 fra 5-[4-(4-bromfenyl-merkapto) -butoksy]-3,3-dimetyl-indolinon-2 og N-klor-4-toluen-sulfonamid-natrium. Prepared analogously to Example 133 from 5-[4-(4-bromophenyl-mercapto)-butoxy]-3,3-dimethyl-indolinone-2 and N-chloro-4-toluene-sulfonamide sodium.
Smeltepunkt: 163-164°C,Melting point: 163-164°C,
Utbytte: 33% av det teoretiske.Yield: 33% of the theoretical.
Eksempel 136 Example 136
6- [ 4-( N- 4- toluensulfonyl- metoksyfenylsulfimino)- butoksy]-3. 4- dihydrokarbostyril 6- [ 4-( N- 4- toluenesulfonyl- methoxyphenylsulfimino)- butoxy]-3. 4- dihydrocarbostyril
Fremstilt analogt med eksempel 133 fra 6-[4-(3-metoksy-fenylmerkapto)-butoksy]-3,4-dihydrokarbostyril og N-klor-4-toluensulfonamid-natrium. Prepared analogously to Example 133 from 6-[4-(3-methoxy-phenylmercapto)-butoxy]-3,4-dihydrocarbostyril and N-chloro-4-toluenesulfonamide sodium.
Smeltepunkt: 110-114°C,Melting point: 110-114°C,
Utbytte: 38% av det teoretiske.Yield: 38% of the theoretical.
Eksempel 137 Example 137
6-[ 4-( N- 4- toluensulfony1- fenylsulfimino)- butoksy]- 3, 4- dihydrokarbostyril 6-[ 4-( N- 4- toluenesulfony1- phenylsulfimino)- butoxy]- 3, 4- dihydrocarbostyril
Fremstilt analogt med eksempel 133 fra 6-(4-fenylmerkapto-butoksy ) -3 , 4-dihydrokarbostyril (R^-verdi = 0,45) og N-klor-4-toluensulfonamid-natrium. Prepared analogously to example 133 from 6-(4-phenylmercapto-butoxy)-3,4-dihydrocarbostyril (R^-value = 0.45) and N-chloro-4-toluenesulfonamide sodium.
Smeltepunkt: 58°C (sintring)Melting point: 58°C (sintering)
R^-verdi: 0,37 (silikagel, etylenklorid/etanol = 9:1), Utbytte: 62% av det teoretiske. R^ value: 0.37 (silica gel, ethylene chloride/ethanol = 9:1), Yield: 62% of the theoretical.
Eksempel 13. 8 Example 13. 8
6-[ 4-( N- 4- toluensulfony1- cykloheksylsulfimino)- butoksy]- 3, 4-dihydrokarbostyril 6-[ 4-( N- 4- toluenesulfony1- cyclohexylsulfimino)- butoxy]- 3, 4-dihydrocarbostyril
Fremstilt analogt med eksempel 133 fra 6-(4-cykloheksy1-merkapto-butoksy)-3,4-dihydrokarbostyril og N-klor-4-toluen-sulfonamid-natrium. Prepared analogously to Example 133 from 6-(4-cyclohexyl-mercapto-butoxy)-3,4-dihydrocarbostyril and N-chloro-4-toluenesulfonamide sodium.
Smeltepunkt: 162-163°C,Melting point: 162-163°C,
Utbytte: 53% av det teoretiske.Yield: 53% of the theoretical.
. Eksempel 139 . Example 139
6-[ 4-( N- 4- toluensulfonyl- 3, 4- diklorfenylsulfimino)- butoksy]-karbostyril 6-[ 4-( N- 4- toluenesulfonyl- 3, 4- dichlorophenylsulfimino)- butoxy]-carbostyril
Fremstilt analogt med eksempel 133 fra 6-[4-(3,4-diklor-fenylmerkapto)-butoksy]-karbostyril (R^-verdi: 0,34) og N-klor-4-toluensulfonamid-natrium. Prepared analogously to example 133 from 6-[4-(3,4-dichloro-phenylmercapto)-butoxy]-carbostyril (R^ value: 0.34) and N-chloro-4-toluenesulfonamide sodium.
R^-verdi: 0,32 (silikagelplate, etylenklorid/etanol = 9:1), Utbytte: 39% av det teoretiske. R^ value: 0.32 (silica gel plate, ethylene chloride/ethanol = 9:1), Yield: 39% of the theoretical.
Claims (5)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19813129444 DE3129444A1 (en) | 1981-07-25 | 1981-07-25 | Sulphoximides, their preparation, and medicaments containing these compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
NO822255L true NO822255L (en) | 1983-01-26 |
Family
ID=6137766
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO822255A NO822255L (en) | 1981-07-25 | 1982-06-30 | PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE SULFIMIN DERIVATIVES. |
Country Status (19)
Country | Link |
---|---|
JP (1) | JPS5824559A (en) |
KR (1) | KR840000491A (en) |
AR (1) | AR230745A1 (en) |
AU (1) | AU556082B2 (en) |
CA (1) | CA1175430A (en) |
CS (1) | CS236488B2 (en) |
DD (1) | DD202871A5 (en) |
DE (2) | DE3129444A1 (en) |
DK (1) | DK329582A (en) |
ES (4) | ES8305333A1 (en) |
FI (1) | FI822550L (en) |
GR (1) | GR76181B (en) |
HU (1) | HU188188B (en) |
NO (1) | NO822255L (en) |
PL (1) | PL137725B1 (en) |
PT (1) | PT75297A (en) |
SU (1) | SU1158041A3 (en) |
YU (1) | YU158182A (en) |
ZA (1) | ZA825273B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2247579B1 (en) * | 2008-01-17 | 2012-04-18 | Bayer Pharma Aktiengesellschaft | Sulphoximine-substituted quinazoline derivatives as immunomodulators, their preparation and use as medicaments |
-
1981
- 1981-07-25 DE DE19813129444 patent/DE3129444A1/en not_active Withdrawn
-
1982
- 1982-06-30 NO NO822255A patent/NO822255L/en unknown
- 1982-07-16 SU SU823463928A patent/SU1158041A3/en active
- 1982-07-20 YU YU01581/82A patent/YU158182A/en unknown
- 1982-07-20 FI FI822550A patent/FI822550L/en not_active Application Discontinuation
- 1982-07-21 DD DD82241832A patent/DD202871A5/en unknown
- 1982-07-21 PL PL1982237600A patent/PL137725B1/en unknown
- 1982-07-21 AR AR290035A patent/AR230745A1/en active
- 1982-07-22 CS CS825591A patent/CS236488B2/en unknown
- 1982-07-22 DK DK329582A patent/DK329582A/en not_active Application Discontinuation
- 1982-07-22 HU HU822373A patent/HU188188B/en unknown
- 1982-07-22 PT PT75297A patent/PT75297A/en unknown
- 1982-07-23 CA CA000407915A patent/CA1175430A/en not_active Expired
- 1982-07-23 ES ES514275A patent/ES8305333A1/en not_active Expired
- 1982-07-23 GR GR68840A patent/GR76181B/el unknown
- 1982-07-23 AU AU86378/82A patent/AU556082B2/en not_active Ceased
- 1982-07-23 ZA ZA825273A patent/ZA825273B/en unknown
- 1982-07-23 JP JP57128814A patent/JPS5824559A/en active Pending
- 1982-07-24 KR KR1019820003316A patent/KR840000491A/en unknown
- 1982-12-18 DE DE19823246980 patent/DE3246980A1/en not_active Withdrawn
-
1983
- 1983-01-07 ES ES518826A patent/ES518826A0/en active Granted
- 1983-01-07 ES ES518828A patent/ES518828A0/en active Granted
- 1983-01-07 ES ES518827A patent/ES8400411A1/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
ES8400412A1 (en) | 1983-10-16 |
FI822550L (en) | 1983-01-26 |
DE3129444A1 (en) | 1983-02-10 |
DE3246980A1 (en) | 1984-06-20 |
PL237600A1 (en) | 1983-03-28 |
CA1175430A (en) | 1984-10-02 |
FI822550A0 (en) | 1982-07-20 |
ES8400410A1 (en) | 1983-10-16 |
HU188188B (en) | 1986-03-28 |
KR840000491A (en) | 1984-02-22 |
JPS5824559A (en) | 1983-02-14 |
ES514275A0 (en) | 1983-04-01 |
ES518827A0 (en) | 1983-10-16 |
ES518826A0 (en) | 1983-10-16 |
ES518828A0 (en) | 1983-10-16 |
ZA825273B (en) | 1984-03-28 |
ES8400411A1 (en) | 1983-10-16 |
SU1158041A3 (en) | 1985-05-23 |
AR230745A1 (en) | 1984-06-29 |
YU158182A (en) | 1984-08-31 |
PL137725B1 (en) | 1986-07-31 |
AU8637882A (en) | 1983-04-14 |
DD202871A5 (en) | 1983-10-05 |
GR76181B (en) | 1984-08-03 |
PT75297A (en) | 1982-08-01 |
AU556082B2 (en) | 1986-10-23 |
ES8305333A1 (en) | 1983-04-01 |
DK329582A (en) | 1983-01-26 |
CS236488B2 (en) | 1985-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO860918L (en) | ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE SULPHONYLAMINOETHYL COMPOUNDS. | |
NO178695B (en) | Analogous Process for the Preparation of Therapeutically Active Sulfonamides | |
NO165237B (en) | ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE BENZEN SULPHONAMIDO-INDANYL COMPOUNDS. | |
NO177300B (en) | Analogous process for the preparation of a quinoline derivative and intermediates | |
CZ300570B6 (en) | Inhibitors of biosynthesis prostaglandin endoperoxide H synthase | |
KR20000022437A (en) | New amidino derivatives and their use as thrombin inhibitors | |
US4698344A (en) | 1-Heteroaryl-4-aryl-pyrazolin-5-ones for use as medicaments | |
US20030050310A1 (en) | Hydroxamic acid derivatives as proteinase inhibitors | |
US4148801A (en) | 3-[(Chlorophenylsulfonyl)methyl]-1,2,4-oxadiazole-5-carboxylic acid derivatives | |
NO158738B (en) | ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE BENZOKSAZIN-2-ON DERIVATIVES. | |
AU2006293867A1 (en) | Sulphonamide derivatives | |
KR102047816B1 (en) | Bisarylsulfonamides useful in the treatment of inflammation and cancer | |
NO845169L (en) | ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE BENZIMIDAZOLE DERIVATIVES | |
CA2494616A1 (en) | Furanthiazole derivatives as heparanase inhibitors | |
NO822255L (en) | PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE SULFIMIN DERIVATIVES. | |
IE52107B1 (en) | Indolinone derivatives | |
US4551464A (en) | Antithrombotic sulfoximino carbostyrils | |
NO142403B (en) | ANALOGUE PROCEDURE FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE ISOQINOLINES | |
NO152843B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PYRIMIDOPYRIMIDINES | |
NO142524B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE CYCLOHEXYLPHENYL DERIVATIVES | |
US3816424A (en) | Benzenesulfonamidopyrimidines | |
EP0145304B1 (en) | Tetrahydro-beta-carboline derivatives and process for the preparation thereof | |
NO792510L (en) | PROCEDURE FOR THE PREPARATION OF OXADIAZOLOTRIAZIN DERIVATIVES | |
SU1685934A1 (en) | 2-(2,6-dimethyl-3,5-diethoxycarbonyl-1,4-dihidropyridine-4-carbo xamido)-ethanesulphoacid sodium salt with antiaggregating activity | |
NO132094B (en) |